CN108976160B - 一种荧光探针及其制备方法和用途 - Google Patents

一种荧光探针及其制备方法和用途 Download PDF

Info

Publication number
CN108976160B
CN108976160B CN201710415036.XA CN201710415036A CN108976160B CN 108976160 B CN108976160 B CN 108976160B CN 201710415036 A CN201710415036 A CN 201710415036A CN 108976160 B CN108976160 B CN 108976160B
Authority
CN
China
Prior art keywords
probe
400mhz
nmr
yield
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710415036.XA
Other languages
English (en)
Other versions
CN108976160A (zh
Inventor
朱麟勇
杨弋
张大生
刘韧玫
鲍丙坤
林秋宁
陈显军
杨立朋
包春燕
葛一会
张晨霞
陈政达
张思铜
李宁峰
华鑫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Naying Shanghai Biotechnology Co ltd
Original Assignee
Naying Shanghai Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naying Shanghai Biotechnology Co ltd filed Critical Naying Shanghai Biotechnology Co ltd
Priority to CN201710415036.XA priority Critical patent/CN108976160B/zh
Priority to PCT/CN2018/088987 priority patent/WO2018223876A1/zh
Publication of CN108976160A publication Critical patent/CN108976160A/zh
Application granted granted Critical
Publication of CN108976160B publication Critical patent/CN108976160B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032Methine dyes, e.g. cyanine dyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036Porphyrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0039Coumarin dyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/005Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056Peptides, proteins, polyamino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • C07D491/147Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/16Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/022Boron compounds without C-boron linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0816Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring comprising Si as a ring atom
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33303Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing amino group
    • C08G65/33317Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing amino group heterocyclic
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1074Heterocyclic compounds characterised by ligands containing more than three nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1088Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1092Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1096Heterocyclic compounds characterised by ligands containing other heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/14Macromolecular compounds
    • C09K2211/1441Heterocyclic
    • C09K2211/1466Heterocyclic containing nitrogen as the only heteroatom
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6432Quenching

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

一种荧光探针及其制备方法和用途,所述荧光探针为加成激活型探针,可用于蛋白的特异性荧光标记,还可用于蛋白的定量、检测、动力学、活性研究以及细胞、组织和活体影像。

Description

一种荧光探针及其制备方法和用途
技术领域
本发明涉及一种荧光探针及其制备方法和用途。
背景技术
荧光特异性标记,是研究蛋白功能并定量的一种重要手段。和其它研究方法相比,荧光标记具有灵敏、原位、即时、可视等不可替代的优势。有机小分子荧光染料的分子结构虽然丰富,但是小分子荧光探针在蛋白特异性标记方面仍存在很多缺陷。无论游离的探针还是已标记的探针都存在同样的荧光发射,也就是说,不管标记上的还是没标记上的探针都在该体系内发射荧光。这种非特征性的荧光发射,显然是当前配体标记技术的严重缺陷。将没有标记上的探针通过洗涤的方法加以去除,是当前解决以上问题的唯一有效方法。显然,在一些需要快速,或者无法洗涤的场合,该技术的应用将受到严重限制。
假若设计一种适用于配体标记技术的荧光激活型蛋白特异标记的方法,它在未标记之前是暗的或发射非常弱的荧光,一旦它标记在蛋白上后,染料的荧光急剧增强。毫无疑问,这类设计的探针将有可能实现与荧光蛋白具有等同的特异性,不仅可以免除游离探针洗涤,大幅降低游离探针的背景干扰,而且势必拓宽此类技术的应用。设计适用于该技术的荧光激活型蛋白特异标记的方法,必须考虑一个合适的荧光失/激活机制。FRET机制首先应用于这方面的设计,在配体上额外加入荧光淬灭基团,正常情况下小分子荧光被与之相连的基团淬灭;一旦配体与化学标签结合后淬灭基团离去,实现荧光激活(Z.X.Chenet.al.J.Am.Chem.Soc.2012,124,12692—12699.)。但是,淬灭基团的引入,大大增加了探针的分子体积,使标记速度大大下降,严重限制了探针在细胞、组织中蛋白的实时跟踪与检测,并且,荧光探针与淬灭基团之间必须具有较好的能级匹配,这样使得长波长,例如,红光发射染料的FRET设计非常困难。另外,一些荧光对极性敏感的染料也被用来设计激活型探针(T.K.Liu.et.al.ACS Chem.Biol.2014,9,2359—2365.),染料处于细胞液等大极性溶剂中,探针没有荧光或者具有较弱荧光,当配体与蛋白结合,探针处于蛋白非极性口袋中,探针发射较强荧光。然而,一方面由于蛋白表面本身就存在一个极性较大的水化层,使探针的荧光增强幅度有限;另一方面,细胞或组织本身是个非常复杂的体系,各个细胞器的极性变化很大,这些都会导致极性敏感的探针在细胞或组织造影中具有很高的背景。
发明内容
本发明人发现,通过将加成激活型荧光染料与配体部分相连,可以实现特异性标记靶蛋白,并实现荧光特异性点亮,探针荧光不受其他亲核试剂的影响,从而获得了一种全新结构的荧光探针,可用于蛋白的特异性标记,标记速度快、适用范围广,能够有效用于靶蛋白的标记、跟踪、定位和定量。
本发明是通过以下技术方案来实施的:
本发明提供一种荧光探针,其特征在于,所述荧光探针包括配体部分A、任选的连接体部分B、荧光染料部分C,所述荧光染料部分C为加成激活型荧光染料基团,包括荧光团D、任选的不饱和结构部分E、双键部分F,所述配体部分A包括能够与靶蛋白特异性识别的基团。
可选地,上述的荧光探针,其具有如式(I)所示的结构,
A-B-C
(I)
其中:
配体部分A包括能够与靶蛋白特异性识别的配体基团、药物基团、小分子抑制剂基团或2-100个氨基酸组成的短肽类基团;
连接体部分B为任选存在的基团,选自亚烷基、改性亚烷基、芳基、
Figure BDA0001313456810000011
Figure BDA0001313456810000021
其中R选自氢、烷基、改性烷基或芳基。
荧光染料部分C为式(I)中的式(I-a)所示结构部分,
Figure BDA0001313456810000022
其中:
双键部分F为式(I-a)中的式(I-a-1)所示结构部分,
Figure BDA0001313456810000023
R1、R2、R3各自独立地选自氢、卤原子、硝基、氰基、羧基、酮基、酯基、酰胺基、膦酸基、膦酸酯基、磺酸基、磺酸酯基、砜基、亚砜基、芳基、杂芳基、烷基或改性烷基;可选地,R2和R3相互连接,与碳原子一起形成脂环或脂杂环;
不饱和结构部分E为任选存在的基团,其为如下式(I-b)所示的结构,为选自亚乙烯基或共轭亚烯基、亚乙炔基或共轭亚炔基、亚芳基、亚杂芳基中的至少一种,且其与D环共轭连接,并且与式(I-a-1)共轭连接,其中不饱和结构部分E所含的各氢原子任选独立地被选自卤原子、硝基、亲水性基团、烷基和改性烷基的取代基取代,所述取代基任选地相互连接构成脂环或脂杂环;
Figure BDA0001313456810000024
荧光团D选自香豆素类基团、芘类基团、氟硼二吡咯甲川类(BODIPY)基团、呫吨类基团、花箐类基团、卟啉类基团。
可选地,上述的荧光探针,其具有如式(I-I)所示的结构,
Figure BDA0001313456810000025
可选地,R2与连接体部分B相互连接形成脂环或脂杂环;可选地,R2与配体部分A相互连接形成脂环或脂杂环;
可选地,式(I-a-1)结构为如下所示:
Figure BDA0001313456810000026
可选地,上述的荧光探针,其特征在于:
所述靶蛋白为提纯品、未提纯品或存在于细胞、组织或活体的原位状态,所述靶蛋白具有亲核基团;
可选地,所述靶蛋白为二氢叶酸还原酶或其突变体、His-tag(ShoheiUchinomiya.et al.Chem.Commun.,2013,49,5022—5024.)或其突变体、激酶或其突变体、组织蛋白酶(Cysteine cathepsins)或其突变体、碳酸酐酶或其突变体、FKBP12或其突变体;
可选地,所述靶蛋白为突变的二氢叶酸还原酶L28C或W22C,或生长因子T790M;
可选地,所述亲核基团选自:巯基、羟基、氨基、咪唑、吡咯;
可选地,所述配体部分A选自甲氨基碟呤类基团、镍配体类基团、锌配体类基团、替尼类药物基团、短肽类基团、苯磺酰胺类基团、雷帕霉素类基团;
所述镍配体类基团是指与镍形成配合物的基团,例如下式3、4所示基团;
所述锌配体类基团是指与锌形成配合物的基团,例如下式5所示基团;
可选地,所述配体部分A选自下式结构:
Figure BDA0001313456810000031
可选地,所述连接体部分B选自:
Figure BDA0001313456810000032
其中R选自氢、烷基、改性烷基或芳基。
可选地,所述不饱和结构部分E选自下式(I-1)~(I-9)中的结构:
Figure BDA0001313456810000033
可选地,所述香豆素类基团的结构如式(II-I)所示:
Figure BDA0001313456810000041
其中,R6-为X0O-或N(X1)(X2)-,X0、X1、X2各自独立地选自氢、烷基和改性烷基,可选地,X1,X2相互连接为饱和或不饱和的脂杂环;
可选地,所述香豆素类基团中下式(II-I-i)所示的母核结构中,所含的各氢原子任选独立地被选自卤原子、硝基、亲水性基团、烷基和改性烷基的取代基取代,所述取代基任选地相互连接构成饱和或不饱和的脂环或脂杂环;
Figure BDA0001313456810000042
可选地,式(II-I-i)上的取代基与X0、X1或X2相互连接形成饱和或不饱和脂杂环;
所述芘类基团的结构如式(II-II)所示,其中所含的各氢原子任选独立地被选自卤原子、硝基、亲水性基团、烷基和改性烷基的取代基取代,所述取代基任选地相互连接构成饱和或不饱和的脂环或脂杂环;
Figure BDA0001313456810000043
可选地,所述氟硼二吡咯甲川类基团的结构如式(II-III)所示,其中,R7、R8各自独立地选自卤原子、烷基、改性烷基;
Figure BDA0001313456810000044
其中,式(II-III)所示氟硼二吡咯甲川类基团中的下式(II-III-i)所示母核结构中,所含的各氢原子任选独立地被选自卤原子、烷基和改性烷基的取代基取代,所述取代基任选地相互连接构成饱和或不饱和的脂环或脂杂环、芳香环或芳香杂环;
Figure BDA0001313456810000045
可选地,所述呫吨类基团的结构如式(II-IV-a)、(II-IV-b)、(II-IV-c)或(II-IV-d)所示,其中:X3、X4、X5、X6、X7各自独立地选自氢、烷基、改性烷基;X4、X5、X6、X7任选相互连接为饱和或不饱和的脂杂环;L为阴离子;X选自O、CRaRb、SiRaRb、GeRaRb、SnRaRb、Se,其中Ra、Rb各自独立地选自氢、烷基和改性烷基,可选地,Ra、Rb相互连接为脂环或脂杂环;
Figure BDA0001313456810000051
其中,所述呫吨类基团中的下式(II-IV-i)所示母核结构中,所含的各氢原子任选独立地被选自卤原子、烷基和改性烷基的取代基取代,所述取代基任选地相互连接构成饱和或不饱和的脂环或脂杂环、芳香环或芳香杂环;可选地,式(II-IV-i)上的取代基与X4、X5、X6、X7相互连接构成饱和或不饱和的脂环或脂杂环、芳香环或芳香杂环;
Figure BDA0001313456810000052
可选地,所述花箐类基团的结构如式(II-V-a)、(II-V-b)、(II-V-c)、(II-V-d)、(II-V-e)或(II-V-f)所示,其中:X、Y各自独立地选自S、O、CRcRd,其中Rc、Rd各自独立地选自氢、烷基、改性烷基;X8、X9各自独立地选自氢、烷基、改性烷基;L为阴离子;
Figure BDA0001313456810000053
其中,所述花箐类基团中的如下式(II-V-i)、(II-V-ii)或(II-V-iii)所示的母核结构中,所含的个氢原子任选独立地被选自亲水性基团、烷基、改性烷基的取代基取代,所述取代基任选地相互连接构成饱和或不饱和的脂环或脂杂环、芳香环或芳香杂环;
Figure BDA0001313456810000061
可选地,所述卟啉类基团的结构如式(II-VI-a)或(II-VI-b)所示,其中所含的各个氢原子任选独立地被选自烷基、改性烷基的取代基取代,所述取代基任选的相互连接构成饱和或不饱和的脂环或脂杂环、芳香环或芳香杂环;其中,M为金属离子;
Figure BDA0001313456810000062
可选地,上述的荧光探针,其特征在于:
所述烷基为具有1~30个碳原子的饱和脂肪族直链或支链的烷基;
所述亚烷基为具有1~30个碳原子的饱和脂肪族直链或支链的亚烷基;
所述改性烷基为烷基的任意碳原子被选自卤原子、-O-、-OH、-CO-、-NO2、-CN、-S-、-SO2-、-(S=O)-、
Figure BDA0001313456810000063
芳基(优选苯基)、亚芳基(优选亚苯基)、伯氨基、仲氨基、叔氨基、季铵盐基、饱和或不饱和的单环或双环亚环烃基、桥联脂杂环中的至少一种基团置换所得的基团,所述改性烷基具有1~30个碳原子,其碳碳单键任选独立地被碳碳双键或碳碳叁键置换;
所述改性亚烷基为亚烷基的任意碳原子被选自卤原子、-O-、-OH、-CO-、-NO2、-CN、-S-、-SO2-、-(S=O)-、
Figure BDA0001313456810000064
芳基(优选苯基)、亚芳基(优选亚苯基)、伯氨基、仲氨基、叔氨基、季铵盐基、饱和或不饱和的单环或双环亚环烃基、桥联脂杂环中的至少一种基团置换所得的基团,所述改性亚烷基具有1~30个碳原子,其碳碳单键任选独立地被碳碳双键或碳碳叁键置换;
这里所述的碳原子被置换,是指碳原子或碳原子与其上的氢原子一起被相应的基团置换。
所述脂环为饱和或不饱和的3~10元单环或多环脂环;
所述脂杂环为环上含有选自N、O、S或Si中的至少一种杂原子的饱和或不饱和的3~10元单环或多环脂杂环,所述脂杂环上含有S原子时,其任选为-S-、-SO-或-SO2-;所述脂杂环任选被卤原子、硝基、烷基、芳基、亲水性基团和改性烷基取代;
所述芳基、亚芳基或芳香环为5~10元芳香单环或芳香稠合双环;
所述杂芳基、亚杂芳基或芳香杂环为环上含有选自N、O、S或Si中的至少一种杂原子的5~10元芳香单环或芳香稠合双环;
所述卤原子各自独立地选自F、Cl、Br、I;
所述亲水性基团为羟基、磺酸基、硫酸基、磷酸基、伯氨基、仲氨基或叔氨基,或它们的盐;
所述单环亚环烃基为3~7元亚环烃基;
所述双环亚环烃基为5~7元双环亚环烃基;
所述桥联脂杂环为环上含有选自N、O、或S中的至少一种杂原子的5~20元桥联脂杂环;
所述阴离子选自:Cl-、I-、Br-、SO4 2-、ClO4 -、PF6 -
所述金属离子选自:Fe3+、Fe2+、Cu2+、Mg2+、Co2+、Zn2+、Ru2+、Sn2+
可选地,R7、R8各自独立地选自:卤原子、C1~C30烷基、C1~C30烷氧基、能包含水溶性基团的改性烷基;
可选地,R7、R8为F,或一起构成-(CH2CH2O)n-,其中,n为1~10;
可选地,式(II-III-i)中所含的各氢原子独立地被下式结构取代:
Figure BDA0001313456810000071
可选地,上述的荧光探针,其特征在于:
所述式(II-I)选自下式(II-I-1)~(II-I-6)中的结构:
Figure BDA0001313456810000072
可选地,式(I)中含下式(I-c)结构,其选自式(II-I-7)~(II-I-18)中的结构:
Figure BDA0001313456810000073
所述式(II-III)选自下式(II-III-1)~(II-III-25)中的结构:
Figure BDA0001313456810000081
可选地,所述式(II-IV-a)、(II-IV-b)、(II-IV-c)或(II-IV-d)选自下式(II-IV-1)~(II-IV-41)中的结构:
Figure BDA0001313456810000091
可选地,所述(II-V-a)、(II-V-b)、(II-V-c)、(II-V-d)、(II-V-e)或(II-V-f)选自下式(II-V-1)~(II-V-14)中的结构:
Figure BDA0001313456810000101
可选地,上述的荧光探针,其特征在于,所述荧光探针选自下式结构:
Figure BDA0001313456810000102
Figure BDA0001313456810000111
Figure BDA0001313456810000121
Figure BDA0001313456810000131
Figure BDA0001313456810000141
Figure BDA0001313456810000151
Figure BDA0001313456810000161
Figure BDA0001313456810000171
Figure BDA0001313456810000181
Figure BDA0001313456810000191
Figure BDA0001313456810000201
本发明还提供制备上述的荧光探针的方法,其特征在于,包括式(III)所示荧光染料与配体以及任选的连接体发生反应的步骤:
Figure BDA0001313456810000202
其中,Y反应后能够与连接体基团或配体键合;可选地,Y选自羧酸基、酰氯基、活性酯、磺酸基、磺酰氯、异氰酸酯、异硫氰酸酯、膦酸基。
本发明还提供一种荧光激活型蛋白特异性标记方法,其特征在于,包括以下步骤:将上述的荧光探针与靶蛋白接触,所述荧光探针的配体部分与靶蛋白发生标记反应,将荧光探针标记到靶蛋白上;可选地,所述将荧光探针标记到靶蛋白上为共价标记;
可选地,所述标记反应的反应介质选自纯蛋白溶液、细胞裂解液或靶蛋白所处在的原位介质;可选地,所述原位介质为细胞内介质、细胞器内介质、活体组织介质、血液或体液。
本发明还提供上述的荧光探针在蛋白荧光标记,蛋白的定量、检测、动力学、活性研究,以及细胞、组织、活体影像中的用途。可选地,所述蛋白包括eDHFR-I50C、eDHFR-N18C、eDHFR-N23C、eDHFR-L28C、6his-cys、cys-6his-、6his-aa-cys-、cys-1aa-6his-、6his-2aa-cys-、cys-2aa-6his-、6his-3aa-cys-、cys-3aa-6his-、6his-4aa-cys-、cys-4aa-6his-、6his-5aa-cys-。
本发明还提供一种探针试剂盒,其特征在于,包括上述的荧光探针。
可选地,所述探针试剂盒还包含生物相容性介质;可选地,所述生物相容性介质选自二甲基亚砜、缓冲剂、生理盐水中的至少一种;可选地,所述缓冲剂包括磷酸盐缓冲液。
本发明所述靶蛋白可通过现有基因工程技术制备而来,也可为来自天然蛋白。
本发明所述的具有加成激活型荧光染料是指具有荧光的荧光团与乙烯或其衍生物连接构成染料后荧光被淬灭,当乙烯或其衍生物的乙烯双键被加成后,荧光强度增强。可选地,所述的具有加成激活型荧光染料为:在25℃下,同等浓度和激发波长的条件下,染料最大荧光发射强度在加成后与加成前的荧光强度之比大于2,优选大于5,更优选大于10的有机染料分子。所述加成激活型染料的浓度的范围在1×10-7M~1×10-5M。
根据具体情况,本领域工作人员可根据需要选择对应的蛋白与配体、
本领域技术人员可利用具有相应配置的仪器设备对靶蛋白进行跟踪监测,根据需要,所用的仪器设备可包括能测试或显示荧光的设备与设施,如荧光光谱仪、荧光显微镜、共聚焦显微镜、酶标仪、流式细胞仪和活体成像仪等设备。
根据需要,操作者可以选择不同种类或发射/激发波长的染料。
根据发明一方面的实施方式,荧光探针荧光发射波长范围广。
根据本发明另一方面的实施方式,荧光探针可用于靶蛋白的特异性标记,荧光探针结合靶蛋白后荧光可以被激活,具有良好的荧光分子开关性质,而且荧光激活倍数高,荧光激活亮度高。
根据本发明另一方面的实施方式,荧光探针可以实现特异性标记细胞内靶蛋白,并且实现荧光特异性点亮,同时,探针荧光不受细胞内环境如细胞内其他亲核试剂的影响。
根据本发明另一方面的实施方式,荧光探针与靶蛋白的结合为共价结合。
根据本发明另一方面的实施方式,荧光探针的荧光强度和靶蛋白浓度具有很好的线性关系,可用于目的蛋白的定量检测,可以测定活性蛋白的含量。
根据本发明另一方面的实施方式,荧光探针可作为细胞亚细胞器标记的有力工具,例如对细胞核、线粒体、高尔基体、内质网、细胞骨架、细胞内膜、溶酶体等的标记。
根据本发明另一方面的实施方式,荧光探针的荧光不受动物内环境的影响,可以应用于活体动物体内靶蛋白的特异性标记。
根据本发明的另一方面,荧光探针可以快速标记到天然蛋白上,可以用于肿瘤的快速检测,指导手术中的肿瘤切除。
根据本发明的另一方面,荧光探针可以对组织、活体等不适宜清洗的样本进行快速造影成像。
根据本发明的另一方面,荧光探针为标记靶蛋白时几乎不产生检测信号,不干扰对样本的检测,可以实现复杂样本的快速定量检测,还可以跟踪标记反应过程的动力学过程。
附图说明
图1为不同探针标记细胞荧光图谱,其中,(1)~(12)分别为探针2、探针11、探针58、探针85、探针93、探针115、探针135、探针142、探针159、探针176、探针189、探针200的细胞标记结果图,左边为暗场荧光图,右边为明场图。A组是过表达相应蛋白标签的Hela细胞,B组是Hela-WT细胞(Hela原始细胞,未表达相应靶蛋白);
图2为不同探针与相应蛋白标签反应后的SDS-PAGE图,其中(1)~(12)分别为探针2、探针11、探针58、探针85、探针93、探针115、探针135、探针142、探针159、探针176、探针189、探针200与相应结合后的SDS-PAGE图;左边为考马斯亮蓝染色图,右边为荧光成像图。
图3~图11分别为探针2、探针4、探针53、探针55、探针84、探针90、探针115、探针129、探针141的荧光强度对相应蛋白标签浓度做的标准曲线;
图12为探针197的荧光强度与探针浓度的探针标准曲线;
图13为不同探针标记不同的细胞器的荧光图谱,其中,A组~C组分别为探针2、探针11、探针48,(1)~(7)分别为细胞核、溶酶体、线粒体、高尔基体、细胞骨架、内质网和细胞内膜;
图14为探针143用于细胞内内源性蛋白的标记实验结果荧光图谱,其中,A为空白组,B为过表达BTK蛋白(内源性蛋白)组;
图15为探针27用于活体小鼠的标记的实验结果荧光图谱,其中A为空白组肝脏,B为样品组肝脏,C为对照组肝脏;
图16为探针2用于活体斑马鱼的标记的实验结果荧光图谱,其中16(1)组为探针荧光通道,16(2)组为mKate荧光通道,16A为注射探针组,16B为未注射探针组;
图17为探针140用于活体小鼠的内源性蛋白的标记的实验结果荧光图谱,图17A为注射探针前成像结果,图17B为注射探针3小时后成像结果;
图18为反映探针2与eDHFR不同突变体的反应动力学的荧光强度随时间的变化曲线,其中I50C、N18C、N23C、L28C为eDHFR的突变体,WT为不含巯基的野生型eDHFR,buffer为探针2的磷酸盐缓冲溶液;
图19为反映探针90与his-tag不同突变体的反应动力学的荧光强度随时间的变化曲线。
具体实施方式
以下对本发明的具体实施方式进行详细说明。应当理解的是,此处所描述的具体实施方式仅用于对本
发明进行示例性说明,并不用于限制本发明。
本发明中“探针”为“荧光探针”的简写。
实施例1
Figure BDA0001313456810000221
化合物2:
化合物1(0.39g,2mmol)于100ml圆底烧瓶中,加入无水甲醇60ml溶解,加入丙二酸(0.25g,2.4mmol),催化量氯化锌,Ar保护条件下油浴加热回流过夜,次日过滤,旋转蒸发除去部分溶剂,体系放入冰箱中冷却结晶,过滤,冷乙醇冲洗三次得黄色晶体0.28g,产率61%。1H-NMR(400MHz,DMSO-d6):δ=11.96(s,1H),7.82(d,1H,J=16.0Hz)7.49(d,1H,J=7.2Hz),6.69(d,1H,J=7.2Hz),6.52(s,1H),6.48(d,1H,J=16.0Hz),6.44(s,1H)。
探针1:
化合物2(0.23g,1mmol)于25ml梨形瓶中,加入化合物3(参照公开文献C.R.Jing,V.C.Cornish.ACS Chem.Biol.,2013,8,1704—1712.)(0.40g,1.2mmol),六氟磷酸苯丙三唑-1-基-氧基三吡咯烷基磷(0.63g,1.2mmol),三乙胺(0.15g,1.5mmol),加入10ml无水二甲基甲酰胺,Ar保护条件下室温搅拌1h,反应完毕,旋转蒸干溶剂,柱色谱分离,得淡黄色晶体0.47g,产率86%。1H-NMR(400MHz,DMSO-d6):δ=11.96(s,1H),7.82(d,1H,J=16.0Hz)7.49(d,1H,J=7.2Hz),7.28(s,1H),6.69(d,1H,J=7.2Hz),6.64(s,2H),6.52(s,1H),6.48(d,1H,J=16.0Hz),6.44(s,1H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例2:
Figure BDA0001313456810000222
化合物5:
化合物4(参照文献公开方法:X.P.Zhang.et al.ACS Macro Lett.2016,5,229—233.)(0.49g,2mmol)按照化合物2的方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=11.96(s,1H),7.78(d,1H,J=16.0Hz),7.51(d,1H,J=7.2Hz),6.71(d,1H,J=7.2Hz),6.49(d,1H,J=16.0Hz),6.52(s,1H),6.44(s,1H),3.41(t,4H,J=8.2Hz),1.21(d,6H,J=8.2Hz)。
探针2:
参照探针1的合成方法,产率92%。1H-NMR(400MHz,DMSO-d6):δ=11.96(s,1H),7.78(d,1H,J=16.0Hz),7.51(d,1H,J=7.2Hz),7.28(s,1H),6.71(d,1H,J=7.2Hz),6.64(s,2H),6.49(d,1H,J=16.0Hz),6.52(s,1H),6.44(s,1H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.41(t,4H,J=8.2Hz),3.30(t,2H,J=6.0Hz),2.08(m,2H),1.21(d,6H,J=8.2Hz)。
实施例3:
Figure BDA0001313456810000231
化合物7:
化合物6(参照文献公开的方法:WO 2006023821(A2))(0.53g,2mmol)按照化合物2的合成方法,产率66%。1H-NMR(400MHz,DMSO-d6):δ=12.10(s,1H),7.76(d,1H,J=16.0Hz),7.46(d,1H,J=9.2Hz),6.84(s,1H),6.70(d,1H,J=16.0Hz),5.99(d,1H,J=9.2Hz),3.26(m,4H),2.88(t,2H,J=6.5Hz),2.75(t,2H,J=6.5Hz),1.96(m,4H)。
探针3:
按照探针1的合成方法,产率88%。1H-NMR(400MHz,DMSO-d6):δ=7.76(d,1H,J=16.0Hz),7.46(d,1H,J=9.2Hz),7.28(s,1H),6.84(s,1H),6.70(d,1H,J=16.0Hz),6.64(s,2H),5.99(d,1H,J=9.2Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),3.26(m,4H),2.88(t,2H,J=6.5Hz),2.75(t,2H,J=6.5Hz),2.08(m,2H),1.96(m,4H)。
实施例4:
Figure BDA0001313456810000232
化合物9:
化合物8(X.J Pei.et al.Analyst.2014,139,5290—5296.)(2.46g,10mmol)于250ml圆底烧瓶中,加乙醇125ml溶解,加入乙酰丙酮锰(4.23g,12mmol),加入30%双氧水50ml,油浴加热回流,反应完毕,过滤,体系倒入1000ml冷水中,过滤,滤饼真空烘干,柱色谱分离得红褐色晶体0.71g,产率31%。1H-NMR(400MHz,DMSO-d6):δ=11.46(s,1H),9.99(s,1H),7.47(dd,1H,J=2.0,11.4Hz),6.30(s,1H)。
化合物10:
参照化合物2的合成方法,产率59%。1H-NMR(400MHz,DMSO-d6):δ=11.96(s,1H),11.81(s,1H),7.82(d,1H,J=16.0Hz),7.47(dd,1H,J=2.0,11.4Hz),6.47(d,1H,J=16.0Hz),6.30(s,1H)。
探针4:
参照探针1的合成方法,产率93%。1H-NMR(400MHz,DMSO-d6):δ=11.96(s,1H),11.81(s,1H),7.82(d,1H,J=16.0Hz),7.47(dd,1H,J=2.0,11.4Hz),7.28(s,1H),6.64(s,2H),6.47(d,1H,J=16.0Hz),6.30(s,1H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例5:
Figure BDA0001313456810000241
化合物12:
化合物11(参照文献公开方法:WO 200623821(A2))(0.73g,2.0mmol)和5-醛基苯硼酸(0.37g,2.4mmol)于100ml圆底烧瓶中,加入10ml甲苯,10ml乙醇,2M K2CO3溶液2ml,反复换气三次,加入四三苯基膦钯(0.12g,0.1mmol)油浴回流6h,反应完毕,旋转蒸干溶剂,残余物溶于100ml二氯甲烷中,分别用水、饱和食盐水洗涤,有机相用无水硫酸钠干燥,旋转蒸干溶剂,柱色谱分离得红褐色产物0.51g,产率79%。1H-NMR(400MHz,CDCl3):δ=9.96(s,1H),7.51(d,2H,J=8.0Hz),7.43(d,2H,J=8.0Hz),7.22(d,1H,J=9.0Hz),6.56(d,1H,J=2.5Hz),6.51(dd,1H,J=2.5 9.0Hz),5.98(s,1H),3.41(q,4H,J=7.0Hz),1.20(t,6H,J=7.0Hz)。
化合物13:
参照化合物2的合成方法,产率71%。1H-NMR(400MHz,DMSO-d6):δ=12.10(s,1H),7.82(d,1H,J=16.0Hz),7.52(d,2H,J=8.0Hz),7.45(d,2H,J=8.0Hz),7.29(d,1H,J=9.0Hz),6.59(d,1H,J=2.5Hz),6.54(dd,1H,J=2.5 9.0Hz),6.48(d,1H,J=16.0Hz),5.99(s,1H),3.43(q,4H,J=7.0Hz),1.20(t,6H,J=7.0Hz)。
探针5:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,DMSO-d6):δ=12.10(s,1H),7.82(d,1H,J=16.0Hz),7.52(d,2H,J=8.0Hz),7.45(d,2H,J=8.0Hz),7.29(d,1H,J=9.0Hz),7.26(s,1H),6.64(s,2H),6.59(d,1H,J=2.5Hz),6.54(dd,1H,J=2.5 9.0Hz),6.48(d,1H,J=16.0Hz),5.99(s,1H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.43(q,4H,J=7.0Hz),3.30(t,2H,J=6.0Hz),2.08(m,2H),1.20(t,6H,J=7.0Hz)。
实施例6:
Figure BDA0001313456810000242
化合物15:
化合物14(参照文献公开方法:W.H.Wu.et al.Chemistry-A European Journal,2012,18,4953—4964.)按照化合物2的合成方法,产率75%。1H-NMR(400MHz,CDCl3):δ=12.03(s,1H),7.92(m,4H),7.85(d,1H,J=16.0Hz),7.81(s,1H),7.36(d,1H,J=9.0Hz),6.63(d,1H,J=8.5Hz),6.54(s,1H),6.48(d,1H,J=16.0Hz),3.47(m,4H),1.24(t,6H,J=7.0Hz)。
探针6:
参照探针1的合成方法,产率96%。1H-NMR(400MHz,DMSO-d6):δ=7.92(m,4H),7.85(d,1H,J=16.0Hz),7.81(s,1H),7.36(d,1H,J=9.0Hz),7.28(s,1H),6.67(s,2H),6.63(d,1H,J=8.5Hz),6.54(s,1H),6.48(d,1H,J=16.0Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.47(m,4H),3.30(t,2H,J=6.0Hz),2.08(m,2H),1.24(t,6H,J=7.0Hz)。
实施例7:
Figure BDA0001313456810000251
化合物17:
化合物16(L.Han.et al.Youji Huaxue,2013,33,1000-1004.)按照15的合成方法,产率67%。1H-NMR(400MHz,CDCl3):δ=11.83(s,1H),8.67(d,1H,J=16.0Hz),8.43(s,1H),7.98(d,1H,J=4.4Hz),7.86(d,1H,J=4.4Hz),7.57(d,1H,J=9.0Hz),6.83(dd,1H,J=2.4 9.0Hz),6.78(d,1H,16.0Hz),6.65(d,1H,J=2.4Hz),3.50(q,4H,J=7.2Hz),1.16(t,6H,J=7.2Hz)。
探针7:
按照探针1的合成方法,产率91%。1H-NMR(400MHz,DMSO-d6):δ=8.67(d,1H,J=16.0Hz),8.43(s,1H),7.98(d,1H,J=4.4Hz),7.86(d,1H,J=4.4Hz),7.57(d,1H,J=9.0Hz),7.29(s,1H),6.83(dd,1H,J=2.4 9.0Hz),6.78(d,1H,16.0Hz),6.65(d,1H,J=2.4Hz),6.64(s,2H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.50(q,4H,J=7.2Hz),3.30(t,2H,J=6.0Hz),2.08(m,2H),1.16(t,6H,J=7.2Hz)。
实施例8:
Figure BDA0001313456810000252
化合物19:
化合物18(按照文献公开的合成方法:M.Y.Wu.et al.Analyst,2013,138,3018—3025.)按照化合物2的合成方法,产率45%。1H-NMR(400MHz,CDCl3):δ=11.83(s,1H),8.41(s,1H),8.39(d,1H,J=11.6Hz),7.69—7.62(m,2H),7.52(d,1H,J=14.4Hz),6.88(dd,1H,J=2.4 9.2Hz),6.69(d,1H,J=2.4Hz),3.58(q,4H,J=7.2Hz),1.22(t,6H,J=7.2Hz)。
探针8:
参照探针1的合成,产率88%。1H-NMR(400MHz,DMSO-d6):δ=8.41(s,1H),8.39(d,1H,J=11.6Hz),7.69—7.62(m,2H),7.52(d,1H,J=14.4Hz),7.28(s,1H),6.88(dd,1H,J=2.4 9.2Hz),6.69(d,1H,J=2.4Hz),6.64(s,2H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.58(q,4H,J=7.2Hz),3.30(t,2H,J=6.0Hz),2.08(m,2H),1.22(t,6H,J=7.2Hz)。
实施例9:
Figure BDA0001313456810000253
化合物21:
化合物20(Poronik,Ye.M.et al.Dyes and Pigments,2006,72,199—207.)(0.42g,2.0mmol)和丙二酸环(亚)异丙酯(0.35g,2.4mmol)于100ml圆底烧瓶中,加入65ml无水乙醇溶解,加催化量的无水氯化锌,Ar保护条件下油浴加热回流过夜,反应完毕,缓慢降温,冷却结晶,过滤,冰乙醇洗三次得黄色针状晶体0.46g,产率83%。1H-NMR(400MHz,CDCl3):δ=7.54(d,1H,J=2.2Hz),6.65(d,1H,J=9.2Hz),6.51(d,1H,J=2.6Hz),3.44(q,4H,J=7.2H),2.55(s,3H),1.23(t,6H,J=7.2Hz)。
化合物22:
化合物21(0.55g,2.0mmol)和多聚甲醛(0.60g,20.0mmol)与100ml圆底烧瓶中,加入65ml无水乙醇,加入催化量无水氯化锌,Ar保护条件下油浴加热回流,反应完毕,过滤,旋转蒸干溶剂,残余物柱色谱分离,橘黄色产物0.18g,产率32%。1H-NMR(400MHz,CDCl3):δ=7.54(d,1H,J=2.2Hz),6.65(d,1H,J=9.2Hz),6.59(m,1H),6.51(d,1H,J=2.6Hz),5.61(m,1H),5.18(m,1H),3.44(q,4H,J=7.2H),1.23(t,6H,J=7.2Hz)。
探针9:
按照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=7.54(d,1H,J=2.2Hz),7.28(s,1H),6.69(s,2H),6.65(d,1H,J=9.2Hz),6.59(m,1H),6.51(d,1H,J=2.6Hz),5.61(m,1H),5.18(m,1H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.44(q,4H,J=7.2H),3.30(t,2H,J=6.0Hz),2.08(m,2H),1.23(t,6H,J=7.2Hz)。
实施例10
Figure BDA0001313456810000261
化合物24:
化合物23(按照文献公开方法:Cuerten,Beate.et al.Photochemistry andPhotobiology,2005,81,641—648.)(0.57g,3.0mmol)于100ml圆底烧瓶中,加入70ml无水丙酮,加入催化量碘,Ar保护条件下油浴加热回流,反应完毕,旋转蒸干溶剂,柱色谱分离得红褐色产物0.37g,产率45%。1H-NMR(400MHz,CDCl3):δ=7.54(d,1H,J=2.2Hz),6.84(s,1H),6.56(s,1H),3.98(s,2H),1.97(d,3H,J=1.6Hz),1.25(s,6H)。
化合物25:
化合物24(0.27g,1mmol)于100ml圆底烧瓶中,加入无水二氯甲烷65ml溶解,加入过量二氧化锰,Ar保护条件下室温搅拌过夜,反应完毕,过量,旋干滤液得固体,固体溶解于50ml无水乙醇中,加入丙二酸(0.13g,12mmol),催化量氯化锌,Ar保护条件下油浴加热回流过夜,次日过滤,旋转蒸去部分溶剂,体系放入冰箱中冷却结晶,过滤,冷乙醇冲洗三次得黄色晶体0.20g,产率65%。1H-NMR(400MHz,DMSO-d6):δ=12.37(s,1H),7.78(d,1H,J=16.0Hz),7.54(d,1H,J=2.2Hz),6.84(s,1H),6.56(s,1H),6.48(d,1H,J=16.0Hz),3.98(s,2H),1.97(d,3H,J=1.6Hz),1.25(s,6H)。
探针10:
按照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=12.37(s,1H),7.78(d,1H,J=16.0Hz),7.54(d,1H,J=2.2Hz),δ=7.28(s,1H),6.84(s,1H),6.64(s,2H),6.56(s,1H),6.48(d,1H,J=16.0Hz),4.12(t,2H,J=5.4Hz),3.98(s,2H),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H),1.97(d,3H,J=1.6Hz),1.25(s,6H)。
实施例11:
Figure BDA0001313456810000271
化合物27:
化合物27(按照文献公开方法:WO 2014025435(A2))按照化合物2的合成方法,得红褐色针状晶体,产率33%。1H-NMR(400MHz,CDCl3):δ=7.83(d,1H,J=16.0Hz),7.51(d,2H,J=4.2Hz),6.48(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),2.65(s,6H)。
探针11:
按照探针1的合成方法,产率78%。1H-NMR(400MHz,DMSO-d6):δ=7.83(d,1H,J=16.0Hz),7.51(d,2H,J=4.2Hz),7.28(s,1H),6.64(s,2H),6.48(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.65(s,6H),2.08(m,2H)。
实施例12:
Figure BDA0001313456810000272
化合物29:
化合物28(按照文献公开的方法合成:WO 2014025435(A2))(0.58g,2.0mmol)于100ml圆底烧瓶中,加无水甲苯70ml溶解,加入苯甲醛(0.21g,2.0mmol)和催化量的无水氯化锌,Ar保护条件下油浴加热回流过夜,次日体系冷却至室温,过滤,旋转蒸干溶剂,残余物溶于100ml二氯甲烷中,分别用饱和碳酸氢钠、饱和食盐水洗涤,有机相用无水硫酸钠干燥,旋转蒸干溶剂,柱色谱分离得产物0.22g,产率31%。1H-NMR(400MHz,CDCl3):δ=7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,4H,J=16.4Hz),7.06(s,1H),6.48(d,1H,J=16.0Hz),3.40(s,2H),2.23(s,3H),1.9(s,3H)。
化合物30:
化合物29(0.19g,0.5mmol)于50ml茄型瓶中,加入30ml甲醇溶解,加入氢氧化锂(24mg,1mmol),水6ml,Ar保护条件下室温搅拌,TLC板检测反应,反应完毕,体系倒入100ml二氯甲烷中,稀盐酸调pH至中性,饱和食盐水洗涤,有机相用无水硫酸钠干燥,旋转蒸干溶剂,残余物柱色谱分离得产物0.14g,产率83%。1H-NMR(400MHz,CDCl3):δ=7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,4H,J=16.4Hz),7.06(s,1H),6.48(d,1H,J=16.0Hz),3.49(s,2H),2.23(s,3H)。
化合物31:
参照化合物25的合成方法,产物经柱色谱分离得纯品,产率69%。1H-NMR(400MHz,CDCl3):δ=7.83(d,1H,J=16.0Hz),7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,4H,J=16.4Hz),7.06(s,1H),6.48(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),2.23(s,3H)。
探针12:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=7.83(d,1H,J=16.0Hz),7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,4H,J=16.4Hz),7.28(s,1H),7.06(s,1H),6.64(s,2H),6.48(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.23(s,3H),2.08(m,2H)。
实施例13:
Figure BDA0001313456810000281
化合物32:
化合物28(0.58g,2.0mmol)于100ml圆底烧瓶中,加无水甲苯70ml溶解,加入苯甲醛(0.63g,6.0mmol)和催化量的无水氯化锌,Ar保护条件下油浴加热回流过夜,次日体系冷却至室温,过滤,旋转蒸干溶剂,残余物溶于100ml二氯甲烷中,分别用饱和碳酸氢钠、饱和食盐水洗涤,有机相用无水硫酸钠干燥,旋转蒸干溶剂,柱色谱分离得产物0.82g,产率83%。1H-NMR(400MHz,CDCl3):δ=8.17(d,2H,J=7.8Hz),7.87(d,2H,J=16.4Hz),7.78(d,2H,J=16.4Hz),7.73(d,4H,J=7.6Hz),7.52(d,4H,J=7.6Hz),7.39(d,2H,J=4.4Hz),7.04(d,2H,J=4.4Hz),3.40(s,2H),2.23(s,3H),1.9(s,3H)。
化合物33:
参照化合物30的合成方法,产率67%。1H-NMR(400MHz,CDCl3):δ=8.19(d,2H,J=7.8Hz),7.87(d,2H,J=16.4Hz),7.78(d,2H,J=16.4Hz),7.73(d,4H,J=7.6Hz),7.52(d,4H,J=7.6Hz),7.39(d,2H,J=4.4Hz),7.04(d,2H,J=4.4Hz),3.70(s,2H),2.23(s,3H)。
化合物34:
参照化合物31的合成方法,产率70%。1H-NMR(400MHz,CDCl3):δ=8.19(d,2H,J=7.8Hz),7.87(d,2H,J=16.4Hz),7.83(d,1H,J=16.0Hz),7.78(d,2H,J=16.4Hz),7.73(d,4H,J=7.6Hz),7.52(d,4H,J=7.6Hz),7.39(d,2H,J=4.4Hz),7.04(d,2H,J=4.4Hz),6.51(d,1H,J=16.0Hz),3.70(s,2H),2.23(s,3H)。
探针13:
参照探针1的合成方法,产率88%。1H-NMR(400MHz,DMSO-d6):δ=8.19(d,2H,J=7.8Hz),7.87(d,2H,J=16.4Hz),7.83(d,1H,J=16.0Hz),7.78(d,2H,J=16.4Hz),7.73(d,4H,J=7.6Hz),7.52(d,4H,J=7.6Hz),7.39(d,2H,J=4.4Hz),7.28(s,1H),7.04(d,2H,J=4.4Hz),6.64(s,2H),6.51(d,1H,J=16.0Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.77(s,2H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.23(s,3H)2.08(m,2H)。
实施例14:
Figure BDA0001313456810000282
化合物35:
参照化合物29的合成方法,产率45%。1H-NMR(400MHz,CDCl3):δ=8.32(d,1H,J=16.4Hz),7.54(d,2H,J=4.2Hz),7.50(d,1H,J=16.4Hz),7.40(d,1H,J=4.8),7.29(d,1H,J=4.8Hz),7.09(d,1H,J=4.4Hz),6.40(d,2H,J=4.2Hz),3.65(s,2H),2.65(s,3H),2.01(s,3H)。
化合物36:
参照化合物30的合成方法,产率83%。1H-NMR(400MHz,CDCl3):δ=8.30(d,1H,J=16.4Hz),7.55(d,2H,J=4.2Hz),7.51(d,1H,J=16.4Hz),7.40(d,1H,J=4.8),7.29(d,1H,J=4.8Hz),7.09(d,1H,J=4.4Hz),6.40(d,2H,J=4.2Hz),3.75(s,2H),2.60(s,3H)。
化合物37:
参照化合物25的合成方法,产率56%。1H-NMR(400MHz,CDCl3):δ=8.30(d,1H,J=16.4Hz),7.81(d,1H,J=16.0Hz),7.55(d,2H,J=4.2Hz),7.51(d,1H,J=16.4Hz),7.40(d,1H,J=4.8),7.29(d,1H,J=4.8Hz),7.09(d,1H,J=4.4Hz),6.49(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),3.75(s,2H),2.60(s,3H)。
探针14:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.30(d,1H,J=16.4Hz),7.81(d,1H,J=16.0Hz),7.55(d,2H,J=4.2Hz),7.51(d,1H,J=16.4Hz),7.40(d,1H,J=4.8),7.35(s,1H),7.29(d,1H,J=4.8Hz),7.09(d,1H,J=4.4Hz),6.64(s,2H),6.49(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.75(s,2H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.60(s,3H)2.08(m,2H)。
实施例15:
Figure BDA0001313456810000291
化合物38:
参照化合物32的合成,产率78%。1H-NMR(400MHz,CDCl3):δ=8.32(d,2H,J=16.4Hz),7.56(d,2H,J=4.2Hz),7.50(d,2H,J=16.4Hz),7.40(d,2H,J=4.8),7.29(d,2H,J=4.8Hz),7.09(d,2H,J=4.4Hz),6.40(d,2H,J=4.2Hz),3.63(s,2H),2.01(s,3H)。
化合物39:
参照化合物33的合成,产率88%。1H-NMR(400MHz,CDCl3):δ=8.32(d,2H,J=16.4Hz),7.56(d,2H,J=4.2Hz),7.50(d,2H,J=16.4Hz),7.40(d,2H,J=4.8),7.29(d,2H,J=4.8Hz),7.09(d,2H,J=4.4Hz),6.40(d,2H,J=4.2Hz),3.73(s,2H)。
化合物40:
参照化合物25的合成,产率65%。1H-NMR(400MHz,CDCl3):δ=8.32(d,2H,J=16.4Hz),7.81(d,1H,J=16.0Hz),7.56(d,2H,J=4.2Hz),7.50(d,2H,J=16.4Hz),7.40(d,2H,J=4.8),7.29(d,2H,J=4.8Hz),7.09(d,2H,J=4.4Hz),6.49(s,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),3.73(s,2H)。
探针15:
参照探针1的合成,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.32(d,2H,J=16.4Hz),7.81(d,1H,J=16.0Hz),7.56(d,2H,J=4.2Hz),7.50(d,2H,J=16.4Hz),7.40(d,2H,J=4.8),7.29(d,2H,J=4.8Hz),7.25(s,1H),7.09(d,2H,J=4.4Hz),6.64(s,2H),6.49(s,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.73(s,2H)3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例16:
Figure BDA0001313456810000301
化合物41:
参照化合物32的合成,产率78%。1H-NMR(400MHz,CDCl3):δ=7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,2H),7.18(d,2H,J=4.2Hz),6.48(d,1H,J=16.0Hz),6.20(d,1H,J=4.2Hz),4.06(s,3H),3.40(s,2H),2.23(s,3H),1.9(s,3H)。
化合物42:
参照化合物33的合成,产率88%。1H-NMR(400MHz,CDCl3):δ=7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,2H),7.18(d,2H,J=4.2Hz),6.48(d,1H,J=16.0Hz),6.20(d,1H,J=4.2Hz),4.06(s,3H),3.60(s,2H),2.23(s,3H)。
化合物43:
参照化合物25的合成,产率65%。1H-NMR(400MHz,CDCl3):δ=7.81(d,1H,J=16.0Hz),7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,2H),7.18(d,2H,J=4.2Hz),6.72(d,1H,J=16.0Hz),6.48(d,1H,J=16.0Hz),6.20(d,1H,J=4.2Hz),4.06(s,3H),2.23(s,3H)。
探针16:
参照探针1的合成,产率89%。1H-NMR(400MHz,DMSO-d6):δ=7.81(d,1H,J=16.0Hz),7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,2H),7.28(s,1H),7.18(d,2H,J=4.2Hz),6.72(d,1H,J=16.0Hz),6.64(s,2H),6.48(d,1H,J=16.0Hz),6.20(d,1H,J=4.2Hz),4.12(t,2H,J=5.4Hz),4.06(s,3H),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.23(s,3H),2.08(m,2H)。
实施例17:
Figure BDA0001313456810000302
化合物44:
参照化合物32的合成,产率78%。1H-NMR(400MHz,CDCl3):δ=7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,2H),7.18(d,2H,J=4.2Hz),6.48(d,1H,J=16.0Hz),6.20(d,1H,J=4.2Hz),3.40(s,2H),2.96(s,6H),2.23(s,3H),1.9(s,3H)。
化合物45:
参照化合物33的合成,产率88%。1H-NMR(400MHz,CDCl3):δ=7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,2H),7.18(d,2H,J=4.2Hz),6.48(d,1H,J=16.0Hz),6.20(d,1H,J=4.2Hz),3.71(s,2H),2.96(s,6H),2.23(s,3H),1.9(s,3H)。
化合物46:
参照化合物25的合成,产率65%。1H-NMR(400MHz,CDCl3):δ=7.83(d,1H,J=16.0Hz),7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,2H),7.18(d,2H,J=4.2Hz),6.52(d,1H,J=16.0Hz),6.48(d,1H,J=16.0Hz),6.20(d,1H,J=4.2Hz),2.96(s,6H),2.23(s,3H)。
探针17:
参照探针1的合成,产率89%。1H-NMR(400MHz,DMSO-d6):δ=7.83(d,1H,J=16.0Hz),7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,2H),7.28(s,1H),7.18(d,2H,J=4.2Hz),6.64(s,2H),6.52(d,1H,J=16.0Hz),6.48(d,1H,J=16.0Hz),6.20(d,1H,J=4.2Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.96(s,6H),2.23(s,3H),2.08(m,2H)。
实施例18:
Figure BDA0001313456810000311
化合物47:
参照化合物32的合成方法,产率83%。1H-NMR(400MHz,CDCl3):δ=7.87(d,2H,J=16.4Hz),7.78(d,2H,J=16.4Hz),7.73(d,4H,J=7.6Hz),7.52(d,4H,J=7.6Hz),7.39(d,2H,J=4.4Hz),7.04(d,2H,J=4.4Hz),3.40(s,2H),2.91(s,6H),2.23(s,3H),1.9(s,3H)。
化合物48:
参照化合物30的合成方法,产率67%。1H-NMR(400MHz,CDCl3):δ=7.87(d,2H,J=16.4Hz),7.78(d,2H,J=16.4Hz),7.73(d,4H,J=7.6Hz),7.52(d,4H,J=7.6Hz),7.39(d,2H,J=4.4Hz),7.04(d,2H,J=4.4Hz),3.90(s,2H),2.91(s,6H),2.23(s,3H)。
化合物49:
参照化合物31的合成方法,产率70%。1H-NMR(400MHz,CDCl3):δ=7.87(d,2H,J=16.4Hz),7.78(d,2H,J=16.4Hz),7.73(d,4H,J=7.6Hz),7.52(d,4H,J=7.6Hz),7.39(d,2H,J=4.4Hz),7.04(d,2H,J=4.4Hz),3.90(s,2H),2.91(s,6H),2.23(s,3H)。
探针18:
参照探针1的合成方法,产率88%。1H-NMR(400MHz,DMSO-d6):δ=7.87(d,2H,J=16.4Hz),7.78(d,2H,J=16.4Hz),7.73(d,4H,J=7.6Hz),7.52(d,4H,J=7.6Hz),7.39(d,2H,J=4.4Hz),7.28(s,1H),7.04(d,2H,J=4.4Hz),6.64(s,2H),4.12(t,2H,J=5.4Hz),3.90(s,2H),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.91(s,6H),2.23(s,3H),2.08(m,2H)。
实施例19:
Figure BDA0001313456810000312
化合物50:
参照化合物32的合成,产率71%。1H-NMR(400MHz,CDCl3):δ=8.32(d,1H,J=16.4Hz),7.54(d,2H,J=4.2Hz),7.50(d,1H,J=16.4Hz),7.45(d,1H,J=4.8),7.20(d,1H,J=4.8Hz),7.09(d,1H,J=4.4Hz),6.40(d,2H,J=4.2Hz),3.65(s,2H),2.65(s,3H),2.01(s,3H)。
化合物51:
参照化合物33的合成,产率84%。1H-NMR(400MHz,CDCl3):δ=8.32(d,1H,J=16.4Hz),7.54(d,2H,J=4.2Hz),7.50(d,1H,J=16.4Hz),7.45(d,1H,J=4.8),7.20(d,1H,J=4.8Hz),7.09(d,1H,J=4.4Hz),6.40(d,2H,J=4.2Hz),3.95(s,2H),2.65(s,3H)。
化合物52:
参照化合物25的合成,产率69%。1H-NMR(400MHz,CDCl3):δ=8.32(d,1H,J=16.4Hz),7.81(d,1H,J=16.0Hz),7.54(d,2H,J=4.2Hz),7.50(d,1H,J=16.4Hz),7.45(d,1H,J=4.8),7.20(d,1H,J=4.8Hz),7.09(d,1H,J=4.4Hz),6.53(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),2.65(s,3H)。
探针19:
参照探针1的合成,产率79%。1H-NMR(400MHz,DMSO-d6):δ=8.32(d,1H,J=16.4Hz),7.81(d,1H,J=16.0Hz),7.54(d,2H,J=4.2Hz),7.50(d,1H,J=16.4Hz),7.45(d,1H,J=4.8),7.28(s,1H),7.20(d,1H,J=4.8Hz),7.09(d,1H,J=4.4Hz),6.64(s,2H),6.53(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.65(s,3H),2.08(m,2H)。
实施例20:
Figure BDA0001313456810000321
化合物53:
2-苯基吡咯(0.3g,2.1mmol)于100ml圆底烧瓶中,加入35ml干燥二氯甲烷溶解,加入乙酰氧基乙酰氯(0.14ml,1.3mmol),Ar保护条件下40℃油浴加热,2h后冷却至室温,加入DIEA(0.73ml,4.2mmol)搅拌15分钟,加入三氟化硼乙醚溶液(0.53ml,4.2mmol),体系室温条件下搅拌30分钟,倒入10ml水淬灭反应,饱和食盐水洗涤有机相,旋转蒸干溶剂,残余物柱色谱分离,得红褐色晶体0.44g,产率49%。1H-NMR(400MHz,CDCl3):δ=7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.44-7.47(m,6H),6.83(d,2H,J=4.4Hz),5.22(s,2H),2.09(s,3H)。
化合物54:
参照化合物33的合成,产率84%。1H-NMR(400MHz,CDCl3):δ=7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.44-7.47(m,6H),6.83(d,2H,J=4.4Hz),5.52(s,2H)。
化合物55:
参照化合物25的合成,产率69%。1H-NMR(400MHz,CDCl3):δ=8.01(d,1H,J=16.0Hz),7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.44-7.47(m,6H),6.83(d,2H,J=4.4Hz),6.48(d,1H,J=16.0Hz)。
探针20:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.44-7.47(m,6H),7.28(s,1H),6.83(d,2H,J=4.4Hz),6.64(s,2H),6.48(d,1H,J=16.0Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例20:
Figure BDA0001313456810000331
化合物56:
参照化合物53的合成方法,产率49%。1H-NMR(400MHz,CDCl3):δ=6.99(d,2H,J=8.8Hz),6.97(d,4H,J=8.8Hz),6.89(d,2H,J=4.4Hz),6.62(d,2H,J=4.4Hz),5.31(s,2H),3.86(s,6H),2.01(s,3H)。
化合物57:
参照化合物33的合成,产率84%。1H-NMR(400MHz,CDCl3):δ=6.99(d,2H,J=8.8Hz),6.97(d,4H,J=8.8Hz),6.89(d,2H,J=4.4Hz),6.62(d,2H,J=4.4Hz),5.46(s,2H),3.86(s,6H)。
化合物58:
参照化合物25的合成,产率69%。1H-NMR(400MHz,CDCl3):δ=7.81(d,1H,J=16.0Hz),6.99(d,2H,J=8.8Hz),6.97(d,4H,J=8.8Hz),6.89(d,2H,J=4.4Hz),6.72(d,1H,J=16.0Hz),6.62(d,2H,J=4.4Hz),3.86(s,6H)。
探针21:
参照探针1的合成,产率87%。1H-NMR(400MHz,DMSO-d6):δ=7.81(d,1H,J=16.0Hz),7.28(s,1H),6.99(d,2H,J=8.8Hz),6.97(d,4H,J=8.8Hz),6.89(d,2H,J=4.4Hz),6.72(d,1H,J=16.0Hz),6.64(s,2H),6.62(d,2H,J=4.4Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.81(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例22:
Figure BDA0001313456810000332
化合物59:
参照化合物54的合成方法,产率49%。1H-NMR(400MHz,CDCl3):δ=7.76(dd,2H,J=1.0 3.6Hz),7.51(dd,2H,J=3.6 5.4Hz),7.15(dd,2H,J=3.6 5.4Hz),6.89(d,2H,J=4.4Hz),6.62(d,2H,J=4.4Hz),5.20(s,2H),2.01(s,3H)。
化合物60:
参照化合物33的合成,产率84%。1H-NMR(400MHz,CDCl3):δ=7.76(dd,2H,J=1.03.6Hz),7.51(dd,2H,J=3.6 5.4Hz),7.15(dd,2H,J=3.6 5.4Hz),6.89(d,2H,J=4.4Hz),6.62(d,2H,J=4.4Hz),5.37(s,2H)。
化合物61:
参照化合物25的合成,产率69%。1H-NMR(400MHz,CDCl3):δ=7.81(d,1H,J=16.0Hz),7.76(dd,2H,J=1.0 3.6Hz),7.51(dd,2H,J=3.6 5.4Hz),7.15(dd,2H,J=3.65.4Hz),6.89(d,2H,J=4.4Hz),6.64(d,1H,J=16.0Hz),6.62(d,2H,J=4.4Hz)。
探针22:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,DMSO-d6):δ=7.81(d,1H,J=16.0Hz),7.76(dd,2H,J=1.0 3.6Hz),7.51(dd,2H,J=3.6 5.4Hz),7.28(s,1H),7.15(dd,2H,J=3.6 5.4Hz),6.89(d,2H,J=4.4Hz),6.62(d,2H,J=4.4Hz),6.64(d,1H,J=16.0Hz),6.54(s,2H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例23:
Figure BDA0001313456810000341
化合物62:
参照化合物54的合成方法,产率49%。1H-NMR(400MHz,CDCl3):δ=7.83(d,2H,J=7.8Hz),7.44(m,4H),7.03(d,2H,J=7.2Hz),6.30(d,2H,J=4.2Hz),5.21(s,2H),2.03(s,3H)。
化合物63:
参照化合物33的合成,产率84%。1H-NMR(400MHz,CDCl3):δ=7.83(d,2H,J=7.8Hz),7.44(m,4H),7.03(d,2H,J=7.2Hz),6.30(d,2H,J=4.2Hz),5.25(s,2H)。
化合物64:
参照化合物25的合成,产率69%。1H-NMR(400MHz,CDCl3):δ=7.83(d,2H,J=7.8Hz),7.78(d,1H,J=16.0Hz),7.44(m,4H),7.03(d,2H,J=7.2Hz),6.30(d,2H,J=4.2Hz)。
探针23:
参照探针1的合成方法,产率87%。1H-NMR(400MHz,DMSO-d6):δ=7.83(d,2H,J=7.8Hz),7.78(d,1H,J=16.0Hz),7.44(m,4H),7.03(d,2H,J=7.2Hz),7.28(s,1H),6.64(s,2H),6.30(d,2H,J=4.2Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例24:
Figure BDA0001313456810000342
化合物65:
参照化合物54的合成方法,产率49%。1H-NMR(400MHz,CDCl3):δ=6.83(d,2H,J=5.6Hz),6.71(d,2H,J=5.6H),6.40(s,2H),5.20(s,2H),2.02(s,3H)。
化合物66:
参照化合物33的合成,产率84%。1H-NMR(400MHz,CDCl3):δ=6.83(d,2H,J=5.6Hz),6.71(d,2H,J=5.6H),6.40(s,2H),5.31(s,2H)。
化合物67:
参照化合物25的合成,产率69%。1H-NMR(400MHz,CDCl3):δ=7.81(d,1H,J=16.0Hz),6.83(d,2H,J=5.6Hz),6.71(d,2H,J=5.6H),6.61(d,1H,J=16.0Hz),6.40(s,2H)。
探针24:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=7.81(d,1H,J=16.0Hz),7.28(s,1H),6.83(d,2H,J=5.6Hz),6.71(d,2H,J=5.6H),6.64(s,2H),6.61(d,1H,J=16.0Hz),6.40(s,2H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例25:
Figure BDA0001313456810000351
化合物68:
化合物28(0.292g,1.0mmol)于50ml圆底烧瓶,加入无水二氯甲烷30ml溶解,Ar保护条件下加入三氟甲基磺酸三甲基硅脂(0.266g,1.2mmol)室温搅拌5分钟,加入甲醇1ml,室温搅拌2小时,反应完毕,加水1ml淬灭反应,分出有机相,无水硫酸钠干燥,旋转蒸干溶剂,残余物柱色谱分离得产物0.17g,产率65%。1H-NMR(400MHz,CDCl3):δ=7.18(d,2H,J=4.2Hz),6.30(d,2H,J=4.2Hz),5.22(s,2H),3.69(s,3H),2.62(s,6H),2.09(s,3H)。
化合物69:
参照化合物33的合成方法,产率65%。1H-NMR(400MHz,CDCl3):δ=7.18(d,2H,J=4.2Hz),6.30(d,2H,J=4.2Hz),5.42(s,2H),3.69(s,3H),2.62(s,6H)。
化合物70:
参照化合物25的合成方法,产率55%。1H-NMR(400MHz,CDCl3):δ=7.83(d,1H,J=16.0Hz),7.18(d,2H,J=4.2Hz),6.83(d,1H,J=16.0Hz),6.30(d,2H,J=4.2Hz),3.69(s,3H),2.62(s,6H)。
探针25:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=7.83(d,1H,J=16.0Hz),7.28(s,1H),7.18(d,2H,J=4.2Hz),6.83(d,1H,J=16.0Hz),6.64(s,2H),6.30(d,2H,J=4.2Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.69(s,3H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.62(s,6H),2.08(m,2H)。
实施例26:
Figure BDA0001313456810000352
化合物71:
参照化合物54的合成方法,产率45%。1H-NMR(400MHz,CDCl3):δ=7.18(d,2H,J=4.2Hz),6.30(d,2H,J=4.2Hz),5.22(s,2H),2.09(s,3H)。
化合物72:
化合物70(0.332g,1.0mmol)于100ml圆底烧瓶中,加入三乙胺(0.244g,2.4mmol),巯基乙醇(0.248g,4.0mmol),加入50ml无水二氯甲烷溶解,Ar保护条件下室温搅拌,反应完毕,体系倒入100ml水中,二氯甲烷萃取,合并有机相,无水硫酸钠干燥,旋转蒸干溶剂,柱色谱分离得产物0.31g,产率81%。1H-NMR(400MHz,CDCl3):δ=7.18(d,2H,J=4.2Hz),6.30(d,2H,J=4.2Hz),5.22(s,2H),2.90(q,4H,J=5.6Hz),2.09(s,3H),1.21(t,6H,J=5.6Hz)。
化合物73:
参照化合物33的合成方法,产率79%。1H-NMR(400MHz,CDCl3):δ=7.18(d,2H,J=4.2Hz),6.30(d,2H,J=4.2Hz),5.42(s,2H),2.90(q,4H,J=5.6Hz),1.21(t,6H,J=5.6Hz)。
化合物74:
参照化合物25的合成方法,产率64%。1H-NMR(400MHz,CDCl3):δ=7.83(d,1H,J=16.0Hz),7.18(d,2H,J=4.2Hz),6.71(d,1H,J=16.0Hz),6.30(d,2H,J=4.2Hz),2.90(q,4H,J=5.6Hz),1.21(t,6H,J=5.6Hz)。
探针26:
参照探针1的合成方法,产率92%。1H-NMR(400MHz,DMSO-d6):δ=7.83(d,1H,J=16.0Hz),7.28(s,1H),7.18(d,2H,J=4.2Hz),6.71(d,1H,J=16.0Hz),6.64(s,2H),6.30(d,2H,J=4.2Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.90(q,4H,J=5.6Hz),2.08(m,2H),1.21(t,6H,J=5.6Hz)。
实施例27:
Figure BDA0001313456810000361
化合物75:
化合物70(0.332g,1.0mmol)于100ml圆底烧瓶中,加入三乙胺(0.244g,2.4mmol),甲醇1ml,加入50ml无水二氯甲烷溶解,Ar保护条件下室温搅拌,反应完毕,体系倒入100ml水中,二氯甲烷萃取,合并有机相,无水硫酸钠干燥,旋转蒸干溶剂,柱色谱分离得产物0.31g,产率81%。1H-NMR(400MHz,CDCl3):δ=7.18(d,2H,J=4.2Hz),6.30(d,2H,J=4.2Hz),5.22(s,2H),3.90(s,6H),2.09(s,3H)。
化合物76:
参照化合物33的合成方法,产率78%。1H-NMR(400MHz,CDCl3):δ=7.18(d,2H,J=4.2Hz),6.30(d,2H,J=4.2Hz),5.42(s,2H),3.90(s,6H)。
化合物77:
参照化合物25的合成方法,产率56%。1H-NMR(400MHz,CDCl3):δ=7.83(d,1H,J=16.0Hz),7.18(d,2H,J=4.2Hz),6.83(d,1H,J=16.0Hz),6.30(d,2H,J=4.2Hz),5.42(s,2H),3.90(s,6H)。
探针27:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=7.83(d,1H,J=16.0Hz),7.28(s,1H),7.18(d,2H,J=4.2Hz),6.83(d,1H,J=16.0Hz),6.64(s,2H),6.30(d,2H,J=4.2Hz),5.42(s,2H),4.12(t,2H,J=5.4Hz),3.90(s,6H),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例28:
Figure BDA0001313456810000371
化合物78:
化合物71(0.464g,1.4mmol)于100ml圆底烧瓶,加入苯乙炔(0.8ml,7.1mmol),1.6M正丁基锂(4.5ml,7.1mmol),溴化锌(1.6g,7.1mmol),二氯二四三苯基膦钯(0.1g,0.14mmol),加无水甲苯75ml,Ar保护条件下,室温搅拌,反应完毕,旋转蒸干溶剂,残余物柱色谱分离的产物0.42g,产率65%。1H-NMR(400MHz,CDCl3):δ=7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.44-7.47(m,6H),6.83(d,2H,J=4.4Hz),5.22(s,2H),2.09(s,3H)。
化合物79:
参照化合物33的合成,产率78%。1H-NMR(400MHz,CDCl3):δ=7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.44-7.47(m,6H),6.83(d,2H,J=4.4Hz),5.52(s,2H)。
化合物80:
参照化合物25的合成,产率56%。1H-NMR(400MHz,CDCl3):δ=8.01(d,1H,J=16.0Hz),7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.44-7.47(m,6H),6.83(d,2H,J=4.4Hz),6.48(d,1H,J=16.0Hz)。
探针28:
参照探针1的合成,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.44-7.47(m,6H),7.28(s,1H),6.83(d,2H,J=4.4Hz),6.64(s,2H),6.48(d,1H,J=16.0Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例29:
Figure BDA0001313456810000372
化合物81:
4’-甲氧基-2-苯基吡咯(0.35g,2.0mmol)于100ml圆底烧瓶中,加入干燥二氯甲烷60ml溶解,冷却至-30℃,加入乙酰氧基乙酰氯(0.22ml,2mmol),Ar保护条件下缓慢升至室温,反应完毕,加入1ml水淬灭反应,体系倒入50ml水中,分出有机相,30ml二氯甲烷萃取水相,合并有机相,无水硫酸钠干燥,旋转蒸干溶剂,残余物柱色谱分离地产物0.355g,产率65%。1H-NMR(400MHz,CDCl3):δ=7.81(d,2H,J=7.2Hz),7.16(d,2H,J=7.2Hz),6.86(d,1H,J=5.4Hz),6.64(d,1H,J=5.4Hz),5.22(s,2H),2.02(s,3H)。
化合物82:
化合物81(0.273g,1.0mmol)于100ml三口瓶中,加入50ml二氯甲烷,Ar保护条件下加入2-甲基吡咯,然后注入0.2ml三氯氧磷,室温搅拌6小时,冰浴条件下注入1ml二异丙基乙胺,搅拌30分钟,加入2ml三氟化硼乙醚溶液,室温搅拌30分钟,加水5ml淬灭反应,体系倒入50ml水中,分出有机相,水相用二氯甲烷萃取,合并有机相,无水硫酸钠干燥,旋转蒸干溶剂,残余物柱色谱分离得产物0.15g,产率39%。1H-NMR(400MHz,CDCl3):δ=7.81(d,2H,J=7.2Hz),7.16(d,2H,J=7.2Hz),6.86(d,1H,J=5.4Hz),6.79(d,1H,J=7.2Hz),6.71(d,1H,J=7.2Hz),6.64(d,1H,J=5.4Hz),5.22(s,2H),2.65(s,3H),2.02(s,3H)。
化合物83:
参照化合物33的合成方法,产率79%。1H-NMR(400MHz,CDCl3):δ=7.81(d,2H,J=7.2Hz),7.16(d,2H,J=7.2Hz),6.86(d,1H,J=5.4Hz),6.79(d,1H,J=7.2Hz),6.71(d,1H,J=7.2Hz),6.64(d,1H,J=5.4Hz),5.52(s,2H),2.65(s,3H)。
化合物84:
参照化合物25的合成方法,产率56%。1H-NMR(400MHz,CDCl3):δ=8.01(d,1H,J=16.0Hz),7.81(d,2H,J=7.2Hz),7.16(d,2H,J=7.2Hz),6.86(d,1H,J=5.4Hz),6.79(d,1H,J=7.2Hz),6.71(d,1H,J=7.2Hz),6.64(d,1H,J=5.4Hz),6.40(d,1H,J=16.0Hz),5.52(s,2H),2.65(s,3H)。
探针29:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.81(d,2H,J=7.2Hz),7.28(s,1H),6.64(s,2H),7.16(d,2H,J=7.2Hz),6.86(d,1H,J=5.4Hz),6.79(d,1H,J=7.2Hz),6.71(d,1H,J=7.2Hz),6.64(d,1H,J=5.4Hz),6.40(d,1H,J=16.0Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.65(s,3H),2.08(m,2H)。
实施例30:
Figure BDA0001313456810000381
化合物85:
参照化合物29的合成方法,产率78%。1H-NMR(400MHz,CDCl3):δ=8.21(m,2H),7.81(d,2H,J=7.2Hz),7.16(d,2H,J=7.2Hz),6.99(d,1H,J=7.2Hz),6.86(d,1H,J=5.4Hz),6.79(d,1H,J=7.2Hz),6.81(d,1H,J=7.2Hz),6.71(d,1H,J=7.2Hz),6.64(d,1H,J=5.4Hz),6.41(d,1H,J=7.2Hz),5.22(s,2H),2.65(s,3H),2.02(s,3H)。
化合物86:
参照化合物33的合成方法,产率78%。1H-NMR(400MHz,CDCl3):δ=8.21(m,2H),7.81(d,2H,J=7.2Hz),7.16(d,2H,J=7.2Hz),6.99(d,1H,J=7.2Hz),6.86(d,1H,J=5.4Hz),6.79(d,1H,J=7.2Hz),6.81(d,1H,J=7.2Hz),6.71(d,1H,J=7.2Hz),6.64(d,1H,J=5.4Hz),6.41(d,1H,J=7.2Hz),5.42(s,2H)。
化合物87:
参照探针35的合成方法,产率56%。1H-NMR(400MHz,CDCl3):δ=8.21(m,2H),8.01(d,1H,J=16.0Hz),7.81(d,2H,J=7.2Hz),7.16(d,2H,J=7.2Hz),6.99(d,1H,J=7.2Hz),6.86(d,1H,J=5.4Hz),6.79(d,1H,J=7.2Hz),6.81(d,1H,J=7.2Hz),6.71(d,1H,J=7.2Hz),6.64(d,1H,J=5.4Hz),6.59(d,1H,J=16.0Hz),6.41(d,1H,J=7.2Hz),5.42(s,2H)。
探针30:
参照探针1的合成方法,产率61%。1H-NMR(400MHz,DMSO-d6):δ=8.21(m,2H),8.01(d,1H,J=16.0Hz),7.81(d,2H,J=7.2Hz),7.28(s,1H),7.16(d,2H,J=7.2Hz),6.99(d,1H,J=7.2Hz),6.86(d,1H,J=5.4Hz),6.79(d,1H,J=7.2Hz),6.81(d,1H,J=7.2Hz),6.71(d,1H,J=7.2Hz),6.69(s,2H),6.64(d,1H,J=5.4Hz),6.59(d,1H,J=16.0Hz),6.41(d,1H,J=7.2Hz),5.42(s,2H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例31:
Figure BDA0001313456810000391
化合物89:
化合物88(Qing Miao et al.,Chem Commun.2009,2541—2543.)按照化合物2的合成方法,产率61%。1H-NMR(400MHz,CDCl3):δ=8.01(d,1H,J=16.0Hz),7.95(d,2H,J=8.2Hz),7.68(d,2H,J=8.2Hz),6.70(d,2H,J=4.0Hz),6.61(d,1H,J=16.0Hz),6.33(d,2H,J=4.0Hz),2.64(s,6H)。
探针31:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.95(d,2H,J=8.2Hz),7.68(d,2H,J=8.2Hz),6.70(d,2H,J=4.0Hz),6.61(d,1H,J=16.0Hz),6.33(d,2H,J=4.0Hz),2.64(s,6H)。
实施例32:
Figure BDA0001313456810000392
化合物90:
参照化合物80的方法,产率16%。1H-NMR(400MHz,CDCl3):δ=8.31(d,1H,J=16.4Hz),7.81(d,2H,J=7.2Hz),7.53(d,2H,J=16.4Hz),7.16(d,2H,J=7.2Hz),6.86(d,1H,J=5.4Hz),6.64(d,1H,J=5.4Hz),3.69(s,3H)。
化合物91:
参照化合物82的合成方法,产率35%。1H-NMR(400MHz,CDCl3):δ=8.31(d,1H,J=16.4Hz),7.81(d,2H,J=7.2Hz),7.53(d,2H,J=16.4Hz),7.16(d,2H,J=7.2Hz),6.86(d,1H,J=5.4Hz),6.75(d,1H,J=4.8Hz),6.64(d,1H,J=5.4Hz),6.51(d,1H,J=4.8Hz),3.69(s,3H),2.62(t,2H,J=1.8Hz),2.0(t,2H,J=1.8Hz)。
探针32:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,CDCl3):δ=8.31(d,1H,J=16.4Hz),7.81(d,2H,J=7.2Hz),7.53(d,2H,J=16.4Hz),7.28(s,1H),7.16(d,2H,J=7.2Hz),6.86(d,1H,J=5.4Hz),6.75(d,1H,J=4.8Hz),6.69(s,2H),6.64(d,1H,J=5.4Hz),6.51(d,1H,J=4.8Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.69(s,3H),3.30(t,2H,J=6.0Hz),2.62(t,2H,J=1.8Hz),2.18(m,2H),2.0(t,2H,J=1.8Hz)。
实施例33:
Figure BDA0001313456810000401
化合物92:
间苯二酚(11.0g,0.1mol)于100ml圆底烧瓶中,加入顺丁烯二酸酐(4.9g,0.05mol),小心加入50ml浓硫酸,氩气保护条件下150℃油浴加热6h,反应完毕,冷却至室温,加入200g碎冰中,过滤,滤饼用冰乙醇洗涤两次,干燥,乙醇重结:得产物16.07g,产率57%。1H-NMR(400MHz,DMSO-d6):δ=8.10(s,1H),7.92(s,1H),7.59(d,2H,J=8.8H),6.56(d,2H,J=8.8H),6.48(s,2H)。
探针33
参照探针1的合成方法,产率88%。1H-NMR(400MHz,DMSO-d6):δ=11.2(s,1H),8.10(s,1H),7.92(s,1H),7.59(d,2H,J=8.8H),7.28(s,1H),6.64(s,2H),6.56(d,2H,J=8.8H),6.48(s,2H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例34:
Figure BDA0001313456810000402
化合物94:
化合物93(按照文献公开方法:M.P.Angela et al.Chem.Eur.J.2014,20,447—455.)(0.467g,1mmol)于50ml圆底烧瓶中,加入无水四氢呋喃30ml,Ar保护条件下加入1M乙烯基氯化镁(1.5ml,1.5mmol),室温搅拌3h,反应完毕,加水1ml淬灭反应,用6M盐酸调为pH=3.0,室温搅拌3h,旋转蒸干溶剂,残余物过柱的产物0.23g,产率98%。1H-NMR(400MHz,DMSO-d6):δ=8.28(d,2H,J=9.4Hz),7.56(d,1H,J=9.4Hz),7.39(dd,2H,J=9.2 2.2Hz),7.37(d,2H,J=2.2Hz),6.0(s,1H),5.38(s,1H)。
化合物95:
化合物94(0.24g,1.0mmol)溶于50ml水中,加入氢氧化钠(0.08g,2.0mmol)溶解,加入溴乙酸(0.21g,1.5mmol),Ar保护条件下室温搅拌2h,反应完毕用3M的稀盐酸调为酸性,二氯甲烷萃取三次,合并有机相,无水硫酸钠干燥,旋转蒸干溶剂,残余物柱色谱分离的产物0.23g,产率78%。1H-NMR(400MHz,DMSO-d6):δ=8.28(d,2H,J=9.4Hz),7.56(d,1H,J=9.4Hz),7.39(dd,2H,J=9.2 2.2Hz),7.37(d,2H,J=2.2Hz),6.0(s,1H),5.38(s,1H)4.81(s,2H)。
探针34:
参照探针1的合成方法,产率93%。1H-NMR(400MHz,DMSO-d6):δ=8.28(d,2H,J=9.4Hz),7.56(d,1H,J=9.4Hz),7.39(dd,2H,J=9.2 2.2Hz),7.31(d,2H,J=2.2Hz),7.28(s,1H),6.64(s,2H),6.0(s,1H),5.38(s,1H)4.81(s,2H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例35:
Figure BDA0001313456810000411
化合物97:
化合物96(参照文献公开方法:Pant Umesh C et al.Indian Journal ofChemistry,Section B.1987,26,947—950.)(2.08g,10.0mmol)于250ml圆底烧瓶中,加入N,N-二甲基间氨基酚(2.74g,20.0mmol)小心加入50ml 85%硫酸,氩气保护条件下120℃油浴加热2h,反应完毕,冷却至室温,加入200g碎冰中,过滤,滤饼用冰乙醇洗涤两次,干燥,固体经柱色谱分离得产物3.71g,产率12%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.61(d,2H,J=9.6Hz),6.69(d,2H,J=9.6Hz),6.51(s,1H),6.45(d,1H,J=16.0Hz),6.38(s,1H),3.45(s,6H)。
探针35:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.61(d,2H,J=9.6Hz),7.28(s,1H),6.69(d,2H,J=9.6Hz),6.64(s,2H),6.51(s,1H),6.45(d,1H,J=16.0Hz),6.38(s,1H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.45(s,6H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例36:
Figure BDA0001313456810000412
化合物98:
参照化合物95的合成方法,产率9%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.61(d,2H,J=9.6Hz),6.69(d,2H,J=9.6Hz),6.51(s,1H),6.45(d,1H,J=16.0Hz),6.38(s,1H),3.32(bs,4H),2.35(bs,4H),1.73(bs,4H)。
探针36:
参照探针1的合成方法,产率94%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.61(d,2H,J=9.6Hz),7.28(s,1H),6.69(d,2H,J=9.6Hz),6.64(s,2H),6.51(s,1H),6.45(d,1H,J=16.0Hz),6.38(s,1H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.32(bs,4H),3.30(t,2H,J=6.0Hz),2.35(bs,4H),2.08(m,2H),1.73(bs,4H)。
实施例37:
Figure BDA0001313456810000413
化合物99:
参照化合物98的合成方法,产率7%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.61(d,2H,J=9.6Hz),6.69(d,2H,J=9.6Hz),6.51(s,1H),6.45(d,1H,J=16.0Hz),6.38(s,1H),3.45(s,3H),1.12(s,6H)。
探针37:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.61(d,2H,J=9.6Hz),7.28(s,1H),6.69(d,2H,J=9.6Hz),6.64(s,2H),6.51(s,1H),6.45(d,1H,J=16.0Hz),6.38(s,1H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.45(s,3H),3.30(t,2H,J=6.0Hz),2.08(m,2H),1.12(s,6H)。
实施例38:
Figure BDA0001313456810000421
化合物100:
N,N-二甲基间氨基酚(13.7g,0.1mol)于100ml圆底烧瓶中,加入顺丁烯二酸酐(4.9g,0.05mol),小心加入50ml浓硫酸,氩气保护条件下150℃油浴加热6h,反应完毕,冷却至室温,加入200g碎冰中,过滤,滤饼用冰乙醇洗涤两次,干燥,乙醇重结晶,重结晶产品经氯离子交换色谱离子交换,浓缩得产物3.78g,产率20%。1H-NMR(400MHz,DMSO-d6):δ=11.2(s,1H),8.10(s,1H),7.92(s,1H),7.59(d,2H,J=8.8H),6.56(d,2H,J=8.8H),6.48(s,2H),3.61(s,12H)。
探针38:
参照探针1的合成方法,产率95%。1H-NMR(400MHz,DMSO-d6):δ=11.2(s,1H),8.10(s,1H),7.92(s,1H),7.59(d,2H,J=8.8H),7.28(s,1H),6.64(s,2H),6.56(d,2H,J=8.8H),6.48(s,2H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.61(s,12H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例39:
Figure BDA0001313456810000422
化合物102:
参照化合物100的合成方法,残了21%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.10(s,2H),6.56(s,2H),6.40(d,1H,J=16.0Hz),3.77(t,4H,J=8.0Hz),3.19(s,6H),2.90(t,4H,J=8.0Hz)。
探针39:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.28(s,1H),7.10(s,2H),6.56(s,2H),6.64(s,2H),6.40(d,1H,J=16.0Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.77(t,4H,J=8.0Hz),3.70(s,2H),3.30(t,2H,J=6.0Hz),3.19(s,6H),2.90(t,4H,J=8.0Hz),2.08(m,2H)。
实施例40:
Figure BDA0001313456810000423
化合物103:
参照化合物100的合成方法,产率17%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.10(s,2H),6.45(d,1H,J=16.0Hz),3.32(bs,8H),2.35(bs,8H),1.73(bs,8H)。
探针40:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.28(s,1H),7.10(s,2H),6.64(s,2H),6.45(d,1H,J=16.0Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.32(bs,8H),3.30(t,2H,J=6.0Hz),2.35(bs,8H),2.08(m,2H),1.73(bs,8H)。
实施例41:
Figure BDA0001313456810000431
化合物104:
参照化合物99的合成方法,产率15%。1H-NMR(400MHz,DMSO-d6):δ=8.10(s,1H),7.92(s,1H),7.59(d,2H,J=8.8H),6.56(d,2H,J=8.8H),6.48(s,2H)。
探针41:
参照探针1的合成方法,产率93%。1H-NMR(400MHz,DMSO-d6):δ=11.2(s,1H),8.10(s,1H),7.92(s,1H),7.59(d,2H,J=8.8H),7.28(s,1H),6.64(s,2H),6.56(d,2H,J=8.8H),6.48(s,2H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例42:
Figure BDA0001313456810000432
化合物105:
参照化合物100的合成方法,产率17%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.10(s,2H),6.56(s,2H),6.40(d,1H,J=16.0Hz),3.19(s,6H),3.19(s,6H),2.65(s,6H),1.23(s,16H)。
探针42:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.10(s,2H),6.56(s,2H),6.40(d,1H,J=16.0Hz),3.19(s,6H),3.19(s,6H),2.65(s,6H),1.23(s,16H)。
实施例43:
Figure BDA0001313456810000441
化合物106:
N’,N’-二甲基间氨基酚(1.37g,10.0mmol)与250ml原地烧瓶中,加入无水二氯甲烷130ml溶解,加入顺丁烯二酸酐(0.98g,10.0mmol)冷却至0℃,加入无水三氯化铝(1.33g,10.0mmol)缓慢恢复至室温,反应完毕,小心加入5ml水淬灭反应,过滤,有机相用饱和食盐水洗涤,合并有机相,无水硫酸钠干燥,旋转蒸干溶剂,残余物柱色谱分离的产品1.32g,产率56%。1H-NMR(400MHz,DMSO-d6):δ=13.25(s,1H),7.94(d,1H,J=15.3Hz),7.63(d,1H,J=9.3Hz),6.90(d,1H,J=15.2Hz),6.24(dd,1H,J=2.4Hz),6.11(d,1H,J=2.4Hz),2.9(s,6H)。
化合物107:
化合物106(2.35g,10.0mmol)加入N,N-二甲基间氨基酚(2.74g,20.0mmol)小心加入50ml 85%硫酸,氩气保护条件下120℃油浴加热2h,反应完毕,冷却至室温,加入200g碎冰中,过滤,滤饼用冰乙醇洗涤两次,干燥,固体经柱色谱分离得,旋转蒸干,经氯离子交换树脂交换,产物4.22g,产率11%。1H-NMR(400MHz,DMSO-d6):δ=12.95(s,1H),7.94(d,1H,J=15.3Hz),7.33(d,2H,J=9.3Hz),7.03(d,2H,J=9.3Hz),6.90(d,1H,J=15.2Hz),6.63(d,1H,J=9.3Hz),3.77(t,2H,J=8.0Hz),3.19(s,9H),2.90(t,2H,J=8.0Hz)。
探针43:
按照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=12.95(s,1H),7.94(d,1H,J=15.3Hz),7.33(d,2H,J=9.3Hz),7.28(s,1H),7.03(d,2H,J=9.3Hz),6.90(d,1H,J=15.2Hz),6.64(s,2H),6.63(d,1H,J=9.3Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.77(t,2H,J=8.0Hz),3.70(s,2H),3.30(t,2H,J=6.0Hz),3.19(s,9H),2.90(t,2H,J=8.0Hz),2.08(m,2H)。
实施例44:
Figure BDA0001313456810000442
化合物108:
参照化合物107的合成方法,15%。1H-NMR(400MHz,DMSO-d6):δ=12.95(s,1H),7.94(d,1H,J=15.3Hz),7.33(d,2H,J=9.3Hz),7.03(d,2H,J=9.3Hz)6.90(d,1H,J=15.2Hz),,6.63(d,1H,J=9.3Hz),3.32(bs,4H),3.12(s,6H),2.35(bs,4H),1.73(bs,4H)。
探针44:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,DMSO-d6):δ=12.95(s,1H),7.94(d,1H,J=15.3Hz),7.33(d,2H,J=9.3Hz),7.28(s,1H),7.03(d,2H,J=9.3Hz),6.90(d,1H,J=15.2Hz),6.64(s,2H),6.63(d,1H,J=9.3Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.32(bs,4H),3.30(t,2H,J=6.0Hz),3.12(s,6H),2.35(bs,4H),2.08(m,2H),1.73(bs,4H)。
实施例45:
Figure BDA0001313456810000451
化合物109:
按照化合物107的合成方法,产率19%。1H-NMR(400MHz,DMSO-d6):δ=12.95(s,1H),7.94(d,1H,J=15.3Hz),7.33(d,2H,J=9.3Hz),7.03(d,2H,J=9.3Hz)6.90(d,1H,J=15.2Hz),,6.63(d,1H,J=9.3Hz),3.12(s,9H),2.71(s,3H),1.26(s,6H)。
探针45:
参照探针1的合成方法,产率95%。1H-NMR(400MHz,DMSO-d6):δ=12.95(s,1H),7.94(d,1H,J=15.3Hz),7.33(d,2H,J=9.3Hz),7.28(s,1H),6.64(s,2H),7.03(d,2H,J=9.3Hz)6.90(d,1H,J=15.2Hz),,6.63(d,1H,J=9.3Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),3.12(s,9H),2.71(s,3H),2.08(m,2H),1.26(s,6H)。
实施例46:
Figure BDA0001313456810000452
化合物111:
化合物110(0.324g,1.0mmol)于100ml圆底烧瓶中,加入无水四氢呋喃呋喃50ml溶解,加入1M甲基溴化镁四氢呋喃溶液(1.5ml,1.5mmol),Ar保护条件下室温搅拌3小时,反应完毕,6M的盐酸调至酸性,室温搅拌30分钟,旋转蒸干溶剂,残余物柱色谱分离得产品0.35g,产率98%。1H-NMR(400MHz,DMSO-d6):δ=7.72(dd,2H,J=2.7 9.2Hz)6.98(dd,2H,J=2.7 9.2Hz),6.72(d,2H,J=7.2Hz),3.37(s,12H),2.91(s,3H),0.54(s,6H)。
化合物112:
化合物111(0.359g,1.0mmol)于100ml圆底烧瓶中,加入25ml乙酸酐溶解,加入乙醛酸(0.10g,1.35mmol)Ar保护条件下80℃油浴加热,反应完毕,体系冷却至室温,倒入100ml水中,过滤,滤饼经柱色谱分离得产品0.104g,产率35%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.72(dd,2H,J=2.7 9.2Hz),6.98(dd,2H,J=2.7 9.2Hz),6.72(d,2H,J=7.2Hz),6.64(d,1H,J=16.0Hz),3.37(s,12H),0.54(s,6H)。
探针46:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.72(dd,2H,J=2.7 9.2Hz),7.28(s,1H),6.98(dd,2H,J=2.7 9.2Hz),6.72(d,2H,J=7.2Hz),6.64(d,1H,J=16.0Hz),6.60(s,2H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.37(s,12H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H),0.54(s,6H)。
实施例47:
Figure BDA0001313456810000461
化合物114:
参照化合物111的合成方法,产率97%。1H-NMR(400MHz,DMSO-d6):δ=7.78(d,2H,J=1.2Hz),7.10(s,2H),3.77(t,4H,J=8.0Hz),3.19(s,6H),2.90(t,4H,J=8.0Hz),2.72(s,3H),0.54(s,6H)。
化合物115:
参照化合物112的合成方法,产率36%。1H-NMR(400MHz,DMSO-d6):δ=12.31(s,1H),8.01(d,1H,J=16.0Hz),7.78(d,2H,J=1.2Hz),7.10(s,2H),6.54(d,1H,J=16.0Hz),3.77(t,4H,J=8.0Hz),3.19(s,6H),2.90(t,4H,J=8.0Hz),0.54(s,6H)。
探针47:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.78(d,2H,J=1.2Hz),7.28(s,1H),7.10(s,2H),6.64(s,2H),6.54(d,1H,J=16.0Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.77(t,4H,J=8.0Hz),3.70(s,2H),3.30(t,2H,J=6.0Hz),3.19(s,6H),2.90(t,4H,J=8.0Hz),2.08(m,2H),0.54(s,6H)。
实施例48:
Figure BDA0001313456810000462
化合物117:
参照化合物116的合成方法,产率97%。1H-NMR(400MHz,DMSO-d6):δ=7.72(d,2H,J=9.2Hz),7.19(d,2H,J=2.4Hz),7.00(dd,2H,J=2.4 9.2Hz),3.37(s,12H),2.75(s,3H),1.72(s,6H)。
化合物118:
参照化合物112的合成方法,产率31%。1H-NMR(400MHz,DMSO-d6):δ=11.95(s,1H),8.01(d,1H,J=16.4Hz),7.72(d,2H,J=9.2Hz),7.19(d,2H,J=2.4Hz),7.00(dd,2H,J=2.4 9.2Hz),6.71(d,1H,J=16.4Hz),3.37(s,12H),1.72(s,6H)。
探针48:
参照探针1的合成方法,产率93%。1H-NMR(400MHz,DMSO-d6):δ=11.95(s,1H),8.01(d,1H,J=16.4Hz),7.72(d,2H,J=9.2Hz),7.28(s,1H),7.19(d,2H,J=2.4Hz),7.00(dd,2H,J=2.49.2Hz),6.71(d,1H,J=16.4Hz),6.64(s,2H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.37(s,12H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H),1.72(s,6H)。
实施例49:
Figure BDA0001313456810000463
化合物120:
参照化合物111合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=7.78(d,2H,J=1.2Hz),7.10(s,2H),3.77(t,4H,J=8.0Hz),3.19(s,6H),2.90(t,4H,J=8.0Hz),2.72(s,3H),1.72(s,6H)。
化合物121:
参照化合物112的合成方法,产率36%。1H-NMR(400MHz,DMSO-d6):δ=8.03(d,1H,J=15.6Hz),7.78(d,2H,J=1.2Hz),7.10(s,2H),6.71(d,1H,J=15.6Hz),3.77(t,4H,J=8.0Hz),3.19(s,6H),2.90(t,4H,J=8.0Hz),1.72(s,6H)。
探针49:
参照探针1的合成方法,产率93%。1H-NMR(400MHz,DMSO-d6):δ=8.03(d,1H,J=15.6Hz),7.78(d,2H,J=1.2Hz),7.28(s,1H),7.10(s,2H),6.71(d,1H,J=15.6Hz),6.64(s,2H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.77(t,4H,J=8.0Hz),3.70(s,2H),3.30(t,2H,J=6.0Hz),3.19(s,6H),2.90(t,4H,J=8.0Hz),2.08(m,2H),1.72(s,6H)。
实施例50:
Figure BDA0001313456810000471
化合物123:
化合物122(参照文献公开方法:Jonathan B Grimm.et al.Nature Methods.,2015,12,244--250.)参照化合物109的合成方法,产率97%。1H-NMR(400MHz,DMSO-d6):δ=6.90(d,2H,J=2.5Hz),6.86(d,2H,J=2.5Hz),6.33(dd,2H,J=2.5Hz),4.27(t,8H,J=7.2Hz),2.76(s,3H),2.57(q,4H,J=7.2Hz)。
化合物124:
参照化合物112的合成方法,产率21%。1H-NMR(400MHz,DMSO-d6):δ=12.13(s,1H),7.92(d,1H,J=16.0Hz),6.90(d,2H,J=2.5Hz),6.86(d,2H,J=2.5Hz),6.61(d,1H,J=16.0Hz),6.33(dd,2H,J=2.5Hz),4.27(t,8H,J=7.2Hz),2.76(s,3H),2.57(q,4H,J=7.2Hz)。
探针50:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=12.13(s,1H),7.92(d,1H,J=16.0Hz),7.28(s,1H),6.90(d,2H,J=2.5Hz),6.86(d,2H,J=2.5Hz),6.64(s,2H),6.61(d,1H,J=16.0Hz),6.33(dd,2H,J=2.5Hz),4.27(t,8H,J=7.2Hz),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.76(s,3H),2.57(q,4H,J=7.2Hz),2.08(m,2H)。
实施例51:(请修改图中Cl-位置)
Figure BDA0001313456810000472
化合物126:
化合物125(参照文献公开方法:Young-Hoon Ahn et al.J.Am.Chem.Soc.2007,129,4501—4511.)参照化合物93的合成方法,产率93%。1H-NMR(400MHz,DMSO-d6):δ=8.28(d,2H,J=9.4Hz),7.56(d,1H,J=9.4Hz),7.39(dd,2H,J=9.2 2.2Hz),7.37(d,2H,J=2.2Hz),6.0(s,1H),5.38(s,1H),3.34(q,2H,J=3.2Hz),1.21(t,3H,J=3.2Hz)。
化合物127:
化合物126(0.30g,1.0mmol)与100ml圆底烧瓶中,加入35ml无水二甲基甲酰胺,加入碳酸钾(0.138g,1.0mmol)、溴乙酸(0.21g,1.5mmol),Ar保护条件下50℃油浴加热,反应完毕,旋转蒸干溶解,残余物柱色谱分离得产品0.10g,产率27%。1H-NMR(400MHz,DMSO-d6):δ=8.28(d,2H,J=9.4Hz),7.56(d,1H,J=9.4Hz),7.39(dd,2H,J=9.2 2.2Hz),7.37(d,2H,J=2.2Hz),6.0(s,1H),5.38(s,1H),4.21(s,2H),3.34(q,2H,J=3.2Hz),1.21(t,3H,J=3.2Hz)。
探针51:
按照探针1的合成方法,产率93%。1H-NMR(400MHz,DMSO-d6):δ=8.28(d,2H,J=9.4Hz),7.56(d,1H,J=9.4Hz),7.39(dd,2H,J=9.2 2.2Hz),7.37(d,2H,J=2.2Hz),7.28(s,1H),6.64(s,2H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H),6.0(s,1H),5.38(s,1H),4.21(s,2H),3.34(q,2H,J=3.2Hz),1.21(t,3H,J=3.2Hz)。
实施例52:
Figure BDA0001313456810000481
化合物129:
化合物128(按照文献公开方法合成:L.X.Wu,K.Burgess,J.Org.Chem.2008,73,8711—8718.)(0.585g,1.0mmol)于100ml的圆底烧瓶中,加入醋酸钯(4.4mg,0.02mmol)、三乙醇胺(0.30g,2.0mmol),加干燥二甲基甲酰胺25ml,加入丙烯酸价值(0.172g,2.0mmol),85℃油浴加热,反应完毕,冷却至室温,旋转蒸干溶剂,残余物柱色谱分离得产物0.461g,产率85%。1H-NMR(400MHz,DMSO-d6):δ=8.11(d,1H,J=16.0Hz),7.95(d,2H,J=8.4Hz),7.27(d,2H,J=9.6Hz),7.12(d,2H,J=8.4Hz),7.07(dd,2H,J=2.4 9.6Hz),6.99(d,2H,J=2.4Hz),6.71(d,1H,J=16.0Hz),3.96(s,3H),3.73(br,8H),1.76(br,12H)。
化合物130:
化合物129(0.271g,0.5mmol)于100ml圆底烧瓶中,加入50ml甲醇、10ml水,加入碳酸钾(0.138g,1.0mmol),Ar保护条件下室温搅拌,反应完毕,体系调至酸性,倒入100ml二氯甲烷中,分出有机相,饱和食盐水洗涤两次,有机相用无水硫酸钠干燥,旋转蒸干溶剂,残余物柱色谱分离得产物0.227g,产率86%。1H-NMR(400MHz,DMSO-d6):δ=11.96(s,1H),8.11(d,1H,J=16.0Hz),7.95(d,2H,J=8.4Hz),7.27(d,2H,J=9.6Hz),7.12(d,2H,J=8.4Hz),7.07(dd,2H,J=2.4 9.6Hz),6.99(d,2H,J=2.4Hz),6.71(d,1H,J=16.0Hz),3.73(br,8H),1.76(br,12H)。
探针51:
参照探针1的合成方法,产率93%。1H-NMR(400MHz,DMSO-d6):δ=8.11(d,1H,J=16.0Hz),7.95(d,2H,J=8.4Hz),7.34(s,1H),7.27(d,2H,J=9.6Hz),7.12(d,2H,J=8.4Hz),7.07(dd,2H,J=2.4 9.6Hz),6.99(d,2H,J=2.4Hz),6.71(d,1H,J=16.0Hz),6.64(s,2H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.73(br,8H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H),1.76(br,12H)。
实施例52:
Figure BDA0001313456810000491
化合物132:
化合物131(参照X.J.Peng et.al.PCT Int.Appl.2012103678公开的方法)(0.283g,0.5mmol)溶于25ml无水乙醇中,丙二酸(0.062g,0.6mmol),加入催化量三乙胺,油浴加热回流2h,反应完毕,旋转蒸干溶剂,残余物柱色谱分离得0.170g,产率56%。1H-NMR(400MHz,DMSO-d6):δ=8.26(d,2H,J=14.4H)8.01(d,1H,J=9.2H),7.68(d,1H,J=9.2H),7.49(t,2H,J=8.0H),7.46(d,2H,J=7.6Hz),7.38(t,2H,J=7.6H),7.33(d,2H,J=8.4Hz),7.22(bp,2H),4.51(q,4H,J=7.2Hz),3.92(s,3H),1.86(s,6H),1.56(t,6H,J=7.2H)。
探针53:
参照探针1的合成方法,产率88%。1H-NMR(400MHz,DMSO-d6):δ=8.26(d,2H,J=14.4H)8.01(d,1H,J=9.2H),7.68(d,1H,J=9.2H),7.49(t,2H,J=8.0H),7.46(d,2H,J=7.6Hz),7.38(t,2H,J=7.6H),7.33(d,2H,J=8.4Hz),7.28(s,1H),7.22(bp,2H),6.64(s,2H),4.51(q,4H,J=7.2Hz),4.12(t,2H,J=5.4Hz),3.92(s,3H),1.86(s,6H),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H),1.56(t,6H,J=7.2H)。
实施例53:
Figure BDA0001313456810000492
化合物133:
参照化合物131的合成方法,产率56%。1H-NMR(400MHz,DMSO-d6):δ=8.26(d,2H,J=14.4H)8.01(d,1H,J=9.2H),7.68(d,1H,J=9.2H),7.46(d,2H,J=7.6Hz),7.38(t,2H,J=7.6H),7.33(d,2H,J=8.4Hz),7.22(bp,2H),4.51(q,4H,J=7.2Hz),3.92(s,3H),1.86(s,6H),1.56(t,6H,J=7.2H。
探针54
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.26(d,2H,J=14.4H)8.01(d,1H,J=9.2H),7.68(d,1H,J=9.2H),7.46(d,2H,J=7.6Hz),7.38(t,2H,J=7.6H),7.33(d,2H,J=8.4Hz),7.28(s,1H),7.22(bp,2H),6.64(s,2H),4.51(q,4H,J=7.2Hz),4.12(t,2H,J=5.4Hz),3.92(s,3H),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H),1.86(s,6H),1.56(t,6H,J=7.2H)。
实施例55:
Figure BDA0001313456810000501
化合物136:
化合物135(参照文献公开方法合成:Mathisa O et.al.J.Am.Soc.Soc.2004,126,13634—13635.)(0.169g,0.5mmol)于50ml圆底烧瓶中,加入25ml无水乙醇溶解,加入丙二酸(62.4mg,0.6mmol),加入催化量的无水氯化锌,氩气保护条件下油浴加热回流2h,反应完毕,旋转蒸去部分溶剂,冷却析出晶体,过滤,滤饼用冷的无水乙醇洗涤两次,得纯品0.164g,产率86%。1H-NMR(400MHz,DMSO-d6):δ=12.1(s,1H),10.28(s,2H),10.25(s,1H),10.17(d,2H,J=4.4Hz),9.46(d,2H,J=4.4Hz),9.39(d,2H,J=4.4Hz),9.36(d,2H,J=4.4Hz),8.01(d,1H,J=8.8Hz),7.8(d,1H,J=8.8Hz),-3.05(s,2H)。
探针55:
参照探针1的合成方法,产率93%。1H-NMR(400MHz,DMSO-d6):δ=10.28(s,2H),10.25(s,1H),10.17(d,2H,J=4.4Hz),9.46(d,2H,J=4.4Hz),9.39(d,2H,J=4.4Hz),9.36(d,2H,J=4.4Hz),8.01(d,1H,J=8.8Hz),7.8(d,1H,J=8.8Hz),7.28(s,1H),6.64(s,2H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H),-3.05(s,2H)。
实施例56:
Figure BDA0001313456810000502
化合物137:
参照化合物2的合成方法,产率78%。1H-NMR(400MHz,CDCl3):δ=7.99-8.39(m,10H),6.75(d,1H,J=16.4Hz),5.41(s,2H)。
探针56:
参照探针1的合成方法,产率88%。1H-NMR(400MHz,CDCl3):δ=7.99-8.39(m,10H),7.28(s,1H),6.75(d,1H,J=16.4Hz),6.64(s,2H),5.41(s,2H),4.12(t,2H,J=5.4Hz),3.87(s,6H),3.70(s,2H),3.30(t,2H,J=6.0Hz),2.08(m,2H)。
实施例57:
Figure BDA0001313456810000503
探针57:
化合物5(0.287g,1.0mmol)与50ml圆底烧瓶中,加入化合物138(0.223g,1.2mmol)、六氟磷酸苯丙三唑-1-基-氧基三吡咯烷基磷(0.63g,1.2mmol),三乙胺(0.15g,1.5mmol),加入10ml无水二甲基甲酰胺,Ar保护条件下室温搅拌1h,反应完毕,旋转蒸干溶剂,柱色谱分离,得淡黄色晶体0.391g,产率86%。1H-NMR(400MHz,DMSO-d6):δ=11.96(s,1H),7.78(d,1H,J=16.0Hz),7.73(d,2H,J=7.2Hz),7.51(d,1H,J=7.2Hz),7.26(d,2H,J=7.2Hz),6.71(d,1H,J=7.2Hz),6.49(d,1H,J=16.0Hz),6.52(s,1H),6.44(s,1H),6.41(br,2H),3.9(s,2H),3.41(t,4H,J=8.2Hz),1.21(d,6H,J=8.2Hz)。
实施例58:
Figure BDA0001313456810000511
探针58:
参照探针57的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=12.10(s,1H),7.76(d,1H,J=16.0Hz),7.73(d,2H,J=7.2Hz),7.46(d,1H,J=9.2Hz),7.26(d,2H,J=7.2Hz),6.84(s,1H),6.70(d,1H,J=16.0Hz),6.41(br,2H),5.99(d,1H,J=9.2Hz),3.9(s,2H),3.26(m,4H),2.88(t,2H,J=6.5Hz),2.75(t,2H,J=6.5Hz),1.96(m,4H)。
实施例59:
Figure BDA0001313456810000512
探针59:
参照探针57的合成方法,产率93%。1H-NMR(400MHz,DMSO-d6):δ=11.96(s,1H),11.81(s,1H),7.82(d,1H,J=16.0Hz),7.73(d,2H,J=7.2Hz),7.47(dd,1H,J=2.0,11.4Hz),7.26(d,2H,J=7.2Hz),6.47(d,1H,J=16.0Hz),6.41(br,2H),6.30(s,1H),3.9(s,2H)。
实施例60:
Figure BDA0001313456810000513
探针60:
参照探针57的合成方法,产率94%。1H-NMR(400MHz,DMSO-d6):δ=7.83(d,1H,J=16.0Hz),7.73(d,2H,J=7.2Hz),7.51(d,2H,J=4.2Hz),7.26(d,2H,J=7.2Hz),6.48(d,1H,J=16.0Hz),6.41(br,2H),6.35(d,2H,J=4.2Hz),3.9(s,2H),2.65(s,6H)。
实施例61:
Figure BDA0001313456810000521
探针61:
参照探针57的合成方法,产率95%。1H-NMR(400MHz,DMSO-d6):δ=7.83(d,1H,J=16.0Hz),7.73(d,2H,J=7.2Hz),7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,4H,J=16.4Hz),7.20(d,2H,J=7.2Hz),7.06(s,1H),6.48(d,1H,J=16.0Hz),6.41(br,2H),6.35(d,2H,J=4.2Hz),3.9(s,2H),2.23(s,3H)。
实施例62:
Figure BDA0001313456810000522
探针62:
参照探针57的合成方法,产率93%。1H-NMR(400MHz,DMSO-d6):δ=8.19(d,2H,J=7.8Hz),7.87(d,2H,J=16.4Hz),7.83(d,1H,J=16.0Hz),7.78(d,2H,J=16.4Hz),7.73(d,4H,J=7.6Hz),7.70(d,2H,J=7.2Hz),7.52(d,4H,J=7.6Hz),7.39(d,2H,J=4.4Hz),7.26(d,2H,J=7.2Hz),7.04(d,2H,J=4.4Hz),6.51(d,1H,J=16.0Hz),6.41(br,2H),3.9(s,2H),3.70(s,2H),2.23(s,3H)。
实施例63:
Figure BDA0001313456810000523
探针63:
参照探针57的合成方法,产率93%。1H-NMR(400MHz,DMSO-d6):δ=8.30(d,1H,J=16.4Hz),7.81(d,1H,J=16.0Hz),7.70(d,2H,J=7.2Hz),7.55(d,2H,J=4.2Hz),7.51(d,1H,J=16.4Hz),7.40(d,1H,J=4.8),7.29(d,1H,J=4.8Hz),7.26(d,2H,J=7.2Hz),7.09(d,1H,J=4.4Hz),6.49(d,1H,J=16.0Hz),6.45(br,2H),6.40(d,2H,J=4.2Hz),3.9(s,2H),3.75(s,2H),2.60(s,3H)。
实施例64:
Figure BDA0001313456810000531
探针64:
参照探针57的合成方法,产率96%。1H-NMR(400MHz,DMSO-d6):δ=7.81(d,1H,J=16.0Hz),7.70(d,2H,J=7.2Hz),7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,2H),7.26(d,2H,J=7.2Hz),7.18(d,2H,J=4.2Hz),6.72(d,1H,J=16.0Hz),6.48(d,1H,J=16.0Hz),6.41(br,2H),6.20(d,1H,J=4.2Hz),4.06(s,3H),3.9(s,2H),2.23(s,3H)。
实施例65:
Figure BDA0001313456810000532
探针65:
参照探针57的合成方法,产率88%。1H-NMR(400MHz,CDCl3):δ=8.01(d,1H,J=16.0Hz),7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.70(d,2H,J=7.2Hz),7.44-7.47(m,6H),7.26(d,2H,J=7.2Hz),6.83(d,2H,J=4.4Hz),6.48(d,1H,J=16.0Hz),6.41(br,2H),3.9(s,2H)。
实施例66:
Figure BDA0001313456810000533
探针66:
参照探针57的合成方法,产率88%。1H-NMR(400MHz,CDCl3):δ=7.81(d,1H,J=16.0Hz),7.70(d,2H,J=7.2Hz),7.26(d,2H,J=7.2Hz),6.99(d,2H,J=8.8Hz),6.97(d,4H,J=8.8Hz),6.89(d,2H,J=4.4Hz),6.72(d,1H,J=16.0Hz),6.62(d,2H,J=4.4Hz),6.41(br,2H),3.9(s,2H),3.86(s,6H)。
实施例67:
Figure BDA0001313456810000534
探针67:
参照探针57的合成方法,产率88%。1H-NMR(400MHz,CDCl3):δ=8.32(d,2H,J=16.4Hz),7.81(d,1H,J=16.0Hz),7.73(d,2H,J=7.2Hz),7.56(d,2H,J=4.2Hz),7.50(d,2H,J=16.4Hz),7.40(d,2H,J=4.8),7.29(d,2H,J=4.8Hz),7.26(d,2H,J=7.2Hz),7.09(d,2H,J=4.4Hz),6.49(s,1H,J=16.0Hz),6.44(br,2H),6.40(d,2H,J=4.2Hz),3.9(s,2H),3.73(s,2H)。
实施例68:
Figure BDA0001313456810000541
探针68:
参照探针57的合成方法,产率88%。1H-NMR(400MHz,CDCl3):δ=7.83(d,1H,J=16.0Hz),7.73(d,2H,J=7.2Hz),7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,2H),7.22(d,2H,J=7.2Hz),7.18(d,2H,J=4.2Hz),6.52(d,1H,J=16.0Hz),6.48(d,1H,J=16.0Hz),6.41(br,2H),6.20(d,1H,J=4.2Hz),3.9(s,2H),2.96(s,6H),2.23(s,3H)。
实施例69:
Figure BDA0001313456810000542
探针69:
参照探针57的合成方法,产率88%。1H-NMR(400MHz,CDCl3):δ=8.32(d,1H,J=16.4Hz),7.81(d,1H,J=16.0Hz),7.73(d,2H,J=7.2Hz),7.54(d,2H,J=4.2Hz),7.50(d,1H,J=16.4Hz),7.45(d,1H,J=4.8),7.26(d,2H,J=7.2Hz),7.20(d,1H,J=4.8Hz),7.09(d,1H,J=4.4Hz),6.53(d,1H,J=16.0Hz),6.45(br,2H),6.40(d,2H,J=4.2Hz),3.9(s,2H),2.65(s,3H)。
实施例70:
Figure BDA0001313456810000543
探针70:
参照探针57的合成方法,产率93%。1H-NMR(400MHz,CDCl3):δ=7.81(d,1H,J=16.0Hz),7.76(dd,2H,J=1.0 3.6Hz),7.73(d,2H,J=7.2Hz),7.51(dd,2H,J=3.65.4Hz),7.26(d,2H,J=7.2Hz),7.15(dd,2H,J=3.6 5.4Hz),6.89(d,2H,J=4.4Hz),6.62(d,2H,J=4.4Hz),6.64(d,1H,J=16.0Hz),6.41(br,2H),3.9(s,2H)。
实施例71:
Figure BDA0001313456810000551
探针71:
参照探针57的合成方法,产率91%。1H-NMR(400MHz,CDCl3):δ=8.01(d,1H,J=16.0Hz),7.81(d,2H,J=7.2Hz),7.70(d,2H,J=7.2Hz),7.26(d,2H,J=7.2Hz),7.16(d,2H,J=7.2Hz),6.86(d,1H,J=5.4Hz),6.79(d,1H,J=7.2Hz),6.71(d,1H,J=7.2Hz),6.64(d,1H,J=5.4Hz),6.45(br,2H),,6.40(d,1H,J=16.0Hz),5.52(s,2H),3.9(s,2H)2.65(s,3H)。
探针72:
Figure BDA0001313456810000552
探针72:
参照探针57的合成方法,产率91%。1H-NMR(400MHz,DMSO-d6):δ=8.10(s,1H),7.92(s,1H),7.70(d,2H,J=7.2Hz),7.59(d,2H,J=8.8H),7.26(d,2H,J=7.2Hz),6.56(d,2H,J=8.8H),6.48(s,2H),6.41(br,2H),3.9(s,2H)。
实施例73:
Figure BDA0001313456810000553
探针73:
参照探针57的合成方法,产率87%。1H-NMR(400MHz,DMSO-d6):δ=11.2(s,1H),8.10(s,1H),7.92(s,1H),7.70(d,2H,J=7.2Hz),7.59(d,2H,J=8.8H),7.26(d,2H,J=7.2Hz),6.56(d,2H,J=8.8H),6.48(s,2H),3.61(s,12H),6.41(br,2H),3.9(s,2H)。
实施例74:
Figure BDA0001313456810000554
探针74:
参照探针57的合成方法,产率93%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.70(d,2H,J=7.2Hz),7.26(d,2H,J=7.2Hz),7.10(s,2H),6.56(s,2H),6.44(br,2H),,6.40(d,1H,J=16.0Hz),3.9(s,2H)3.77(t,4H,J=8.0Hz),3.19(s,6H),2.90(t,4H,J=8.0Hz)。
实施例75:
Figure BDA0001313456810000561
探针75:
参照探针57的合成方法,产率91%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.70(d,2H,J=7.2Hz),7.26(d,2H,J=7.2Hz),7.10(s,2H),6.45(d,1H,J=16.0Hz),3.32(bs,8H),6.41(br,2H),3.9(s,2H),2.35(bs,8H),1.73(bs,8H)。
实施例76:
Figure BDA0001313456810000562
探针76:
参照探针57的合成方法,产率96%。1H-NMR(400MHz,DMSO-d6):δ=8.10(s,1H),7.92(s,1H),7.70(d,2H,J=7.2Hz),7.59(d,2H,J=8.8H),7.26(d,2H,J=7.2Hz),6.56(d,2H,J=8.8H),6.48(s,2H),6.41(br,2H),3.9(s,2H)。
实施例77:
Figure BDA0001313456810000563
探针77:
参照探针57的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.72(dd,2H,J=2.7 9.2Hz),7.70(d,2H,J=7.2Hz),7.26(d,2H,J=7.2Hz),6.98(dd,2H,J=2.79.2Hz),6.72(d,2H,J=7.2Hz),6.64(d,1H,J=16.0Hz),6.41(br,2H),3.37(s,12H),3.9(s,2H),0.54(s,6H)。
实施例78:
Figure BDA0001313456810000564
探针78:
参照探针57的合成方法,产率92%。1H-NMR(400MHz,DMSO-d6):δ=12.31(s,1H),8.01(d,1H,J=16.0Hz),7.78(d,2H,J=1.2Hz),7.70(d,2H,J=7.2Hz),7.26(d,2H,J=7.2Hz),7.10(s,2H),6.54(d,1H,J=16.0Hz),6.41(br,2H),3.9(s,2H),3.77(t,4H,J=8.0Hz),3.19(s,6H),2.90(t,4H,J=8.0Hz),0.54(s,6H)。
实施例79:
Figure BDA0001313456810000571
探针79:
参照探针57的合成方法,产率91%。1H-NMR(400MHz,DMSO-d6):δ=11.95(s,1H),8.01(d,1H,J=16.4Hz),7.72(d,2H,J=9.2Hz),7.70(d,2H,J=7.2Hz),7.26(d,2H,J=7.2Hz),7.19(d,2H,J=2.4Hz),7.00(dd,2H,J=2.4 9.2Hz),6.71(d,1H,J=16.4Hz),6.41(br,2H),3.9(s,2H),3.37(s,12H),1.72(s,6H)。
实施例80:
Figure BDA0001313456810000572
探针80:
参照探针57的合成方法,产率79%。1H-NMR(400MHz,DMSO-d6):δ=12.13(s,1H),7.92(d,1H,J=16.0Hz),7.70(d,2H,J=7.2Hz),7.26(d,2H,J=7.2Hz),6.90(d,2H,J=2.5Hz),6.86(d,2H,J=2.5Hz),6.61(d,1H,J=16.0Hz),6.41(br,2H),6.33(dd,2H,J=2.5Hz),4.27(t,8H,J=7.2Hz),3.9(s,2H),2.76(s,3H),2.57(q,4H,J=7.2Hz)。
实施例81:
Figure BDA0001313456810000573
探针81:
参照探针57的合成方法,产率91%。1H-NMR(400MHz,DMSO-d6):δ=8.26(d,2H,J=14.4H)8.01(d,1H,J=9.2H),7.70(d,2H,J=7.2Hz),7.68(d,1H,J=9.2H),7.49(t,2H,J=8.0H),7.46(d,2H,J=7.6Hz),7.38(t,2H,J=7.6H),7.33(d,2H,J=8.4Hz),7.26(d,2H,J=7.2Hz),7.22(bp,2H),6.41(br,2H),4.51(q,4H,J=7.2Hz),3.92(s,3H),3.9(s,2H),1.86(s,6H),1.56(t,6H,J=7.2H)。
实施例82::
Figure BDA0001313456810000574
探针82:
参照探针57的合成方法,产率81%。1H-NMR(400MHz,DMSO-d6):δ=12.1(s,1H),10.28(s,2H),10.25(s,1H),10.17(d,2H,J=4.4Hz),9.58(s,1H),9.46(d,2H,J=4.4Hz),9.39(d,2H,J=4.4Hz),9.36(d,2H,J=4.4Hz),8.01(d,1H,J=8.8Hz),7.85(m,3H),7.42(d,2H,J=7.8Hz),7.30(s,2H),4.32(d,2H,J=6.0Hz),-3.05(s,2H)。
实施例83:
Figure BDA0001313456810000581
探针83:
化合物5(0.287g,1.0mmol)于100ml圆底烧瓶中,加入N-羟基琥珀酰亚胺(0.138g,1.2mmol)、1-乙基-(3-二甲基氨基丙基)碳酰二亚胺盐酸盐(0.287g,1.5mmol)和4-N,N-二甲基吡啶(0.146g,1.2mmol),加入干燥二氯甲烷25ml溶解,Ar保护条件加室温搅拌,反应完毕,体系倒入100ml水中,分出有机相,水相用二氯甲烷萃取三次,合并有机相,无水硫酸钠干燥,旋转蒸干溶剂,无需纯化,直接加入化合物139(按照文献公开的方法:Suman Lata.etal.J.AM.CHEM.SOC.2005,127,10205—10215.)(0.262g,1.0mmol),加入干燥二甲基甲酰胺15ml溶解,加三乙胺(0.100g,1.3mmol),Ar保护条件下室温搅拌,反应完毕,旋转蒸干溶剂,残余物经反相色谱分离得纯品0.297g,产率56%。1H-NMR(400MHz,DMSO-d6):δ=11.96(s,1H),7.78(d,1H,J=16.0Hz),7.51(d,1H,J=7.2Hz),6.71(d,1H,J=7.2Hz),6.49(d,1H,J=16.0Hz),6.52(s,1H),6.44(s,1H),3.47(d,4H,J=5.6Hz),3.41(t,4H,J=8.2Hz),3.31(t,1H,J=5.6Hz),2.69(t,2H,J=5.6Hz),1.62(m,2H),1.21(d,6H,J=8.2Hz)。
实施例84:
Figure BDA0001313456810000582
探针84:
参照探针83的合成方法,产率68%。1H-NMR(400MHz,DMSO-d6):δ=12.10(s,1H),7.76(d,1H,J=16.0Hz),7.46(d,1H,J=9.2Hz),6.84(s,1H),6.70(d,1H,J=16.0Hz),5.99(d,1H,J=9.2Hz),3.47(d,4H,J=5.6Hz),3.31(t,1H,J=5.6Hz),3.26(m,4H),2.88(t,2H,J=6.5Hz),2.75(t,2H,J=6.5Hz),2.69(t,2H,J=5.6Hz),1.62(m,2H),1.96(m,4H)。
实施例85:
Figure BDA0001313456810000583
探针85:
参照探针83的合成方法,产61%。1H-NMR(400MHz,DMSO-d6):δ=11.96(s,1H),11.81(s,1H),7.82(d,1H,J=16.0Hz),7.47(dd,1H,J=2.0,11.4Hz),6.47(d,1H,J=16.0Hz),6.30(s,1H)3.47(d,4H,J=5.6Hz),3.31(t,1H,J=5.6Hz),2.69(t,2H,J=5.6Hz),1.62(m,2H)。
实施例86:
Figure BDA0001313456810000591
探针86:
参照探针83的合成方法,产率57%。1H-NMR(400MHz,DMSO-d6):δ=7.83(d,1H,J=16.0Hz),7.51(d,2H,J=4.2Hz),6.48(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),3.47(d,4H,J=5.6Hz),3.31(t,1H,J=5.6Hz),2.69(t,2H,J=5.6Hz),2.65(s,6H),1.62(m,2H)。
实施例87:
Figure BDA0001313456810000592
探针87:
参照探针83的合成方法,56%。1H-NMR(400MHz,DMSO-d6):δ=7.83(d,1H,J=16.0Hz),7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,4H,J=16.4Hz),7.06(s,1H),6.48(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),3.47(d,4H,J=5.6Hz),3.31(t,1H,J=5.6Hz),2.69(t,2H,J=5.6Hz),2.23(s,3H),1.62(m,2H)。
实施例88:
Figure BDA0001313456810000593
探针88:
参照探针83的合成方法,59%。1H-NMR(400MHz,DMSO-d6):δ=8.30(d,1H,J=16.4Hz),7.81(d,1H,J=16.0Hz),7.55(d,2H,J=4.2Hz),7.51(d,1H,J=16.4Hz),7.40(d,1H,J=4.8),7.29(d,1H,J=4.8Hz),7.09(d,1H,J=4.4Hz),6.49(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),3.75(s,2H),3.47(d,4H,J=5.6Hz),3.31(t,1H,J=5.6Hz),2.69(t,2H,J=5.6Hz),2.60(s,3H),1.62(m,2H)。
探针89:
Figure BDA0001313456810000594
探针89:
参照探针83的合成方法,61%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.44-7.47(m,6H),6.83(d,2H,J=4.4Hz),6.48(d,1H,J=16.0Hz),3.47(d,4H,J=5.6Hz),3.31(t,1H,J=5.6Hz),2.69(t,2H,J=5.6Hz),1.62(m,2H)。
实施例90:
Figure BDA0001313456810000601
探针90:
化合物140(按照文献公开的方法:Suman Lata.et al.J.AM.CHEM.SOC.2005,127,10205—10215.)参照探针83的合成方法,产率45%。1H-NMR(400MHz,DMSO-d6):δ=11.96(s,1H),7.78(d,1H,J=16.0Hz),7.68(br,1H)7.51(d,1H,J=7.2Hz),,6.88(br,1H),6.71(d,1H,J=7.2Hz),6.49(d,1H,J=16.0Hz),6.52(s,1H),6.44(s,1H),5.03(s,2H),3.56(t,1H,J=1.2Hz),3.36-3.50(m,12H),3.20-3.33(m,6H),2.37(m,2H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H),1.21(d,6H,J=8.2Hz)。
实施例91:
Figure BDA0001313456810000602
探针91:
参照探针83的合成方法,产率55%。1H-NMR(400MHz,DMSO-d6):δ=12.10(s,1H),7.76(d,1H,J=16.0Hz),7.68(br,1H),7.46(d,1H,J=9.2Hz),6.88(br,1H),6.84(s,1H),6.70(d,1H,J=16.0Hz),5.99(d,1H,J=9.2Hz),5.03(s,2H),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,10H),2.88(t,2H,J=6.5Hz),2.75(t,2H,J=6.5Hz),2.37(m,2H),2.05(m,2H),1.96(m,4H),1.46-1.65(m,12H),1.45(s,18H)。
实施例92:
Figure BDA0001313456810000603
探针92:
参照探针83的合成方法,产率57%。1H-NMR(400MHz,DMSO-d6):δ=11.96(s,1H),11.81(s,1H),7.82(d,1H,J=16.0Hz),7.68(br,1H),7.47(dd,1H,J=2.0,11.4Hz),6.88(br,1H),,6.47(d,1H,J=16.0Hz),6.30(s,1H)5.03(s,2H),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),2.37(m,2H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H)。
探针93:
Figure BDA0001313456810000611
参照探针83的合成方法,产率67%。1H-NMR(400MHz,DMSO-d6):δ=7.83(d,1H,J=16.0Hz),7.68(br,1H),7.51(d,2H,J=4.2Hz),6.88(br,1H),6.48(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),5.03(s,2H),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),2.65(s,6H),2.37(m,2H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H)。
探针94:
Figure BDA0001313456810000612
探针94:
参照探针83的合成方法,产率62%。1H-NMR(400MHz,DMSO-d6):δ=7.83(d,1H,J=16.0Hz),7.68(br,1H),6.88(br,1H),7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,4H,J=16.4Hz),7.06(s,1H),6.48(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),5.03(s,2H),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),2.37(m,2H),2.23(s,3H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H)。
实施例95:
Figure BDA0001313456810000613
探针95:
参照探针83的合成方法,产率56%。1H-NMR(400MHz,DMSO-d6):δ=7.81(d,1H,J=16.0Hz),7.68(br,1H),7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,2H),7.18(d,2H,J=4.2Hz),6.88(br,1H),6.72(d,1H,J=16.0Hz),6.48(d,1H,J=16.0Hz),6.20(d,1H,J=4.2Hz),5.03(s,2H),4.06(s,3H),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),2.37(m,2H),2.23(s,3H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H)。
实施例96:
Figure BDA0001313456810000621
探针96:
参照探针83的合成方法,产率61%。1H-NMR(400MHz,DMSO-d6):δ=8.30(d,1H,J=16.4Hz),7.81(d,1H,J=16.0Hz),7.68(br,1H),7.55(d,2H,J=4.2Hz),7.51(d,1H,J=16.4Hz),7.40(d,1H,J=4.8),7.29(d,1H,J=4.8Hz),7.09(d,1H,J=4.4Hz),6.88(br,1H),6.49(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),5.03(s,2H),3.75(s,2H),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),2.60(s,3H),2.37(m,2H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H)。
实施例97:
Figure BDA0001313456810000622
探针97:
参照实施例83的合成方法,产率62%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.68(br,1H),7.44-7.47(m,6H),6.83(d,2H,J=4.4Hz),6.88(br,1H),6.48(d,1H,J=16.0Hz),5.03(s,2H),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),2.37(m,2H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H)。
实施例98:
Figure BDA0001313456810000623
探针98:
参照探针83的方法,产率63%。1H-NMR(400MHz,DMSO-d6):δ=7.81(d,1H,J=16.0Hz),7.68(br,1H),6.99(d,2H,J=8.8Hz),6.97(d,4H,J=8.8Hz),6.89(d,2H,J=4.4Hz),6.81(br,1H),6.72(d,1H,J=16.0Hz),6.62(d,2H,J=4.4Hz),5.03(s,2H),3.86(s,6H),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),2.37(m,2H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H)。
实施例99:
Figure BDA0001313456810000631
探针99;
参照探针83的合成方法,产率62%。1H-NMR(400MHz,DMSO-d6):δ=7.81(d,1H,J=16.0Hz),7.76(dd,2H,J=1.0 3.6Hz),7.68(br,1H),7.51(dd,2H,J=3.6 5.4Hz),7.15(dd,2H,J=3.65.4Hz),6.89(d,2H,J=4.4Hz),6.83(br,1H),6.62(d,2H,J=4.4Hz),6.64(d,1H,J=16.0Hz),5.03(s,2H),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),2.37(m,2H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H)。
实施例100:
Figure BDA0001313456810000632
探针100:
参照探针83的合成方法,产率55%。1H-NMR(400MHz,CDCl3):δ=8.01(d,1H,J=16.0Hz),7.81(d,2H,J=7.2Hz),7.68(br,1H),6.88(br,1H),7.16(d,2H,J=7.2Hz),6.86(d,1H,J=5.4Hz),6.79(d,1H,J=7.2Hz),6.71(d,1H,J=7.2Hz),6.64(d,1H,J=5.4Hz),6.40(d,1H,J=16.0Hz),5.52(s,2H),5.03(s,2H),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),2.65(s,3H),2.37(m,2H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H)。
实施例101:
Figure BDA0001313456810000633
探针101:
参照探针83的合成方法,产率55%。1H-NMR(400MHz,DMSO-d6):δ=8.10(s,1H),7.92(s,1H),7.68(br,1H),6.88(br,1H),7.59(d,2H,J=8.8H),6.56(d,2H,J=8.8H),6.48(s,2H),5.03(s,2H),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),2.37(m,2H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H)。
实施例102:
Figure BDA0001313456810000641
探针102:
参照探针83的合成方法,产率58%。1H-NMR(400MHz,DMSO-d6):δ=11.2(s,1H),8.10(s,1H),7.92(s,1H),7.68(br,1H),,7.59(d,2H,J=8.8H),6.88(br,1H),6.56(d,2H,J=8.8H),6.48(s,2H),5.03(s,2H),3.61(s,12H),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),2.37(m,2H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H)。
实施例103:
Figure BDA0001313456810000642
探针103:
参照探针83的合成方法,产率63%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.68(br,1H),7.10(s,2H),6.88(br,1H),6.56(s,2H),6.40(d,1H,J=16.0Hz),5.03(s,2H),3.77(t,4H,J=8.0Hz),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),3.19(s,6H),2.90(t,4H,J=8.0Hz),2.37(m,2H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H)。
实施例104:
Figure BDA0001313456810000643
探针104:
参照探针83的合成方法,产率63%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.68(br,1H),6.88(br,1H),7.10(s,2H),6.45(d,1H,J=16.0Hz),5.03(s,2H),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),3.12(bs,8H),2.37(m,2H),2.05(m,2H),2.35(bs,8H),1.73(bs,8H),1.46-1.65(m,12H),1.45(s,18H)。
实施例105:
Figure BDA0001313456810000651
探针105:
参照探针83的合成方法,产率61%。1H-NMR(400MHz,DMSO-d6):δ=8.10(s,1H),7.92(s,1H),7.68(br,1H),7.59(d,2H,J=8.8H),6.88(br,1H),6.56(d,2H,J=8.8H),6.48(s,2H),5.03(s,2H),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),2.37(m,2H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H)。
实施例106:
Figure BDA0001313456810000652
探针106:
参照探针83的合成方法,产率61%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.72(dd,2H,J=2.79.2Hz),7.68(br,1H),6.98(dd,2H,J=2.79.2Hz),6.88(br,1H),6.72(d,2H,J=7.2Hz),6.64(d,1H,J=16.0Hz),5.03(s,2H),3.56(t,1H,J=1.2Hz),3.40-3.50(m,8H),3.37(s,12H),3.20-3.33(m,6H),2.37(m,2H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H),0.54(s,6H)。
实施例107:
Figure BDA0001313456810000653
探针107:
参照探针83的合成方法,产率61%。1H-NMR(400MHz,DMSO-d6):δ=12.31(s,1H),8.01(d,1H,J=16.0Hz),7.78(d,2H,J=1.2Hz),7.68(br,1H),7.10(s,2H),6.88(br,1H),6.54(d,1H,J=16.0Hz),5.03(s,2H),3.56(t,1H,J=1.2Hz),3.77(t,4H,J=8.0Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),3.19(s,6H),2.90(t,4H,J=8.0Hz),2.37(m,2H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H),0.54(s,6H)。
实施例108:
Figure BDA0001313456810000661
探针108:
参照探针83的合成方法,产率63%。1H-NMR(400MHz,DMSO-d6):δ=12.13(s,1H),7.92(d,1H,J=16.0Hz),7.68(br,1H),6.88(br,1H),6.90(d,2H,J=2.5Hz),6.86(d,2H,J=2.5Hz),6.61(d,1H,J=16.0Hz),6.33(dd,2H,J=2.5Hz),5.03(s,2H),4.27(t,8H,J=7.2Hz),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),2.76(s,3H),2.57(q,4H,J=7.2Hz),2.37(m,2H),2.05(m,2H),1.46-1.65(m,12H),1.45(s,18H)。
实施例109:
Figure BDA0001313456810000662
探针109:
参照探针83的合成方法,产率57%。1H-NMR(400MHz,DMSO-d6):δ=11.95(s,1H),8.01(d,1H,J=16.4Hz),7.72(d,2H,J=9.2Hz),7.68(br,1H),7.19(d,2H,J=2.4Hz),7.00(dd,2H,J=2.49.2Hz),6.88(br,1H),6.71(d,1H,J=16.4Hz),5.03(s,2H),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.37(s,12H),3.20-3.33(m,6H),2.37(m,2H),2.05(m,2H),1.72(s,6H),1.46-1.65(m,12H),1.45(s,18H)。
实施例110:
Figure BDA0001313456810000663
探针110:
参照探针83的合成方法,产率63%。1H-NMR(400MHz,DMSO-d6):δ=8.03(d,1H,J=15.6Hz),7.78(d,2H,J=1.2Hz),7.68(br,1H),7.10(s,2H),6.88(br,1H),6.71(d,1H,J=15.6Hz),5.03(s,2H),3.77(t,4H,J=8.0Hz),3.56(t,1H,J=1.2Hz),3.36-3.50(m,8H),3.20-3.33(m,6H),3.19(s,6H),2.90(t,4H,J=8.0Hz),2.37(m,2H),2.05(m,2H),1.72(s,6H),1.46-1.65(m,12H),1.45(s,18H)。
实施例111:
Figure BDA0001313456810000671
探针111:
化合物141(按照文献公开方法合成:Tae-Hyuk Kwon.et al.Chem.Eur.J.2008,14,9613—9619.)参照探针1的合成方法,产率87%。1H-NMR(400MHz,DMSO-d6):δ=8.52(d,4H,J=4.4Hz),7.78(d,1H,J=16.0Hz),7.71(t,4H,J=7.6Hz),7.58(d,4H,J=7.8Hz),7.51(d,1H,J=7.2Hz),7.22(t,4H,J=6.0Hz),7.12(s,2H),6.71(d,1H,J=7.2Hz),6.49(d,1H,J=16.0Hz),6.52(s,1H),6.44(s,1H),3.86(s,8H),3.76(s,4H),3.41(m,6H),2.76(t,2H,J=7.2Hz),1.21(d,6H,J=8.2Hz)。
实施例112:
Figure BDA0001313456810000672
探针112:
参照探针1的合成方法,产率87%。1H-NMR(400MHz,DMSO-d6):δ=8.52(d,4H,J=4.4Hz),7.76(d,1H,J=16.0Hz),7.71(t,4H,J=7.6Hz),7.58(d,4H,J=7.8Hz),7.46(d,1H,J=9.2Hz),7.22(t,4H,J=6.0Hz),7.12(s,2H),6.84(s,1H),6.70(d,1H,J=16.0Hz),5.99(d,1H,J=9.2Hz),3.86(s,8H),3.76(s,4H),3.41(t,2H,J=7.4Hz),3.26(m,4H),2.88(t,2H,J=6.5Hz),2.82(t,2H,J=7.2Hz),2.75(t,2H,J=6.5Hz),1.96(m,4H)。
实施例113:
Figure BDA0001313456810000673
探针113:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=11.96(s,1H),8.52(d,4H,J=4.4Hz),7.82(d,1H,J=16.0Hz),7.71(t,4H,J=7.6Hz),7.58(d,4H,J=7.8Hz),7.47(dd,1H,J=2.0,11.4Hz),7.22(t,4H,J=6.0Hz),7.12(s,2H),6.47(d,1H,J=16.0Hz),6.30(s,1H),3.86(s,8H),3.76(s,4H),3.41(t,2H,J=7.4Hz),2.76(t,2H,J=7.2Hz)。
实施例114:
Figure BDA0001313456810000681
探针114:
参照探针1的合成方法,产率92%。1H-NMR(400MHz,CDCl3):δ=8.52(d,4H,J=4.4Hz),7.83(d,1H,J=16.0Hz),7.71(t,4H,J=7.6Hz),7.58(d,4H,J=7.8Hz),7.51(d,2H,J=4.2Hz),7.22(t,4H,J=6.0Hz),7.12(s,2H),6.48(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),3.86(s,8H),3.76(s,4H),3.41(t,2H,J=7.4Hz),2.76(t,2H,J=7.2Hz),2.65(s,6H)。
实施例115:
Figure BDA0001313456810000682
探针115:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,CDCl3):δ=8.52(d,4H,J=4.4Hz),7.83(d,1H,J=16.0Hz),7.71(t,4H,J=7.6Hz),7.58(d,4H,J=7.8Hz),7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,4H,J=16.4Hz),7.22(t,4H,J=6.0Hz),7.12(s,2H),3.86(s,8H),7.06(s,1H),6.48(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),3.86(s,8H),3.76(s,4H),3.41(t,2H,J=7.4Hz),2.76(t,2H,J=7.2Hz),2.23(s,3H)。
实施例116:
Figure BDA0001313456810000683
探针116:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,CDCl3):δ=8.52(d,4H,J=4.4Hz),7.81(d,1H,J=16.0Hz),7.71(t,4H,J=7.6Hz),7.58(d,4H,J=7.8Hz),7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.26-7.32(m,2H),7.22(t,4H,J=6.0Hz),7.12(s,2H),7.18(d,2H,J=4.2Hz),6.72(d,1H,J=16.0Hz),6.48(d,1H,J=16.0Hz),6.20(d,1H,J=4.2Hz),4.06(s,3H),3.86(s,8H),3.76(s,4H),3.41(t,2H,J=7.4Hz),2.76(t,2H,J=7.2Hz),2.23(s,3H)。
实施例117:
Figure BDA0001313456810000691
探针117:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,CDCl3):δ=8.52(d,4H,J=4.4Hz),8.30(d,1H,J=16.4Hz),7.81(d,1H,J=16.0Hz),7.71(t,4H,J=7.6Hz),7.58(d,4H,J=7.8Hz),7.55(d,2H,J=4.2Hz),7.51(d,1H,J=16.4Hz),7.40(d,1H,J=4.8),7.29(d,1H,J=4.8Hz),7.22(t,4H,J=6.0Hz),7.12(s,2H),7.09(d,1H,J=4.4Hz),6.49(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),3.86(s,8H),3.76(s,4H),3.75(s,2H),3.41(t,2H,J=7.4Hz),2.76(t,2H,J=7.2Hz),2.60(s,3H)。
实施例118:
Figure BDA0001313456810000692
探针118:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,CDCl3):δ=8.52(d,4H,J=4.4Hz),8.01(d,1H,J=16.0Hz),7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.71(t,4H,J=7.6Hz),7.58(d,4H,J=7.8Hz),7.44-7.47(m,6H),7.22(t,4H,J=6.0Hz),7.12(s,2H),6.83(d,2H,J=4.4Hz),6.48(d,1H,J=16.0Hz),3.86(s,8H),3.76(s,4H),3.41(t,2H,J=7.4Hz),2.76(t,2H,J=7.2Hz)。
实施例119:
Figure BDA0001313456810000693
探针119:
参照探针1的合成方法,产率90%。1H-NMR(400MHz,CDCl3):δ=8.52(d,4H,J=4.4Hz),7.81(d,1H,J=16.0Hz),7.71(t,4H,J=7.6Hz),7.58(d,4H,J=7.8Hz),7.22(t,4H,J=6.0Hz),7.12(s,2H),6.99(d,2H,J=8.8Hz),6.97(d,4H,J=8.8Hz),6.89(d,2H,J=4.4Hz),6.72(d,1H,J=16.0Hz),6.62(d,2H,J=4.4Hz),3.86(m,14H),3.76(s,4H),3.41(t,2H,J=7.4Hz),2.76(t,2H,J=7.2Hz)。
实施例120:
Figure BDA0001313456810000701
探针120:
参照探针1的合成方法,产率92%。1H-NMR(400MHz,CDCl3):δ=8.52(d,4H,J=4.4Hz),7.81(d,1H,J=16.0Hz),7.76(dd,2H,J=1.0 3.6Hz),7.71(t,4H,J=7.6Hz),7.58(d,4H,J=7.8Hz),7.51(dd,2H,J=3.6 5.4Hz),7.22(t,4H,J=6.0Hz),7.15(dd,2H,J=3.6 5.4Hz),7.12(s,2H),6.89(d,2H,J=4.4Hz),6.62(d,2H,J=4.4Hz),6.64(d,1H,J=16.0Hz),3.86(s,8H),3.76(s,4H),3.41(t,2H,J=7.4Hz),2.76(t,2H,J=7.2Hz)。
实施例121:
Figure BDA0001313456810000702
探针121:
参照探针1的合成方法,产率90%。1H-NMR(400MHz,DMSO-d6):δ=8.52(d,4H,J=4.4Hz),8.10(s,1H),7.92(s,1H),7.71(t,4H,J=7.6Hz),7.59(d,2H,J=8.8H),7.56(d,4H,J=7.8Hz),7.22(t,4H,J=6.0Hz),7.12(s,2H),6.56(d,2H,J=8.8H),6.48(s,2H),3.86(s,8H),3.76(s,4H),3.41(t,2H,J=7.4Hz),2.76(t,2H,J=7.2Hz)。
实施例122:
Figure BDA0001313456810000703
探针122:
参照探针1的合成方法,产率86%。1H-NMR(400MHz,DMSO-d6):δ=8.52(d,4H,J=4.4Hz),8.10(s,1H),7.92(s,1H),7.71(t,4H,J=7.6Hz),7.59(d,2H,J=8.8H),7.58(d,4H,J=7.8Hz),7.22(t,4H,J=6.0Hz),7.12(s,2H),6.56(d,2H,J=8.8H),6.48(s,2H),3.86(s,8H),3.76(s,4H),3.61(s,12H),3.41(t,2H,J=7.4Hz),2.76(t,2H,J=7.2Hz)。
实施例123:
Figure BDA0001313456810000711
探针123:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.52(d,4H,J=4.4Hz),8.01(d,1H,J=16.0Hz),7.71(t,4H,J=7.6Hz),7.58(d,4H,J=7.8Hz),7.22(t,4H,J=6.0Hz),7.12(s,2H),7.10(s,2H),6.56(s,2H),6.40(d,1H,J=16.0Hz),3.86(s,8H),3.77(t,4H,J=8.0Hz),3.76(s,4H),3.41(t,2H,J=7.4Hz),3.19(s,6H),2.90(t,4H,J=8.0Hz),2.76(t,2H,J=7.2Hz)。
实施例124:
Figure BDA0001313456810000712
探针124:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,DMSO-d6):δ=8.52(d,4H,J=4.4Hz),,8.10(s,1H),7.92(s,1H),7.71(t,4H,J=7.6Hz),7.59(d,2H,J=8.8H),7.56(d,4H,J=7.8Hz),7.22(t,4H,J=6.0Hz),7.12(s,2H),6.56(d,2H,J=8.8H),6.48(s,2H),3.86(s,8H),3.76(s,4H),3.41(t,2H,J=7.4Hz),2.76(t,2H,J=7.2Hz)。
实施例125:
Figure BDA0001313456810000713
探针125:
参照探针1的合成方法,产率82%。1H-NMR(400MHz,DMSO-d6):δ=8.52(d,4H,J=4.4Hz),8.01(d,1H,J=16.0Hz),7.72(dd,2H,J=2.79.2Hz),7.71(t,4H,J=7.6Hz),7.58(d,4H,J=7.8Hz),7.22(t,4H,J=6.0Hz),7.12(s,2H),6.98(dd,2H,J=2.79.2Hz),6.72(d,2H,J=7.2Hz),6.64(d,1H,J=16.0Hz),3.37(s,12H),3.86(s,8H),3.76(s,4H),3.41(t,2H,J=7.4Hz),2.76(t,2H,J=7.2Hz),0.54(s,6H)。
实施例126:
Figure BDA0001313456810000721
探针126:
参照探针1的合成方法,产率85%。1H-NMR(400MHz,DMSO-d6):δ=8.52(d,4H,J=4.4Hz),8.01(d,1H,J=16.0Hz),7.78(d,2H,J=1.2Hz),7.71(t,4H,J=7.6Hz),7.58(d,4H,J=7.8Hz),7.22(t,4H,J=6.0Hz),7.12(s,2H),7.10(s,2H),6.54(d,1H,J=16.0Hz),3.86(s,8H),3.76(s,4H),3.77(t,4H,J=8.0Hz),3.41(t,2H,J=7.4Hz),3.19(s,6H),2.90(t,4H,J=8.0Hz),2.76(t,2H,J=7.2Hz),0.54(s,6H)。
实施例127:
Figure BDA0001313456810000722
探针127:
参照探针1的合成方法,产率85%。1H-NMR(400MHz,DMSO-d6):δ=9.41(s,1H),8.38(s,1H),8.17(t,1H,J=12.6Hz),7.88(m,1H),7.78(d,1H,J=16.0Hz),7.51(d,1H,J=7.2Hz),7.38(dd,2H,J=8.2 17.2Hz),7.05(s,1H),6.71(d,1H,J=7.2Hz),6.49(d,1H,J=16.0Hz),6.52(s,1H),6.44(s,1H),5.41(s,2H),5.20(s,1H),4.00-3.87(m,3H),3.77(dd,1H,J=7.8 12.6Hz),3.41(t,4H,J=8.2Hz),2.29(m,1H),2.15(m,1H),1.21(d,6H,J=8.2Hz)。
实施例128:
Figure BDA0001313456810000723
探针128:
参照探针1的合成方法,产率85%。1H-NMR(400MHz,DMSO-d6):δ=9.41(s,1H),8.38(s,1H),8.17(t,1H,J=12.6Hz),7.88(m,1H),7.76(d,1H,J=16.0Hz),7.46(d,1H,J=9.2Hz),7.38(dd,2H,J=8.2 17.2Hz),7.05(s,1H),6.84(s,1H),6.70(d,1H,J=16.0Hz),5.99(d,1H,J=9.2Hz),5.41(s,2H),5.20(s,1H),4.00-3.87(m,3H),3,77(dd,1H,J=7.812.6Hz),3.26(m,4H),2.88(t,2H,J=6.5Hz),2.75(t,2H,J=6.5Hz),2.29(m,1H),2.15(m,1H),1.96(m,4H)。
实施例129:
Figure BDA0001313456810000731
探针129:
参照探针1的合成方法,产率85%。1H-NMR(400MHz,DMSO-d6):δ=11.62(s,1H),9.41(s,1H),8.38(s,1H),8.17(t,1H,J=12.6Hz),7.88(m,1H),7.82(d,1H,J=16.0Hz),7.47(dd,1H,J=2.0,11.4Hz),7.38(dd,2H,J=8.2 17.2Hz),7.05(s,1H),6.47(d,1H,J=16.0Hz),6.30(s,1H),5.41(s,2H),5.20(s,1H),4.00-3.87(m,3H),3,77(dd,1H,J=7.812.6Hz),2.29(m,1H),2.15(m,1H)。
实施例130:
Figure BDA0001313456810000732
探针130:
参照探针1的合成方法,产率81%。1H-NMR(400MHz,CDCl3):δ=9.41(s,1H),8.38(s,1H),8.17(t,1H,J=12.6Hz),7.88(m,1H),7.83(d,1H,J=16.0Hz),7.51(d,2H,J=4.2Hz),7.38(dd,2H,J=8.2 17.2Hz),7.05(s,1H),6.48(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),5.41(s,2H),5.20(s,1H),4.00-3.87(m,3H),3,77(dd,1H,J=7.8 12.6Hz),2.65(s,6H),2.29(m,1H),2.15(m,1H)。
实施例131:
Figure BDA0001313456810000733
探针131:
参照探针1的合成方法,产率88%。1H-NMR(400MHz,CDCl3):δ=9.41(s,1H),8.38(s,1H),8.17(t,1H,J=12.6Hz),,8.01(d,1H,J=16.0Hz),7.88(m,1H),7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.44-7.47(m,6H),7.38(dd,2H,J=8.2 17.2Hz),7.05(s,1H),6.83(d,2H,J=4.4Hz),6.48(d,1H,J=16.0Hz),5.41(s,2H),5.20(s,1H),4.00-3.87(m,3H),3,77(dd,1H,J=7.8 12.6Hz),2.29(m,1H),2.15(m,1H)。
实施例132:
Figure BDA0001313456810000741
探针132:
参照探针1的合成方法,产率92%。1H-NMR(400MHz,CDCl3):δ=9.41(s,1H),8.38(s,1H),8.17(t,1H,J=12.6Hz),7.88(m,1H),7.81(d,1H,J=16.0Hz),7.38(dd,2H,J=8.217.2Hz),7.05(s,1H),6.99(d,2H,J=8.8Hz),6.97(d,4H,J=8.8Hz),6.89(d,2H,J=4.4Hz),6.72(d,1H,J=16.0Hz),6.62(d,2H,J=4.4Hz),5.41(s,2H),5.20(s,1H),4.00-3.87(m,3H),3.86(s,6H),3.77(dd,1H,J=7.8 12.6Hz),2.29(m,1H),2.15(m,1H)。
实施例133:
Figure BDA0001313456810000742
探针133:
参照探针1的合成方法,产率86%。1H-NMR(400MHz,CDCl3):δ=9.41(s,1H),8.38(s,1H),8.17(t,1H,J=12.6Hz),7.88(m,1H),7.81(d,1H,J=16.0Hz),7.76(dd,2H,J=1.03.6Hz),7.51(dd,2H,J=3.6 5.4Hz),7.38(dd,2H,J=8.2 17.2Hz),7.15(dd,2H,J=3.65.4Hz),7.05(s,1H),6.89(d,2H,J=4.4Hz),6.62(d,2H,J=4.4Hz),6.64(d,1H,J=16.0Hz),5.41(s,2H),5.20(s,1H),4.00-3.87(m,3H),3.77(dd,1H,J=7.8 12.6Hz),2.29(m,1H),2.15(m,1H)。
实施例134:
Figure BDA0001313456810000743
探针134:
参照探针1的合成方法,产率86%。1H-NMR(400MHz,CDCl3):δ=9.41(s,1H),8.38(s,1H),8.17(t,1H,J=12.6Hz),8.01(d,1H,J=16.0Hz),7.88(m,1H),7.81(d,2H,J=7.2Hz),7.38(dd,2H,J=8.2 17.2Hz),7.16(d,2H,J=7.2Hz),7.05(s,1H),6.86(d,1H,J=5.4Hz),6.79(d,1H,J=7.2Hz),6.71(d,1H,J=7.2Hz),6.64(d,1H,J=5.4Hz),6.40(d,1H,J=16.0Hz),5.52(s,2H),5.41(s,2H),5.20(s,1H),4.00-3.87(m,3H),3.77(dd,1H,J=7.812.6Hz),2.65(s,3H),2.29(m,1H),2.15(m,1H)。
实施例135:
Figure BDA0001313456810000751
探针135:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=9.41(s,1H),8.38(s,1H),8.17(t,1H,J=12.6Hz),8.10(s,1H),7.92(s,1H),7.88(m,1H),7.59(d,2H,J=8.8H),7.38(dd,2H,J=8.2 17.2Hz),7.05(s,1H),6.56(d,2H,J=8.8H),6.48(s,2H),5.41(s,2H),5.20(s,1H),4.00-3.87(m,3H),3.77(dd,1H,J=7.8 12.6Hz),2.29(m,1H),2.15(m,1H)。
实施例136:
Figure BDA0001313456810000752
探针136:
参照探针1的合成方法,产率92%。1H-NMR(400MHz,DMSO-d6):δ=9.41(s,1H),8.38(s,1H),8.17(t,1H,J=12.6Hz),8.10(s,1H),7.92(s,1H),7.88(m,1H),7.59(d,2H,J=8.8H),7.38(dd,2H,J=8.2 17.2Hz),7.05(s,1H),6.56(d,2H,J=8.8H),6.48(s,2H),5.41(s,2H),5.20(s,1H),4.00-3.87(m,3H),3.77(dd,1H,J=7.8 12.6Hz),3.61(s,12H),2.29(m,1H),2.15(m,1H)。
实施例137:
Figure BDA0001313456810000753
探针137:
参照探针1的合成方法,产率92%。1H-NMR(400MHz,DMSO-d6):δ=9.41(s,1H),8.38(s,1H),8.17(t,1H,J=12.6Hz),7.88(m,1H),7.38(dd,2H,J=8.2 17.2Hz),8.01(d,1H,J=16.0Hz),7.10(s,2H),7.05(s,1H),6.56(s,2H),6.40(d,1H,J=16.0Hz),5.41(s,2H),5.20(s,1H),4.00-3.87(m,3H),3.77(dd,1H,J=7.8 12.6Hz),3.77(t,4H,J=8.0Hz),3.19(s,6H),2.90(t,4H,J=8.0Hz),2.29(m,1H),2.15(m,1H)。
实施例138:
Figure BDA0001313456810000761
探针138:
参照探针1的合成方法,产率96%。1H-NMR(400MHz,DMSO-d6):δ=9.41(s,1H),8.38(s,1H),8.17(t,1H,J=12.6Hz),8.10(s,1H),7.92(s,1H),7.88(m,1H),7.38(dd,2H,J=8.2 17.2Hz),7.59(d,2H,J=8.8H),7.05(s,1H),6.56(d,2H,J=8.8H),6.48(s,2H),5.41(s,2H),5.20(s,1H),4.00-3.87(m,3H),3.77(dd,1H,J=7.8 12.6Hz),2.29(m,1H),2.15(m,1H)。
实施例139:
Figure BDA0001313456810000762
探针139:
参照探针1的合成方法,产率90%。1H-NMR(400MHz,DMSO-d6):δ=9.41(s,1H),8.38(s,1H),8.17(t,1H,J=12.6Hz),8.01(d,1H,J=16.0Hz),7.88(m,1H),7.72(dd,2H,J=2.79.2Hz),7.38(dd,2H,J=8.2 17.2Hz),7.05(s,1H),6.98(dd,2H,J=2.7 9.2Hz),6.72(d,2H,J=7.2Hz),6.64(d,1H,J=16.0Hz),5.41(s,2H),5.20(s,1H),4.00-3.87(m,3H),3.77(dd,1H,J=7.8 12.6Hz),3.37(s,12H),2.29(m,1H),2.15(m,1H),0.54(s,6H)。
实施例140:
Figure BDA0001313456810000763
探针140:
参照探针1的合成方法,产率86%。1H-NMR(400MHz,DMSO-d6):δ=9.41(s,1H),8.38(s,1H),8.17(t,1H,J=12.6Hz),8.01(d,1H,J=16.0Hz),7.88(m,1H),7.78(d,2H,J=1.2Hz),7.38(dd,2H,J=8.2 17.2Hz),7.10(s,2H),7.05(s,1H),6.54(d,1H,J=16.0Hz),5.41(s,2H),5.20(s,1H),4.00-3.87(m,3H),3.82(dd,1H,J=7.8 12.6Hz),3.77(t,4H,J=8.0Hz),3.19(s,6H),2.90(t,4H,J=8.0Hz),2.29(m,1H),2.15(m,1H),0.54(s,6H)。
实施例141:
Figure BDA0001313456810000771
探针141:
参照探针1的合成方法,产率86%。1H-NMR(400MHz,DMSO-d6):δ=8.31(s,1H),7.78(d,1H,J=16.0Hz),7.65(d,2H,J=8.4Hz),7.51(d,1H,J=7.2Hz),7.35(t,2H,J=8.0Hz),7.15(m,3H),7.06(d,2H,J=8.0Hz),6.71(d,1H,J=7.2Hz),6.49(d,1H,J=16.0Hz),6.52(s,1H),6.44(s,1H),4.90(m,1H),4.25(m,1H),3.44(m,1H),3.41(t,4H,J=8.2Hz),2.86(t,1H,J=10.8Hz),2.32(m,2H),1.98(m,1H),1.70(m,1H),1.21(d,6H,J=8.2Hz)。
实施例142:
Figure BDA0001313456810000772
探针142:
参照探针1的合成方法,产率88%。1H-NMR(400MHz,DMSO-d6):δ=8.31(s,1H),7.76(d,1H,J=16.0Hz),7.65(d,2H,J=8.4Hz),7.46(d,1H,J=9.2Hz),7.35(t,2H,J=8.0Hz),7.15(m,3H),7.06(d,2H,J=8.0Hz),6.84(s,1H),6.70(d,1H,J=16.0Hz),5.99(d,1H,J=9.2Hz),4.90(m,1H),4.25(m,1H),3.44(m,1H),3.26(m,4H),2.88(t,2H,J=6.5Hz),2.86(t,1H,J=10.8Hz),2.75(t,2H,J=6.5Hz),2.32(m,2H),1.98(m,1H),1.90(m,4H),1.70(m,1H)。
实施例143:
Figure BDA0001313456810000773
探针143:
参照探针1的合成方法,产率88%。1H-NMR(400MHz,DMSO-d6):δ=11.85(s,1H),8.31(s,1H),7.82(d,1H,J=16.0Hz),7.65(d,2H,J=8.4Hz),7.47(dd,1H,J=2.0,11.4Hz),7.35(t,2H,J=8.0Hz),7.15(m,3H),7.06(d,2H,J=8.0Hz),6.47(d,1H,J=16.0Hz),6.30(s,1H),4.90(m,1H),4.25(m,1H),3.44(m,1H),2.86(t,1H,J=10.8Hz),2.32(m,2H),1.98(m,1H),1.70(m,1H)。
实施例144:
Figure BDA0001313456810000781
探针144:
参照探针1的合成方法,产率88%。1H-NMR(400MHz,CDCl3):δ=8.31(s,1H),7.83(d,1H,J=16.0Hz),7.65(d,2H,J=8.4Hz),7.51(d,2H,J=4.2Hz),7.35(t,2H,J=8.0Hz),7.15(m,3H),7.06(d,2H,J=8.0Hz),6.48(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),4.90(m,1H),4.25(m,1H),3.44(m,1H),2.86(t,1H,J=10.8Hz),2.65(s,6H),2.32(m,2H),1.98(m,1H),1.70(m,1H)。
实施例145:
Figure BDA0001313456810000782
探针145:
参照探针1的合成方法,产率84%。1H-NMR(400MHz,CDCl3):δ=8.31(s,1H),8.19(d,2H,J=7.8Hz),7.87(d,2H,J=16.4Hz),7.83(d,1H,J=16.0Hz),7.78(d,2H,J=16.4Hz),7.73(d,4H,J=7.6Hz),7.65(d,2H,J=8.4Hz),7.52(d,4H,J=7.6Hz),7.39(d,2H,J=4.4Hz),7.35(t,2H,J=8.0Hz),7.15(m,3H),7.06(d,2H,J=8.0Hz),7.04(d,2H,J=4.4Hz),6.51(d,1H,J=16.0Hz),4.90(m,1H),4.25(m,1H),3.70(s,2H),3.44(m,1H),2.86(t,1H,J=10.8Hz),2.32(m,2H),2.23(s,3H),1.98(m,1H),1.70(m,1H)。
实施例146:
Figure BDA0001313456810000783
探针146:
参照探针1的合成方法,产率84%。1H-NMR(400MHz,CDCl3):δ=8.31(s,1H),8.01(d,1H,J=16.0Hz),7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.65(d,2H,J=8.4Hz),7.44-7.47(m,6H),7.35(t,2H,J=8.0Hz),7.15(m,3H),7.06(d,2H,J=8.0Hz),6.83(d,2H,J=4.4Hz),6.48(d,1H,J=16.0Hz),4.90(m,1H),4.25(m,1H),3.44(m,1H),2.86(t,1H,J=10.8Hz),2.32(m,2H),1.98(m,1H),1.70(m,1H)。
实施例147:
Figure BDA0001313456810000791
探针147:
参照探针1的合成方法,产率84%。1H-NMR(400MHz,CDCl3):δ=8.31(s,1H),7.81(d,1H,J=16.0Hz),7.65(d,2H,J=8.4Hz),7.35(t,2H,J=8.0Hz),7.15(m,3H),7.06(d,2H,J=8.0Hz),6.99(d,2H,J=8.8Hz),6.97(d,4H,J=8.8Hz),6.89(d,2H,J=4.4Hz),6.72(d,1H,J=16.0Hz),6.62(d,2H,J=4.4Hz),4.90(m,1H),4.25(m,1H),3.86(s,6H),3.44(m,1H),2.86(t,1H,J=10.8Hz),2.32(m,2H),1.98(m,1H),1.70(m,1H)。
实施例148:
Figure BDA0001313456810000792
探针148:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,CDCl3):δ=8.31(s,1H),7.81(d,1H,J=16.0Hz),7.76(dd,2H,J=1.0 3.6Hz),7.65(d,2H,J=8.4Hz),7.51(dd,2H,J=3.6 5.4Hz),7.35(t,2H,J=8.0Hz),7.21(m,3H),7.15(dd,2H,J=3.6 5.4Hz),7.06(d,2H,J=8.0Hz),6.89(d,2H,J=4.4Hz),6.62(d,2H,J=4.4Hz),6.64(d,1H,J=16.0Hz),4.90(m,1H),4.25(m,1H),3.44(m,1H),2.86(t,1H,J=10.8Hz),2.32(m,2H),1.98(m,1H),1.70(m,1H)。
实施例149:
Figure BDA0001313456810000793
探针149:
参照探针1的合成方法,产率93%。1H-NMR(400MHz,DMSO-d6):δ=8.31(s,1H),8.10(s,1H),7.92(s,1H),7.65(d,2H,J=8.4Hz),7.59(d,2H,J=8.8H),7.35(t,2H,J=8.0Hz),7.15(m,3H),7.06(d,2H,J=8.0Hz),6.56(d,2H,J=8.8H),6.48(s,2H),4.90(m,1H),4.25(m,1H),3.44(m,1H),2.86(t,1H,J=10.8Hz),2.32(m,2H),1.98(m,1H),1.70(m,1H)。
实施例150:
Figure BDA0001313456810000801
探针150:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.31(s,1H),8.10(s,1H),7.92(s,1H),7.65(d,2H,J=8.4Hz),7.59(d,2H,J=8.8H),7.35(t,2H,J=8.0Hz),7.15(m,3H),7.06(d,2H,J=8.0Hz),6.56(d,2H,J=8.8H),6.48(s,2H),4.90(m,1H),4.25(m,1H),,3.61(s,12H)3.44(m,1H),2.86(t,1H,J=10.8Hz),2.32(m,2H),1.98(m,1H),1.70(m,1H)。
实施例151:
Figure BDA0001313456810000802
探针151:
参照探针1的合成方法,产率86%。1H-NMR(400MHz,DMSO-d6):δ=8.31(s,1H),8.01(d,1H,J=16.0Hz),7.65(d,2H,J=8.4Hz),7.35(t,2H,J=8.0Hz),7.15(m,3H),7.10(s,2H),7.06(d,2H,J=8.0Hz),6.56(s,2H),6.40(d,1H,J=16.0Hz),4.90(m,1H),4.25(m,1H),3.77(t,4H,J=8.0Hz),3.44(m,1H),3.19(s,6H),2.90(t,4H,J=8.0Hz),2.86(t,1H,J=10.8Hz),2.32(m,2H),1.98(m,1H),1.70(m,1H)。
实施例152:
Figure BDA0001313456810000803
探针152:
参照探针1的合成方法,产率87%。1H-NMR(400MHz,DMSO-d6):δ=8.31(s,1H),
8.10(s,1H),7.92(s,1H),7.65(d,2H,J=8.4Hz),7.59(d,2H,J=8.8H),7.35(t,2H,J=8.0Hz),7.15(m,3H),7.06(d,2H,J=8.0Hz),6.56(d,2H,J=8.8H),6.48(s,2H),4.90(m,1H),4.25(m,1H),3.44(m,1H),2.86(t,1H,J=10.8Hz),2.32(m,2H),1.98(m,1H),1.70(m,1H)。
实施例153:
Figure BDA0001313456810000811
探针153:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.31(s,1H),8.01(d,1H,J=16.0Hz),7.72(dd,2H,J=2.7 9.2Hz),7.65(d,2H,J=8.4Hz),7.35(t,2H,J=8.0Hz),7.15(m,3H),7.06(d,2H,J=8.0Hz),6.98(dd,2H,J=2.7 9.2Hz),6.72(d,2H,J=7.2Hz),6.64(d,1H,J=16.0Hz),4.90(m,1H),4.25(m,1H),3.44(m,1H),3.37(s,12H),2.86(t,1H,J=10.8Hz),2.32(m,2H),1.98(m,1H),1.70(m,1H),0.54(s,6H)。
实施例154:
Figure BDA0001313456810000812
探针154:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=8.31(s,1H),8.01(d,1H,J=16.0Hz),7.78(d,2H,J=1.2Hz),7.65(d,2H,J=8.4Hz),7.35(t,2H,J=8.0Hz),7.15(m,3H),7.10(s,2H),7.06(d,2H,J=8.0Hz),6.54(d,1H,J=16.0Hz),4.90(m,1H),4.25(m,1H),3.77(t,4H,J=8.0Hz),3.44(m,1H),3.19(s,6H),2.90(t,4H,J=8.0Hz),2.86(t,1H,J=10.8Hz),2.32(m,2H),1.98(m,1H),1.70(m,1H),0.54(s,6H)。
实施例155:
Figure BDA0001313456810000813
探针155:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,DMSO-d6):δ=8.31(s,1H),8.26(d,2H,J=14.4H)8.01(d,1H,J=9.2H),7.68(d,1H,J=9.2H),7.65(d,2H,J=8.4Hz),7.49(t,2H,J=8.0H),7.46(d,2H,J=7.6Hz),7.38(t,2H,J=7.6H),7.35(t,2H,J=8.0Hz),7.33(d,2H,J=8.4Hz),7.22(bp,2H),7.15(m,3H),7.06(d,2H,J=8.0Hz),4.90(m,1H),4.51(q,4H,J=7.2Hz),4.25(m,1H),3.92(s,3H),3.44(m,1H),2.86(t,1H,J=10.8Hz),2.32(m,2H),1.98(m,1H),1.86(s,6H),1.70(m,1H),1.56(t,6H,J=7.2H)。
实施例156:
Figure BDA0001313456810000821
探针156:
化合物144(按照文献公开方法合成:T.H.Zhang.et al.Chemmistry andBiology.2012,19,140—154..)参照探针1的合成方法,产率90%。1H-NMR(400MHz,DMSO-d6):δ=10.53(s,1H),10.20(s,1H),9.94(b,1H),9.75(s,1H),9.35(s,1H),8.75(d,1H,J=4.8Hz),8.59(d,1H,J=4.8Hz),8.56(dt,1H,J=4.8 7.8Hz),8.17(s,1H),7.89(d,1H,J=9.0Hz),7.78(d,1H,J=16.0Hz),7.77(d,2H,J=9.0Hz),7.69(d,2H,J=9.0Hz),7.65(m,2H),7.51(d,1H,J=7.2Hz),7.49(m,2H),6.76(m,1H),6.71(d,1H,J=7.2Hz),6.52(s,1H),6.49(d,1H,J=16.0Hz),6.48(d,1H,J=15.6Hz),6.44(s,1H),3.96(d,2H,J=6.0Hz),3.41(t,4H,J=8.2Hz),2.79(s,6H),1.21(d,6H,J=8.2Hz)。
实施例157:
Figure BDA0001313456810000822
探针157:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,DMSO-d6):δ=10.53(s,1H),10.20(s,1H),9.94(b,1H),9.75(s,1H),9.35(s,1H),8.75(d,1H,J=4.8Hz),8.59(d,1H,J=4.8Hz),8.56(dt,1H,J=4.8 7.8Hz),8.17(s,1H),7.89(d,1H,J=9.0Hz),7.77(d,2H,J=9.0Hz),7.76(d,1H,J=16.0Hz),7.69(d,2H,J=9.0Hz),7.65(m,2H),7.49(m,2H),7.46(d,1H,J=9.2Hz),6.84(s,1H),6.76(m,1H),6.70(d,1H,J=16.0Hz),6.48(d,1H,J=15.6Hz),5.99(d,1H,J=9.2Hz),3.96(d,2H,J=6.0Hz),3.26(m,4H),2.88(t,2H,J=6.5Hz),2.79(s,6H),2.75(t,2H,J=6.5Hz),1.96(m,4H)。
实施例158:
Figure BDA0001313456810000823
探针158:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=11.81(s,1H),10.53(s,1H),10.20(s,1H),9.94(b,1H),9.75(s,1H),9.35(s,1H),8.75(d,1H,J=4.8Hz),8.59(d,1H,J=4.8Hz),8.56(dt,1H,J=4.8 7.8Hz),8.17(s,1H),7.89(d,1H,J=9.0Hz),7.82(d,1H,J=16.0Hz),7.77(d,2H,J=9.0Hz),7.69(d,2H,J=9.0Hz),7.65(m,2H),7.49(m,2H),7.47(dd,1H,J=2.0,11.4Hz),6.76(m,1H),6.48(d,1H,J=15.6Hz),6.47(d,1H,J=16.0Hz),6.30(s,1H),3.96(d,2H,J=6.0Hz),2.79(s,6H)。
实施例159:
Figure BDA0001313456810000831
探针159:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,CDCl3):δ=10.53(s,1H),10.20(s,1H),9.94(b,1H),9.75(s,1H),9.35(s,1H),8.75(d,1H,J=4.8Hz),8.59(d,1H,J=4.8Hz),8.56(dt,1H,J=4.8 7.8Hz),8.17(s,1H),7.89(d,1H,J=9.0Hz),7.83(d,1H,J=16.0Hz),7.77(d,2H,J=9.0Hz),7.69(d,2H,J=9.0Hz),7.65(m,2H),7.51(d,2H,J=4.2Hz),7.49(m,2H),6.76(m,1H),6.52(d,1H,J=16.0Hz),6.48(d,1H,J=15.6Hz),6.40(d,2H,J=4.2Hz),3.96(d,2H,J=6.0Hz),2.79(s,6H),2.65(s,6H)。
实施例160:
Figure BDA0001313456810000832
探针160:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,CDCl3):δ=10.53(s,1H),10.20(s,1H),9.94(b,1H),9.75(s,1H),9.35(s,1H),8.75(d,1H,J=4.8Hz),8.59(d,1H,J=4.8Hz),8.56(dt,1H,J=4.8 7.8Hz),8.17(s,1H),7.89(d,1H,J=9.0Hz),7.83(d,1H,J=16.0Hz),7.77(d,2H,J=9.0Hz),7.69(d,2H,J=9.0Hz),7.65(m,2H),7.56(d,2H,J=2.4Hz),7.51(d,2H,J=4.2Hz),7.49(m,2H),7.26-7.32(m,4H,J=16.4Hz),7.06(s,1H),6.76(m,1H),6.52(d,1H,J=16.0Hz),6.48(d,1H,J=15.6Hz),6.40(d,2H,J=4.2Hz),3.96(d,2H,J=6.0Hz),2.79(s,6H),2.23(s,3H)。
实施例161:
Figure BDA0001313456810000833
探针161:
参照探针1的合成方法,产率93%。1H-NMR(400MHz,CDCl3):δ=10.53(s,1H),10.20(s,1H),9.94(b,1H),9.75(s,1H),9.35(s,1H),8.75(d,1H,J=4.8Hz),8.59(d,1H,J=4.8Hz),8.56(dt,1H,J=4.8 7.8Hz),8.30(d,1H,J=16.4Hz),8.17(s,1H),7.89(d,1H,J=9.0Hz),7.81(d,1H,J=16.0Hz),7.77(d,2H,J=9.0Hz),7.69(d,2H,J=9.0Hz),7.65(m,2H),7.55(d,2H,J=4.2Hz),7.51(d,1H,J=16.4Hz),7.49(m,2H),7.40(d,1H,J=4.8),7.29(d,1H,J=4.8Hz),7.09(d,1H,J=4.4Hz),6.76(m,1H),6.49(d,1H,J=16.0Hz),6.48(d,1H,J=15.6Hz),6.40(d,2H,J=4.2Hz),3.96(d,2H,J=6.0Hz),3.75(s,2H),2.79(s,6H),2.60(s,3H)。
实施例162:
Figure BDA0001313456810000841
探针162:
参照探针1的合成方法,产率93%。1H-NMR(400MHz,CDCl3):δ=10.53(s,1H),10.20(s,1H),9.94(b,1H),9.75(s,1H),9.35(s,1H),8.75(d,1H,J=4.8Hz),8.59(d,1H,J=4.8Hz),8.56(dt,1H,J=4.8 7.8Hz),8.17(s,1H),8.01(d,1H,J=16.0Hz),7.89(d,1H,J=9.0Hz),7.79-7.82(m,4H),7.77(d,2H,J=9.0Hz),7.72(d,2H,J=4.4Hz),7.69(d,2H,J=9.0Hz),7.65(m,2H),7.49(m,2H),7.44-7.47(m,6H),6.83(d,2H,J=4.4Hz),6.76(m,1H),6.58(d,1H,J=16.0Hz)6.48(d,1H,J=15.6Hz),3.96(d,2H,J=6.0Hz),2.79(s,6H)。
实施例163:
Figure BDA0001313456810000842
探针163:
参照探针1的合成方法,产率90%。1H-NMR(400MHz,CDCl3):δ=10.53(s,1H),10.20(s,1H),9.94(b,1H),9.75(s,1H),9.35(s,1H),8.75(d,1H,J=4.8Hz),8.59(d,1H,J=4.8Hz),8.56(dt,1H,J=4.8 7.8Hz),8.17(s,1H),7.89(d,1H,J=9.0Hz),7.81(d,1H,J=16.0 Hz),7.77(d,2H,J=9.0Hz),7.69(d,2H,J=9.0Hz),7.65(m,2H),7.49(m,2H),6.99(d,2H,J=8.8Hz),6.97(d,4H,J=8.8Hz),6.89(d,2H,J=4.4Hz),6.76(m,1H),6.72(d,1H,J=16.0Hz),6.62(d,2H,J=4.4Hz),6.48(d,1H,J=15.6Hz),3.96(d,2H,J=6.0Hz),3.86(s,6H),2.79(s,6H)。
实施例164:
Figure BDA0001313456810000851
探针164:
参照探针1的合成方法,产率90%。1H-NMR(400MHz,CDCl3):δ=10.53(s,1H),10.20(s,1H),9.94(b,1H),9.75(s,1H),9.35(s,1H),8.75(d,1H,J=4.8Hz),8.59(d,1H,J=4.8Hz),8.56(dt,1H,J=4.8 7.8Hz),8.17(s,1H),7.89(d,1H,J=9.0Hz),7.81(d,1H,J=16.0Hz),7.77(d,2H,J=9.0Hz),7.76(dd,2H,J=1.0 3.6Hz),7.69(d,2H,J=9.0Hz),7.65(m,2H),7.51(dd,2H,J=3.6 5.4Hz),7.49(m,2H),7.15(dd,2H,J=3.6 5.4Hz),6.89(d,2H,J=4.4Hz),6.76(m,1H),6.62(d,2H,J=4.4Hz),6.64(d,1H,J=16.0Hz),6.48(d,1H,J=15.6Hz),3.96(d,2H,J=6.0Hz),2.79(s,6H)。
实施例165:
Figure BDA0001313456810000852
探针165:
参照探针1的合成方法,产率90%。1H-NMR(400MHz,DMSO-d6):δ=10.53(s,1H),10.20(s,1H),9.94(b,1H),9.75(s,1H),9.35(s,1H),8.75(d,1H,J=4.8Hz),8.59(d,1H,J=4.8Hz),8.56(dt,1H,J=4.8 7.8Hz),8.17(s,1H),8.10(s,1H),7.92(s,1H),7.89(d,1H,J=9.0Hz),7.77(d,2H,J=9.0Hz),7.69(d,2H,J=9.0Hz),7.65(m,2H),7.59(d,2H,J=8.8H),7.49(m,2H),6.76(m,1H),6.56(d,2H,J=8.8H),6.48(d,1H,J=15.6Hz),6.40(s,2H),3.96(d,2H,J=6.0Hz),2.79(s,6H)。
实施例166:
Figure BDA0001313456810000853
探针166:
参照探针1的合成方法,产率86%。1H-NMR(400MHz,DMSO-d6):δ=10.53(s,1H),10.20(s,1H),9.94(b,1H),9.75(s,1H),9.35(s,1H),8.75(d,1H,J=4.8Hz),8.59(d,1H,J=4.8Hz),8.56(dt,1H,J=4.8 7.8Hz),8.17(s,1H),8.10(s,1H),7.92(s,1H),7.89(d,1H,J=9.0Hz),7.77(d,2H,J=9.0Hz),7.69(d,2H,J=9.0Hz),7.65(m,2H),7.59(d,2H,J=8.8H),7.49(m,2H),6.76(m,1H),6.56(d,2H,J=8.8H),6.51(s,2H),6.48(d,1H,J=15.6Hz),3.96(d,2H,J=6.0Hz),,3.61(s,12H)2.79(s,6H)。
实施例167:
Figure BDA0001313456810000861
探针167:
参照探针1的合成方法,产率88%。1H-NMR(400MHz,DMSO-d6):δ=10.53(s,1H),10.20(s,1H),9.94(b,1H),9.75(s,1H),9.35(s,1H),8.75(d,1H,J=4.8Hz),8.59(d,1H,J=4.8Hz),8.56(dt,1H,J=4.8 7.8Hz),8.17(s,1H),8.10(s,1H),7.92(s,1H),7.89(d,1H,J=9.0Hz),7.77(d,2H,J=9.0Hz),7.69(d,2H,J=9.0Hz),7.65(m,2H),7.59(d,2H,J=8.8H),7.49(m,2H),6.76(m,1H),6.56(d,2H,J=8.8H),6.52(d,1H,J=15.6Hz),6.48(s,2H),3.96(d,2H,J=6.0Hz),2.79(s,6H)。
实施例168:
Figure BDA0001313456810000862
探针168:
参照探针1的合成方法,产率88%。1H-NMR(400MHz,DMSO-d6):δ=10.53(s,1H),10.20(s,1H),9.94(b,1H),9.75(s,1H),9.35(s,1H),8.75(d,1H,J=4.8Hz),8.59(d,1H,J=4.8Hz),8.56(dt,1H,J=4.8 7.8Hz),8.17(s,1H),7.94(d,1H,J=15.3Hz),7.89(d,1H,J=9.0Hz),7.77(d,2H,J=9.0Hz),7.69(d,2H,J=9.0Hz),7.65(m,2H),7.49(m,2H),7.33(d,2H,J=9.3Hz),7.03(d,2H,J=9.3Hz),6.90(d,1H,J=15.2Hz),6.76(m,1H),6.63(d,1H,J=9.3Hz),6.48(d,1H,J=15.6Hz),3.96(d,2H,J=6.0Hz),3.77(t,2H,J=8.0Hz),3.19(s,9H),2.90(t,2H,J=8.0Hz),2.79(s,6H)。
实施例169:
Figure BDA0001313456810000863
探针169:
参照探针1的合成方法,产率88%。1H-NMR(400MHz,DMSO-d6):δ=10.53(s,1H),10.20(s,1H),9.94(b,1H),9.75(s,1H),9.35(s,1H),8.75(d,1H,J=4.8Hz),8.59(d,1H,J=4.8Hz),8.56(dt,1H,J=4.8 7.8Hz),8.17(s,1H),8.01(d,1H,J=16.0Hz),7.89(d,1H,J=9.0Hz),7.77(d,2H,J=9.0Hz),7.72(dd,2H,J=2.7 9.2Hz),7.69(d,2H,J=9.0Hz),7.65(m,2H),7.49(m,2H),6.98(dd,2H,J=2.7 9.2Hz),6.72(d,2H,J=7.2Hz),6.76(m,1H),6.64(d,1H,J=16.0Hz),6.48(d,1H,J=15.6Hz),3.96(d,2H,J=6.0Hz),3.37(s,12H),2.79(s,6H),0.54(s,6H)。
实施例170:
Figure BDA0001313456810000871
探针170:
参照探针1的合成方法,产率88%。1H-NMR(400MHz,DMSO-d6):δ=10.53(s,1H),10.20(s,1H),9.94(b,1H),9.75(s,1H),9.35(s,1H),8.75(d,1H,J=4.8Hz),8.59(d,1H,J=4.8Hz),8.56(dt,1H,J=4.8 7.8Hz),8.17(s,1H),8.01(d,1H,J=16.0Hz),7.89(d,1H,J=9.0Hz),7.78(d,2H,J=1.2Hz),7.77(d,2H,J=9.0Hz),7.69(d,2H,J=9.0Hz),7.65(m,2H),7.49(m,2H),7.10(s,2H),6.76(m,1H),6.54(d,1H,J=16.0Hz),6.48(d,1H,J=15.6Hz),3.96(d,2H,J=6.0Hz),3.77(t,4H,J=8.0Hz),3.19(s,6H),2.90(t,4H,J=8.0Hz),2.79(s,6H),0.54(s,6H)。
实施例171:
Figure BDA0001313456810000872
探针171:
化合物145(按照文献公开方法合成:T.H.Zhang.et al.Chemmistry andBiology.2012,19,140—154..)参照探针1的合成方法,产率90%。1H-NMR(400MHz,DMSO-d6):δ=10.27(s,1H),9.87(s,1H),9.48(br,1H),8.95(t,1H,J=6.0Hz),8.83(br,1H),8.76(d,1H,J=7.8Hz),8.68(d,1H,J=5.4Hz),8.52(s,1H),8.03(d,2H,J=7.8Hz),7.78(d,1H,J=16.0Hz),7.69(m,1H),7.59(d,1H,J=5.4Hz),7.53(dt,1H,J=1.8 7.8Hz),7.51(d,1H,J=7.2Hz),7.47(d,1H,J=8.4Hz),7.35(m,2H),6.74(m,1H),6.71(d,1H,J=7.2Hz),6.49(d,1H,J=16.0Hz),6.52(s,1H),6.44(s,1H),6.40(d,1H,J=15.6Hz),4.52(d,2H,J=6.0Hz),3.94(d,2H,J=6.0Hz),3.41(t,4H,J=8.2Hz),2.84(s,6H),1.21(d,6H,J=8.2Hz)。
实施例172:
Figure BDA0001313456810000873
探针172:
参照探针1的合成方法,产率88%。1H-NMR(400MHz,DMSO-d6):δ=10.27(s,1H),9.87(s,1H),9.48(br,1H),8.95(t,1H,J=6.0Hz),8.83(br,1H),8.76(d,1H,J=7.8Hz),8.68(d,1H,J=5.4Hz),8.52(s,1H),8.03(d,2H,J=7.8Hz),7.76(d,1H,J=16.0Hz),7.69(m,1H),7.59(d,1H,J=5.4Hz),7.53(dt,1H,J=1.8 7.8Hz),7.47(d,1H,J=8.4Hz),7.46(d,1H,J=9.2Hz),7.35(m,2H),6.84(s,1H),6.74(m,1H),6.70(d,1H,J=16.0Hz),6.40(d,1H,J=15.6Hz),5.99(d,1H,J=9.2Hz),4.52(d,2H,J=6.0Hz),3.94(d,2H,J=6.0Hz),3.26(m,4H),2.88(t,2H,J=6.5Hz),2.84(s,6H),2.75(t,2H,J=6.5Hz),1.96(m,4H)。
实施例173:
Figure BDA0001313456810000881
探针173:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,DMSO-d6):δ=11.81(s,1H),10.27(s,1H),9.87(s,1H),9.48(br,1H),8.95(t,1H,J=6.0Hz),8.83(br,1H),8.76(d,1H,J=7.8Hz),8.68(d,1H,J=5.4Hz),8.52(s,1H),8.03(d,2H,J=7.8Hz),7.82(d,1H,J=16.0Hz),7.69(m,1H),7.59(d,1H,J=5.4Hz),7.53(dt,1H,J=1.8 7.8Hz),7.47(d,1H,J=8.4Hz),7.43(dd,1H,J=2.0,11.4Hz),7.35(m,2H),6.74(m,1H),6.47(d,1H,J=16.0Hz),6.40(d,1H,J=15.6Hz),6.30(s,1H),4.52(d,2H,J=6.0Hz),3.94(d,2H,J=6.0Hz),2.84(s,6H)。
实施例174:
Figure BDA0001313456810000882
探针174:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,CDCl3):δ=10.27(s,1H),9.87(s,1H),9.48(br,1H),8.95(t,1H,J=6.0Hz),8.83(br,1H),8.76(d,1H,J=7.8Hz),8.68(d,1H,J=5.4Hz),8.52(s,1H),8.03(d,2H,J=7.8Hz),7.83(d,1H,J=16.0Hz),7.69(m,1H),7.59(d,1H,J=5.4Hz),7.53(dt,1H,J=1.8 7.8Hz),7.51(d,2H,J=4.2Hz),7.47(d,1H,J=8.4Hz),7.35(m,2H),6.74(m,1H),6.48(d,1H,J=16.0Hz),6.45(d,1H,J=15.6Hz),6.40(d,2H,J=4.2Hz),4.52(d,2H,J=6.0Hz),3.94(d,2H,J=6.0Hz),2.84(s,6H),2.65(s,6H)。
实施例175:
Figure BDA0001313456810000891
探针175:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,CDCl3):δ=10.27(s,1H),9.87(s,1H),9.48(br,1H),8.95(t,1H,J=6.0Hz),8.83(br,1H),8.76(d,1H,J=7.8Hz),8.68(d,1H,J=5.4Hz),8.52(s,1H),8.30(d,1H,J=16.4Hz),8.03(d,2H,J=7.8Hz),7.81(d,1H,J=16.0Hz),7.69(m,1H),7.59(d,1H,J=5.4Hz),7.55(d,2H,J=4.2Hz),7.53(dt,1H,J=1.8 7.8Hz),7.51(d,1H,J=16.4Hz),7.47(d,1H,J=8.4Hz),7.40(d,1H,J=4.8),7.35(m,2H),7.29(d,1H,J=4.8Hz),7.09(d,1H,J=4.4Hz),6.74(m,1H),6.49(d,1H,J=16.0Hz),6.45(d,1H,J=15.6Hz),6.40(d,2H,J=4.2Hz),4.52(d,2H,J=6.0Hz),3.94(d,2H,J=6.0Hz),3.75(s,2H),2.84(s,6H),2.60(s,3H)。
实施例176:
Figure BDA0001313456810000892
探针176:
参照探针1的合成方法,产率91%。1H-NMR(400MHz,CDCl3):δ=10.27(s,1H),9.87(s,1H),9.48(br,1H),8.95(t,1H,J=6.0Hz),8.83(br,1H),8.76(d,1H,J=7.8Hz),8.68(d,1H,J=5.4Hz),8.52(s,1H),8.03(d,2H,J=7.8Hz),8.01(d,1H,J=16.0Hz),7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.69(m,1H),7.59(d,1H,J=5.4Hz),7.53(dt,1H,J=1.87.8Hz),7.50(d,1H,J=8.4Hz),7.44-7.47(m,6H),7.35(m,2H),6.83(d,2H,J=4.4Hz),6.74(m,1H),6.48(d,1H,J=16.0Hz),6.40(d,1H,J=15.6Hz),4.52(d,2H,J=6.0Hz),3.94(d,2H,J=6.0Hz),2.84(s,6H)。
实施例177:
Figure BDA0001313456810000893
探针177:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,CDCl3):δ=10.27(s,1H),9.87(s,1H),9.48(br,1H),8.95(t,1H,J=6.0Hz),8.83(br,1H),8.76(d,1H,J=7.8Hz),8.68(d,1H,J=5.4Hz),8.52(s,1H),8.03(d,2H,J=7.8Hz),6.99(d,2H,J=8.8Hz),6.97(d,4H,J=8.8Hz),6.89(d,2H,J=4.4Hz),7.81(d,1H,J=16.0Hz),7.69(m,1H),7.59(d,1H,J=5.4Hz),7.53(dt,1H,J=1.8 7.8Hz),7.47(d,1H,J=8.4Hz),7.35(m,2H),6.74(m,1H),6.72(d,1H,J=16.0Hz),6.62(d,2H,J=4.4Hz),6.40(d,1H,J=15.6Hz),4.52(d,2H,J=6.0Hz),3.94(d,2H,J=6.0Hz),3.86(s,6H),2.84(s,6H)。
实施例178:
Figure BDA0001313456810000901
探针178:
参照探针1的合成方法,产率92%。1H-NMR(400MHz,CDCl3):δ=10.27(s,1H),9.87(s,1H),9.48(br,1H),8.95(t,1H,J=6.0Hz),8.83(br,1H),8.76(d,1H,J=7.8Hz),8.68(d,1H,J=5.4Hz),8.52(s,1H),8.03(d,2H,J=7.8Hz),7.81(d,1H,J=16.0Hz),7.76(dd,2H,J=1.0 3.6Hz),7.69(m,1H),7.59(d,1H,J=5.4Hz),7.53(dt,1H,J=1.8 7.8Hz),7.51(dd,2H,J=3.6 5.4Hz),7.47(d,1H,J=8.4Hz),7.35(m,2H),7.15(dd,2H,J=3.6 5.4Hz),6.89(d,2H,J=4.4Hz),6.74(m,1H),6.64(d,1H,J=16.0Hz),6.62(d,2H,J=4.4Hz),6.40(d,1H,J=15.6Hz),4.52(d,2H,J=6.0Hz),3.94(d,2H,J=6.0Hz),2.84(s,6H)。
实施例179:
Figure BDA0001313456810000902
探针179:
参照探针1的合成方法,产率92%。1H-NMR(400MHz,DMSO-d6):δ=10.27(s,1H),9.87(s,1H),9.48(br,1H),8.95(t,1H,J=6.0Hz),8.83(br,1H),8.76(d,1H,J=7.8Hz),8.68(d,1H,J=5.4Hz),8.52(s,1H),8.10(s,1H),8.03(d,2H,J=7.8Hz),7.92(s,1H),7.69(m,1H),7.63(d,1H,J=5.4Hz),7.59(d,2H,J=8.8H),7.53(dt,1H,J=1.8 7.8Hz),7.47(d,1H,J=8.4Hz),7.35(m,2H),6.74(m,1H),6.56(d,2H,J=8.8H),6.48(s,2H),6.40(d,1H,J=15.6Hz),4.52(d,2H,J=6.0Hz),3.94(d,2H,J=6.0Hz),2.84(s,6H)。
实施例180:
Figure BDA0001313456810000911
探针180:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=10.27(s,1H),9.87(s,1H),9.48(br,1H),8.95(t,1H,J=6.0Hz),8.83(br,1H),8.76(d,1H,J=7.8Hz),8.68(d,1H,J=5.4Hz),8.52(s,1H),8.10(s,1H),8.03(d,2H,J=7.8Hz),7.92(s,1H),7.69(m,1H),7.63(d,1H,J=5.4Hz),7.59(d,2H,J=8.8H),7.53(dt,1H,J=1.8 7.8Hz),7.47(d,1H,J=8.4Hz),7.35(m,2H),6.74(m,1H),6.56(d,2H,J=8.8H),6.48(s,2H),6.40(d,1H,J=15.6Hz),4.52(d,2H,J=6.0Hz),3.94(d,2H,J=6.0Hz),3.61(s,12H),2.84(s,6H)。
实施例181:
Figure BDA0001313456810000912
探针181:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=10.27(s,1H),9.87(s,1H),9.48(br,1H),8.95(t,1H,J=6.0Hz),8.83(br,1H),8.76(d,1H,J=7.8Hz),8.68(d,1H,J=5.4Hz),8.52(s,1H),8.01(d,1H,J=16.0Hz),8.03(d,2H,J=7.8Hz),7.69(m,1H),7.59(d,1H,J=5.4Hz),7.53(dt,1H,J=1.8 7.8Hz),7.47(d,1H,J=8.4Hz),7.35(m,2H),7.10(s,2H),6.74(m,1H),6.45(d,1H,J=16.0Hz),6.40(d,1H,J=15.6Hz),4.52(d,2H,J=6.0Hz),3.94(d,2H,J=6.0Hz),3.32(bs,8H),2.84(s,6H),2.35(bs,8H),1.73(bs,8H)。
实施例182:
Figure BDA0001313456810000913
探针182:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=10.27(s,1H),9.87(s,1H),9.48(br,1H),8.95(t,1H,J=6.0Hz),8.83(br,1H),8.76(d,1H,J=7.8Hz),8.68(d,1H,J=5.4Hz),8.52(s,1H),8.10(s,1H),8.03(d,2H,J=7.8Hz),7.92(s,1H),7.69(m,1H),7.63(d,1H,J=5.4Hz),7.59(d,2H,J=8.8H),7.53(dt,1H,J=1.8 7.8Hz),7.47(d,1H,J=8.4Hz),7.35(m,2H),6.74(m,1H),6.56(d,2H,J=8.8H),6.48(s,2H),6.40(d,1H,J=15.6Hz),4.52(d,2H,J=6.0Hz),3.94(d,2H,J=6.0Hz),2.84(s,6H)。
实施例183:
Figure BDA0001313456810000921
探针183:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=10.27(s,1H),9.87(s,1H),9.48(br,1H),8.95(t,1H,J=6.0Hz),8.83(br,1H),8.76(d,1H,J=7.8Hz),8.68(d,1H,J=5.4Hz),8.52(s,1H),8.01(d,1H,J=16.0Hz),8.03(d,2H,J=7.8Hz),7.72(dd,2H,J=2.7 9.2Hz),7.69(m,1H),7.59(d,1H,J=5.4Hz),7.53(dt,1H,J=1.8 7.8Hz),7.47(d,1H,J=8.4Hz),7.35(m,2H),6.98(dd,2H,J=2.7 9.2Hz),6.74(m,1H),6.72(d,2H,J=7.2Hz),6.64(d,1H,J=16.0Hz),6.40(d,1H,J=15.6Hz),4.52(d,2H,J=6.0Hz),3.94(d,2H,J=6.0Hz),3.37(s,12H),2.84(s,6H),0.54(s,6H)。
实施例184:
Figure BDA0001313456810000922
探针184:
化合物5(0.575g,2.0mmol)于50ml圆底烧瓶中,加入2,4-二甲氧基苯胺(0.306g,2.0mmol)、2-醛基噻吩(0.246g,2.2mmol)、乙异腈(0.091g,2.2ml),加入20ml甲醇,Ar保护条件下室温搅拌48h,反应完毕,体系过滤,旋转蒸干溶剂,残余物溶于50ml二氯甲烷,分别用饱和食盐水和水洗涤两次,有机相用无水硫酸钠干燥,旋转蒸干有机相,残余物经柱色谱分离得产物0.357g,产率31%。1H-NMR(400MHz,DMSO-d6):δ=7.85(t,1H,J=5.0Hz),7.78(d,1H,J=16.0Hz),7.51(d,1H,J=7.2Hz),7.18(d,1H,J=5.0Hz),7.04(d,1H,J=3.2Hz),6.83(d,1H,J=5.0Hz),6.71(d,1H,J=7.2Hz),6.67(d,1H,J=8.8Hz),6.52(s,1H),6.49(d,1H,J=16.0Hz),6.44(s,1H),6.40(d,1H,J=2.8Hz),6.25(dd,1H,J=2.4 8.8Hz),4.15(s,3H),4.00(d,1H,J=5.0Hz),3.84(s,3H),3.75(s,3H),3.41(t,4H,J=8.2Hz),2.75(s,3H),1.21(d,6H,J=8.2Hz)。
实施例185:
Figure BDA0001313456810000923
探针185:
参照探针184的合成方法,产率34%。1H-NMR(400MHz,DMSO-d6):δ=7.85(t,1H,J=5.0Hz),7.76(d,1H,J=16.0Hz),7.46(d,1H,J=9.2Hz),7.18(d,1H,J=5.0Hz),7.04(d,1H,J=3.2Hz),6.84(s,1H),6.83(d,1H,J=5.0Hz),6.70(d,1H,J=16.0Hz),6.67(d,1H,J=8.8Hz),6.40(d,1H,J=2.8Hz),6.25(dd,1H,J=2.4 8.8Hz),5.99(d,1H,J=9.2Hz),4.15(s,3H),4.00(d,1H,J=5.0Hz),3.84(s,3H),3.75(s,3H),3.26(m,4H),2.88(t,2H,J=6.5Hz),2.75(t,2H,J=6.5Hz),2.65(s,3H),1.96(m,4H)。
实施例186:
Figure BDA0001313456810000931
探针186:
参照探针184的合成方法,产率34%。1H-NMR(400MHz,DMSO-d6):δ=11.81(s,1H),7.85(t,1H,J=5.0Hz),7.82(d,1H,J=16.0Hz),7.47(dd,1H,J=2.0,11.4Hz),7.18(d,1H,J=5.0Hz),7.04(d,1H,J=3.2Hz),6.83(d,1H,J=5.0Hz),6.67(d,1H,J=8.8Hz),6.47(d,1H,J=16.0Hz),6.40(d,1H,J=2.8Hz),6.30(s,1H),6.25(dd,1H,J=2.4 8.8Hz),4.15(s,3H),4.00(d,1H,J=5.0Hz),3.84(s,3H),3.75(s,3H),2.75(s,3H)。
实施例187:
Figure BDA0001313456810000932
探针187:
参照探针184的合成方法,产率29%。1H-NMR(400MHz,CDCl3):δ=7.85(t,1H,J=5.0Hz),7.83(d,1H,J=16.0Hz),7.51(d,2H,J=4.2Hz),7.18(d,1H,J=5.0Hz),7.04(d,1H,J=3.2Hz),6.83(d,1H,J=5.0Hz),6.67(d,1H,J=8.8Hz),6.48(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),6.35(d,1H,J=2.8Hz),6.25(dd,1H,J=2.4 8.8Hz),4.15(s,3H),4.00(d,1H,J=5.0Hz),3.84(s,3H),3.75(s,3H),2.65(s,6H),2.75(s,3H)。
实施例188:
Figure BDA0001313456810000933
探针188:
参照探针184的合成方法,产率32%。1H-NMR(400MHz,CDCl3):δ=8.30(d,1H,J=16.4Hz),7.85(t,1H,J=5.0Hz),7.81(d,1H,J=16.0Hz),7.55(d,2H,J=4.2Hz),7.51(d,1H,J=16.4Hz),7.40(d,1H,J=4.8),7.29(d,1H,J=4.8Hz),7.18(d,1H,J=5.0Hz),7.09(d,1H,J=4.4Hz),7.04(d,1H,J=3.2Hz),6.83(d,1H,J=5.0Hz),6.67(d,1H,J=8.8Hz),6.49(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),6.35(d,1H,J=2.8Hz),6.25(dd,1H,J=2.4 8.8Hz),4.15(s,3H),4.00(d,1H,J=5.0Hz),3.84(s,3H),3.75(s,2H),3.70(s,3H),2.75(s,3H),2.60(s,3H)。
实施例189:
Figure BDA0001313456810000941
探针189:
参照探针184的合成方法,产率30%。1H-NMR(400MHz,CDCl3):δ=8.01(d,1H,J=16.0Hz),7.85(t,1H,J=5.0Hz),7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.44-7.47(m,6H),7.18(d,1H,J=5.0Hz),7.04(d,1H,J=3.2Hz),6.90(d,2H,J=4.4Hz),6.83(d,1H,J=5.0Hz),6.67(d,1H,J=8.8Hz),6.48(d,1H,J=16.0Hz),6.40(d,1H,J=2.8Hz),6.25(dd,1H,J=2.4 8.8Hz),4.15(s,3H),4.00(d,1H,J=5.0Hz),3.84(s,3H),3.75(s,3H),2.75(s,3H)。
实施例190:
Figure BDA0001313456810000942
探针190:
参照探针184的合成方法,产率30%。1H-NMR(400MHz,CDCl3):δ=7.85(t,1H,J=5.0Hz),7.81(d,1H,J=16.0Hz),7.18(d,1H,J=5.0Hz),7.04(d,1H,J=3.2Hz),6.99(d,2H,J=8.8Hz),6.95(d,4H,J=8.8Hz),6.89(d,2H,J=4.4Hz),6.83(d,1H,J=5.0Hz),6.72(d,1H,J=16.0Hz),6.67(d,1H,J=8.8Hz),6.60(d,2H,J=4.4Hz),6.40(d,1H,J=2.8Hz),6.25(dd,1H,J=2.4 8.8Hz),4.15(s,3H),4.00(d,1H,J=5.0Hz),3.90(s,6H),3.84(s,3H),3.75(s,3H),2.75(s,3H)。
实施例191:
Figure BDA0001313456810000943
探针191:
参照探针184的合成方法,产率32%。1H-NMR(400MHz,CDCl3):δ=7.85(t,1H,J=5.0Hz),7.81(d,1H,J=16.0Hz),7.76(dd,2H,J=1.0 3.6Hz),7.51(dd,2H,J=3.65.4Hz),7.18(d,1H,J=5.0Hz),7.15(dd,2H,J=3.6 5.4Hz),7.04(d,1H,J=3.2Hz),6.89(d,2H,J=4.4Hz),6.83(d,1H,J=5.0Hz),6.67(d,1H,J=8.8Hz),6.64(d,1H,J=16.0Hz),6.62(d,2H,J=4.4Hz),6.40(d,1H,J=2.8Hz),6.25(dd,1H,J=2.4 8.8Hz),4.15(s,3H),4.00(d,1H,J=5.0Hz),3.84(s,3H),3.75(s,3H),2.75(s,3H)。
实施例192:
Figure BDA0001313456810000951
探针192:
参照探针184的合成方法,产率32%。1H-NMR(400MHz,DMSO-d6):δ=8.10(s,1H),7.92(s,1H),7.85(t,1H,J=5.0Hz),7.59(d,2H,J=8.8H),7.18(d,1H,J=5.0Hz),7.04(d,1H,J=3.2Hz),6.83(d,1H,J=5.0Hz),6.67(d,1H,J=8.8Hz),6.56(d,2H,J=8.8H),6.48(s,2H),6.40(d,1H,J=2.8Hz),6.25(dd,1H,J=2.4 8.8Hz),4.15(s,3H),4.00(d,1H,J=5.0Hz),3.84(s,3H),3.75(s,3H),2.75(s,3H)。
实施例193:
Figure BDA0001313456810000952
探针193:
参照探针184的合成方法,产率31%。1H-NMR(400MHz,DMSO-d6):δ=8.10(s,1H),7.92(s,1H),7.85(t,1H,J=5.0Hz),7.59(d,2H,J=8.8H),7.18(d,1H,J=5.0Hz),7.04(d,1H,J=3.2Hz),6.83(d,1H,J=5.0Hz),6.67(d,1H,J=8.8Hz),6.56(d,2H,J=8.8H),6.48(s,2H),6.40(d,1H,J=2.8Hz),6.25(dd,1H,J=2.4 8.8Hz),4.15(s,3H),4.00(d,1H,J=5.0Hz),3.84(s,3H),3.75(s,3H),3.61(s,12H),2.75(s,3H)。
实施例194:
Figure BDA0001313456810000953
探针194:
参照探针184的合成方法,产率30%。1H-NMR(400MHz,DMSO-d6):δ=8.10(s,1H),7.92(s,1H),7.85(t,1H,J=5.0Hz),7.59(d,2H,J=8.8H),7.18(d,1H,J=5.0Hz),7.04(d,1H,J=3.2Hz),6.83(d,1H,J=5.0Hz),6.67(d,1H,J=8.8Hz),6.56(d,2H,J=8.8H),6.48(s,2H),6.40(d,1H,J=2.8Hz),6.25(dd,1H,J=2.4 8.8Hz),4.15(s,3H),4.00(d,1H,J=5.0Hz),3.84(s,3H),3.75(s,3H),2.75(s,3H)。
实施例195:
Figure BDA0001313456810000954
探针195:
参照探针184的合成方法,产率29%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.72(dd,2H,J=2.7 9.2Hz),7.85(t,1H,J=5.0Hz),7.18(d,1H,J=5.0Hz),7.04(d,1H,J=3.2Hz),6.98(dd,2H,J=2.7 9.2Hz),6.83(d,1H,J=5.0Hz),6.72(d,2H,J=7.2Hz),6.67(d,1H,J=8.8Hz),6.64(d,1H,J=16.0Hz),6.40(d,1H,J=2.8Hz),6.25(dd,1H,J=2.4 8.8Hz),4.15(s,3H),4.00(d,1H,J=5.0Hz),3.84(s,3H),3.37(s,12H),3.75(s,3H),2.75(s,3H),0.54(s,6H)。
实施例196:
Figure BDA0001313456810000961
探针196:
参照探针184的合成方法,产率29%。1H-NMR(400MHz,DMSO-d6):δ=8.01(d,1H,J=16.0Hz),7.85(t,1H,J=5.0Hz),7.78(d,2H,J=1.2Hz),7.18(d,1H,J=5.0Hz),7.10(s,2H),7.04(d,1H,J=3.2Hz),6.83(d,1H,J=5.0Hz),6.67(d,1H,J=8.8Hz),6.54(d,1H,J=16.0Hz),6.40(d,1H,J=2.8Hz),6.25(dd,1H,J=2.4 8.8Hz),4.15(s,3H),4.00(d,1H,J=5.0Hz),3.84(s,3H),3.77(t,4H,J=8.0Hz),3.75(s,3H),3.19(s,6H),2.90(t,4H,J=8.0Hz),2.75(s,3H),0.54(s,6H)。
实施例197:
Figure BDA0001313456810000962
探针197:
锌粉(0.130g,2.0mmol)于100ml三口烧瓶中,加入50ml无水四氢呋喃,加入少量碘单质,Ar保护条件下室温搅拌30分钟,加入化合物146(参照文献公开方法合成,Anne-Marie.R.Dechert et al.Bioorg.Med.Chem.2010.18.6230-6237.)(0.504g,1.0mmol)40℃油浴加热2小时,体系冷却至室温,注入化合物4(0.245g,1.0mmol)的5ml的无水四氢呋喃溶液,室温搅拌过夜,次日,加入3N的盐酸,室温搅拌30分钟,反应完毕,过滤,旋转蒸干溶剂,残余物经反相柱分离得产物0.449g,产率69%。1H-NMR(400MHz,DMSO-d6):δ=7.78(d,1H,J=16.0Hz),7.51(d,1H,J=7.2Hz),7.28(m,10H),6.71(d,1H,J=7.2Hz),6.49(d,1H,J=16.0Hz),6.52(s,1H),6.44(s,1H),4.53(m,1H),4.38(m,1H),3.9(s,2H),3.41(t,4H,J=8.2Hz),3.07(dd,1H,J=6.8 13.8Hz),2.94(dd,1H,J=8.4 13.8Hz),2.86(t,2H,J=7.2Hz),1.87(m,1H),1.60(m,3H),1.36(m,2H),1.21(d,6H,J=8.2Hz)。
实施例198:
Figure BDA0001313456810000971
探针198:
按照探针197的合成方法,产率71%。1H-NMR(400MHz,DMSO-d6):δ=11.81(s,1H),7.82(d,1H,J=16.0Hz),7.47(dd,1H,J=2.0,11.4Hz),7.28(m,10H),6.47(d,1H,J=16.0Hz),6.30(s,1H),4.53(m,1H),4.38(m,1H),3.9(s,2H),3.07(dd,1H,J=6.8 13.8Hz),2.94(dd,1H,J=8.4 13.8Hz),2.86(t,2H,J=7.2Hz),1.87(m,1H),1.60(m,3H),1.36(m,2H)。
实施例199:
Figure BDA0001313456810000972
探针199:
按照探针197的合成方法,产率71%。1H-NMR(400MHz,CDCl3):δ=7.83(d,1H,J=16.0Hz),7.51(d,2H,J=4.2Hz),7.28(m,10H),6.48(d,1H,J=16.0Hz),6.40(d,2H,J=4.2Hz),4.53(m,1H),4.38(m,1H),3.9(s,2H),3.07(dd,1H,J=6.8 13.8Hz),2.94(dd,1H,J=8.4 13.8Hz),2.86(t,2H,J=7.2Hz),2.65(s,6H),1.87(m,1H),1.60(m,3H),1.36(m,2H)。
实施例200:
Figure BDA0001313456810000973
探针200:
化合物54(0.374g,1.0mmol)于100ml圆底烧瓶中,加入35ml无水二氯甲烷溶解,加入活性二氧化锰(0.348g,4.0mmol),Ar保护条件下室温搅拌,反应完毕,过滤,滤液直接旋干溶剂,无需分离,直接用于下一步。
锌粉(0.130g,2.0mmol)于100ml三口烧瓶中,加入50ml无水四氢呋喃,加入少量碘单质,Ar保护条件下室温搅拌30分钟,加入化合物146(参照文献公开方法合成,Anne-Marie.R.Dechert et al.Bioorg.Med.Chem.2010.18.6230-6237.)(0.504g,1.0mmol)40℃油浴加热2小时,体系冷却至室温,注入上步的化合物的5ml的无水四氢呋喃溶液,室温搅拌过夜,次日,加入3N的盐酸,室温搅拌30分钟,反应完毕,过滤,旋转蒸干溶剂,残余物经反相柱分离得产物0.475g,产率61%。1H-NMR(400MHz,CDCl3):δ=8.01(d,1H,J=16.0Hz),7.79-7.82(m,4H),7.72(d,2H,J=4.4Hz),7.44-7.47(m,6H),7.28(m,10H),6.83(d,2H,J=4.4Hz),6.48(d,1H,J=16.0Hz),4.53(m,1H),4.38(m,1H),3.9(s,2H),3.07(dd,1H,J=6.813.8Hz),2.94(dd,1H,J=8.4 13.8Hz),2.86(t,2H,J=7.2Hz),1.87(m,1H),1.60(m,3H),1.36(m,2H)。
实施例201:
Figure BDA0001313456810000981
探针201:
参照探针200的合成方法,产率59%。1H-NMR(400MHz,CDCl3):δ=7.81(d,1H,J=16.0Hz),7.28(m,10H),6.99(d,2H,J=8.8Hz),6.97(d,4H,J=8.8Hz),6.89(d,2H,J=4.4Hz),6.72(d,1H,J=16.0Hz),6.62(d,2H,J=4.4Hz),4.53(m,1H),4.38(m,1H),3.9(s,2H),3.86(s,6H),3.07(dd,1H,J=6.8 13.8Hz),2.94(dd,1H,J=8.4 13.8Hz),2.86(t,2H,J=7.2Hz),1.87(m,1H),1.60(m,3H),1.36(m,2H)。
实施例202:
Figure BDA0001313456810000982
探针202:
参照探针200的合成方法,产率57%。1H-NMR(400MHz,CDCl3):δ=7.81(d,1H,J=16.0Hz),7.76(dd,2H,J=1.0 3.6Hz),7.51(dd,2H,J=3.6 5.4Hz),7.28(m,10H),7.15(dd,2H,J=3.65.4Hz),6.89(d,2H,J=4.4Hz),6.62(d,2H,J=4.4Hz),6.64(d,1H,J=16.0Hz),4.53(m,1H),4.38(m,1H),3.9(s,2H),3.07(dd,1H,J=6.8 13.8Hz),2.94(dd,1H,J=8.4 13.8Hz),2.86(t,2H,J=7.2Hz),1.87(m,1H),1.60(m,3H),1.36(m,2H)。
实施例203:
Figure BDA0001313456810000983
探针203:
参照探针200的合成方法,产率57%。1H-NMR(400MHz,CDCl3):δ=7.83(d,1H,J=16.0Hz),7.28(m,10H),7.18(d,2H,J=4.2Hz),6.83(d,1H,J=16.0Hz),6.30(d,2H,J=4.2Hz),5.42(s,2H),4.53(m,1H),4.38(m,1H),4.01(s,2H),3.90(s,6H),3.07(dd,1H,J=6.8 13.8Hz),2.94(dd,1H,J=8.4 13.8Hz),2.86(t,2H,J=7.2Hz),1.87(m,1H),1.60(m,3H),1.36(m,2H)。
实施例204:
Figure BDA0001313456810000991
探针204:
参照探针200的合成方法,产率60%。1H-NMR(400MHz,DMSO-d6):δ=8.26(d,2H,J=14.4H)8.01(d,1H,J=9.2H),7.68(d,1H,J=9.2H),7.49(t,2H,J=8.0H),7.46(d,2H,J=7.6Hz),7.38(t,2H,J=7.6H),7.33(d,2H,J=8.4Hz),7.28(m,10H),7.22(bp,2H),4.59(m,1H),4.51(q,4H,J=7.2Hz),4.38(m,1H),3.92(s,3H),3.85(s,2H),3.07(dd,1H,J=6.813.8Hz),2.94(dd,1H,J=8.4 13.8Hz),2.86(t,2H,J=7.2Hz),1.87(m,1H),1.81(s,6H),1.60(m,3H),1.56(t,6H,J=7.2H),1.36(m,2H)。
实施例205:
Figure BDA0001313456810000992
探针205:
参照探针200的合成方法,产率60%。1H-NMR(400MHz,DMSO-d6):δ=12.1(s,1H),10.28(s,2H),10.25(s,1H),10.17(d,2H,J=4.4Hz),9.46(d,2H,J=4.4Hz),9.39(d,2H,J=4.4Hz),9.36(d,2H,J=4.4Hz),8.01(d,1H,J=8.8Hz),7.8(d,1H,J=8.8Hz),7.28(m,10H),4.53(m,1H),4.38(m,1H),3.9(s,2H),3.07(dd,1H,J=6.8 13.8Hz),2.94(dd,1H,J=8.4 13.8Hz),2.86(t,2H,J=7.2Hz),1.87(m,1H),1.60(m,3H),1.36(m,2H),-3.05(s,2H)。
实施例206:
Figure BDA0001313456810000993
化合物147:
参照文献公开方法(L,Zhao et al.Adv.Funct.Mater.2014,24,363—371.)1H-NMR(400MHz,CDCl3):δ=7.34(d,J=8.8Hz,1H),6.55(dd,J=8.8,2.8Hz,1H),6.46(d,J=2.0Hz,1H),5.93(s,1H),3.20(t,J=8.0Hz,4H),2.33(s,3H),1.56(m,4H),1.28(m,20H),0.88(m,6H)。
化合物148:
参照化合物4的合成方法,产率33%。1H-NMR(400MHz,CDCl3):δ=10.01(s,1H),7.34(d,J=8.8Hz,1H),6.55(dd,J=8.8,2.8Hz,1H),6.46(d,J=2.0Hz,1H),5.93(s,1H),3.20(t,J=8.0Hz,4H),1.56(m,4H),1.28(m,20H),0.88(m,6H)。
化合物149:
参照化合物2的合成方法,产率79%。1H-NMR(400MHz,CDCl3):δ=7.81(d,J=16.0Hz,1H),7.36(d,J=8.8Hz,1H),7.01(d,J=16.0Hz,1H),6.59(dd,J=8.8,2.8Hz,1H),6.42(d,J=2.0Hz,1H),5.91(s,1H),3.23(t,J=8.0Hz,4H),1.55(m,4H),1.28(m,20H),0.88(m,6H)。
探针206:
参照探针1的合成方法,产率89%。1H-NMR(400MHz,DMSO-d6):δ=7.81(d,J=16.0Hz,1H),7.36(d,J=8.8Hz,1H),7.28(s,1H),7.01(d,J=16.0Hz,1H),6.59(dd,J=8.8,2.8Hz,1H),6.64(s,2H),6.42(d,J=2.0Hz,1H),5.91(s,1H),4.12(t,J=5.4Hz,2H),3.87(s,6H),3.70(s,2H),3.30(t,J=6.0Hz,2H),3.23(t,J=8.0Hz,4H),2.08(m,2H),1.55(m,4H),1.28(m,20H),0.88(m,6H)。
实施例207:
Figure BDA0001313456810001001
化合物150:
参照文献公开方法(L,Y,Zhu.et al.J.AM.CHEM.SOC.2010,132,10645—10647.),1H-NMR(400MHz,DMSO-d6):δ=7.44(d,J=8.8Hz,1H),6.60(dd,J=8.8,2Hz,1H),6.47(s,1H),6.10(s,1H),5.64(s,1H),4.67(s,2H),4.16(s,2H),3.47(q,J=6.8Hz,2H),1.12(t,J=6.8Hz,3H)。
化合物151:
参照探针1的合成方法,产率77%。1H-NMR(400MHz,DMSO-d6):δ=7.45(d,J=8.8Hz,1H),6.61(dd,J=8.8,2Hz,1H),6.49(s,1H),6.10(s,1H),5.64(s,1H),4.69(s,2H),4.18(s,2H),3.68-3.55(m,56H),3.50(t,J=4.8Hz,2H),3.49(q,J=6.8Hz,2H),3.24(s,3H),2.87(t,J=4.8Hz,2H),1.12(t,J=6.8Hz,3H)。
化合物152:
参照化合物25的合成方法,产率45%。1H-NMR(400MHz,DMSO-d6):δ=7.98(d,J=16.0Hz,1H),7.45(d,J=8.8Hz,1H),6.98(d,J=16.0Hz,1H),6.61(dd,J=8.8,2Hz,1H),6.49(s,1H),6.10(s,1H),5.64(s,1H),4.18(s,2H),3.68-3.55(m,56H),3.50(t,J=4.8Hz,2H),3.49(q,J=6.8Hz,2H),3.24(s,3H),2.87(t,J=4.8Hz,2H),1.12(t,J=6.8Hz,3H)。
探针207:
参照探针1的合成方法,产率78%。1H-NMR(400MHz,DMSO-d6):δ=7.98(d,J=16.0Hz,1H),7.66(s,1H),7.28(s,1H),7.45(d,J=8.8Hz,1H),6.98(d,J=16.0Hz,1H),6.64(s,2H),6.61(dd,J=8.8,2Hz,1H),6.49(s,1H),6.10(s,1H),5.64(s,1H),4.18(s,2H),4.12(t,J=5.4Hz,2H),3.86(s,6H),3.70(s,2H),3.68-3.55(m,56H),3.50(t,J=4.8Hz,2H),3.49(q,J=6.8Hz,2H),3.30(t,J=6.0Hz,2H),3.24(s,3H),2.87(t,J=4.8Hz,2H),2.08(m,2H),1.12(t,J=6.8Hz,3H)。
实施例208:
Figure BDA0001313456810001002
化合物153:
参照文献公开的方法(H,Volker.et al.Angew.Chem,Int,Ed,2005,44,7887—7891.)1H-NMR(400MHz,DMSO-d6):δ=7.47(d,J=8.9Hz,1H),6.56(dd,J=9.0,2.4Hz,1H),6.45(d,J=2.4Hz,1H),6.14(s,1H),5.53(s,1H),4.68(s,2H),4.21(s,4H)。
化合物154:
参照探针1的合成方法,产率67%。1H-NMR(400MHz,DMSO-d6):δ=7.47(d,J=8.9Hz,1H),6.56(dd,J=9.0,2.4Hz,1H),6.45(d,J=2.4Hz,1H),6.14(s,1H),5.53(s,1H),4.68(s,2H),4.21(s,4H),3.56—3.61(m,48H),3.51(t,J=5.2Hz,4H),3.21(s,6H),2.87(t,J=5.2Hz,4H)。
化合物155:
参照化合物25的合成方法,产率76%。1H-NMR(400MHz,DMSO-d6):δ=8.11(d,J=16.0Hz,1H),7.49(d,J=8.9Hz,1H),7.89(d,J=16.0Hz,1H),6.61(dd,J=9.0,2.4Hz,1H),6.49(d,J=2.4Hz,1H),6.14(s,1H),5.53(s,1H),4.21(s,4H),3.56—3.61(m,48H),3.51(t,J=5.2Hz,4H),3.21(s,6H),2.87(t,J=5.2Hz,4H)。
探针208:
按照探针1的合成方法,产率91%。1H-NMR(400MHz,DMSO-d6):δ=8.11(d,J=16.0Hz,1H),7.49(d,J=8.9Hz,1H),7.28(s,1H),6.89(d,J=16.0Hz,1H),6.64(s,2H),6.61(dd,J=9.0,2.4Hz,1H),6.49(d,J=2.4Hz,1H),6.14(s,1H),5.53(s,1H),4.21(s,4H),4.12(t,J=5.4Hz,2H),3.86(s,6H),3.70(s,2H),3.56—3.61(m,48H),3.51(t,J=5.2Hz,4H),3.30(t,J=6.0Hz,2H),3.21(s,6H),2.87(t,J=5.2Hz,4H),2.08(m,2H)。
实施例209:
将探针加入含有巯基乙醇的PBS溶液中,配置为探针终浓度为2uM,巯基乙醇为10mM的混合溶液,将混合溶液至于37℃孵育72小时,相同条件下,未加巯基乙醇的探针溶液作为对比,同样置于37℃孵育72小时,使用荧光分光光度计检测样品荧光强度变化,结果如表1所示。
由表1中游离探针量子产率可知,通过乙烯基或乙烯基衍生物的引入,有效的淬灭了荧光团的荧光,使其自身本底荧光接近PBS缓冲液本底荧光水平,当与巯基乙醇加成后,由探针的量子产率可知,探针的荧光强度急剧增强,荧光激活倍数达几百倍到几千倍以上,并且亮度较高,说明本发明探针为加成激活型探针,具有很好的荧光开关的性质,而未加巯基乙醇的样品荧光没有变化,说明探针性质稳定。
综上可知:本发明探针性质稳定,具有良好的荧光分子开关的性质,并且结构灵活可控,波长方便可调。
实施例210:
将探针与对应的靶蛋白混合得混合样品,混合样品中的探针终浓度为2uM(其中,探针83-89加入2uM的氯化镍,探针90-110加入4uM的氯化镍,探针111-126加入2uM的氯化锌),靶蛋白终浓度为5Um,其中,探针1-56对应于eDHFR(L28C)(C.R.Jing,V.W.Cornish.ACSChem.Biol.2013,8,17104—1712.),探针57-84对应于人的碳酸酐酶(hCAⅡ)(YousukeTakaoka.et al.J.AM.CHEM.SOC.2006,128,3272—3280.),探针83-110对应于改性HIS-tag(Shohei Uchinomiya.et al.Chem.Commun.,2013,49,5022—5024.),探针111-126对应于D4-tag(Hiroshi Nonaka.et al.J.AM.CHEM.SOC.2007,129,15777—15779.),探针127-140对应于生长因子(Caterina.Carmi.et al.J.Med.Chem.2012,55,2251—2264.),探针141-155对应于蛋白BTK(Nora Liu.et al.Org.Biomol.Chem.,2015,13,5147—5157.),探针156-183对应于蛋白JNK(T.H.Zhang.et al.Chemistry and Biology.2012,19,140—154.)探针184-196对应于蛋白PDI(Shili.Xu.et al.PNAS.2012,109,16348—16353.),探针197-205对应于组蛋白酶(Leslie O.et al.ACS Chem.Biol.2015,10,1977—1988.),将混合样品至于37℃孵育2小时,使用荧光分光光度计检测样品荧光强度变化,结果如表1所示。
由表1中的游离探针量子产率可知:本发明的探针以及探针未与靶蛋白结合时荧光极低,自身本底荧光接近PBS缓冲液本底荧光水平,当探针与靶蛋白结合后,由结合靶蛋白量子产率可知,探针的荧光强度急剧增强,荧光激活倍数达几百倍到几千倍以上,并且亮度较高,说明本发明的探针可与靶蛋白结合,并且荧光激活倍数高,具有很好的荧光开关的性质。
表1探针发射强度检测结果
Figure BDA0001313456810001021
Figure BDA0001313456810001031
Figure BDA0001313456810001041
Figure BDA0001313456810001051
Figure BDA0001313456810001061
Figure BDA0001313456810001071
Figure BDA0001313456810001081
Figure BDA0001313456810001091
Figure BDA0001313456810001101
Figure BDA0001313456810001111
下述实施例中,探针83—探针89使用时首先加入一倍当量的氯化镍,探针90—探针110使用时首先加入2倍当量氯化镍,探针111—探针126使用时首先加入一倍当量的氯化锌。
实施例211:
Hela细胞为例检测探针在哺乳动物细胞中的标记效果。将表达了蛋白标签的Hela细胞、未表达蛋白标签的Hela-WT细胞(Hela原始细胞)种植于14mm玻璃底96孔细胞培养板中。细胞铺板10小时后,将探针2、探针11、探针58、探针85、探针93、探针115、探针135、探针142、探针159、探针176、探针189、探针200分别加入至表达了蛋白标签的Hela细胞和未表达蛋白标签的Hela-WT细胞的培养基中并稀释至5μM。细胞置于37℃二氧化碳培养箱孵育2小时,使用Leica TPS-8共聚焦显微镜成像检测标记细胞荧光变化,结果如图1中(1)~(12)所示。图1B组结果显示加入上述探针后2h内在Hela-WT细胞中未能检测到相应的荧光信号,说明探针荧光不受细胞内亲核试剂的影响;而图1A组中表达了蛋白标签的Hela细胞可以检测到强烈的荧光信号,荧光信号增强200~610倍不等。
以上实验说明探针可以实现特异性标记细胞内蛋白标签,并且实现荧光特异性点亮,同时,探针荧光不受细胞内亲核试剂影响。
实施例212:
通过SDS-PAGE确定探针与蛋白形成共价结合,并通过活体成像仪确认探针标记于蛋白上并激活荧光。将探针2、探针11、探针58、探针85、探针93、探针115、探针135、探针142、探针159、探针176、探针189、探针200分别加入对应的蛋白中配制为探针最终浓度为2uM,对应蛋白最终浓度5uM,样品置于37℃孵育2小时,酶标仪检测样品荧光被激活,收集个样品,加入等体积的2×SDS-PAGE Loading Buffer,煮沸裂解5min,冰浴2min,12000rpm离心10min,取上层清液,检测的样品进行SDS-PAGE鉴定,结果如图2中(1)~(12)所示。
从图2可以看到,以上探针荧光被激活,并且,与相应靶蛋白结合为共价结合。
实施例213:
将不同蛋白标签分别加入探针2、探针4、探针53、探针55、探针84、探针90、探针115、探针129、探针135的溶液中,各探针的浓度均为30uM,制得靶蛋白终浓度为0.1uM、0.5uM、0.7uM、1.2uM、4.5uM、8.1uM、13.1uM、14.8uM的混合样品溶液,将混合样品溶液置于37℃反应1小时,使用荧光分光光度计检测样品激发发射光谱变化,根据发射光谱强度绘制靶蛋白浓度与荧光强度关系图,结果分别如图3~图11所示。
从图3~~图11中可以看出,靶蛋白浓度在0.1uM~14.8uM的范围内与探针的荧光强度都具有较好的线性关系,因此,可以根据标准曲线对蛋白标签进行定量检测。
实施例214:
组织蛋白酶活性受多种因素的调节,因此,测定信使RNA和蛋白总量不能很好地反应蛋白的活性,为验证探针具有检测蛋白活性的功能,将0.1uM、0.5uM、0.75uM、1.5uM、4.5uM、7.5uM、10.0uM、12.5uM、15.0uM的探针197分别加入到50uM组织蛋白酶中,样品至于37℃孵育3小时,酶标仪检测样品荧光强度,根据样品荧光强度绘制荧光强度随探针浓度的关系图,结果如图12所示,荧光强度随探针的浓度增加呈线性变化,说明探针被蛋白全部激活,并在荧光强度范围内与荧光强度具有较好的线性关系。
将待测组织蛋白酶加入探针197,配置为探针197终浓度为30uM的样品溶液,将样品溶液至于37℃孵育3小时,酶标仪检测样品荧光强度,根据样品荧光强度和标准曲线得出活性蛋白浓度为3.75uM,经考马斯亮蓝法测定蛋白总浓度为5.0uM,从而得出该组蛋白酶中活性蛋白占蛋白总量的75%。
由以上实验可知,本发明探针可用于定量检测活性蛋白。
实施例215:
为验证探针2、探针27、探针48可以应用于标记不同细胞器定位的目标蛋白,以Hela细胞为例检测了探针标记不同亚细胞蛋白标签的效果。Hela细胞5000细胞每孔种植于96孔玻璃底细胞培养板中,14小时后使用lipo2000试剂盒转染eDHFR-L28C不同细胞器定位质粒;转染后24小时去除原有培养基,使用无酚红DMEM培养基清洗2次,使用含有0.2μM探针的无酚红培养基孵育细胞2小时,使用leica TCS-8共聚焦显微镜成像检测细胞标记效果。结果如图13显示,探针可以在免洗的情况下清晰展示多种亚细胞器结构,其中包括但不限于细胞核、溶酶体、线粒体、高尔基体、细胞骨架、内质网和细胞内膜。
以上结果说明的探针具有很好的特异性,可以作为细胞亚细胞器标记的有力工具。
实施例216:
人的B淋巴细胞为例检测探针在哺乳动物细胞中内源性蛋白的标记效果。人的B淋巴细胞内源性的表达Bruton酪氨酸激酶(BTK),将人的B淋巴细胞种植于于14mm玻璃底96孔细胞培养板中,细胞密度3000/孔,培养12小时。将细胞分为A、B两组,A组细胞加入探针143加入细胞的培养基中并分别稀释至1Μm,细胞置于37℃二氧化碳培养箱孵育30分钟,B组细胞在加入探针143前首先加入2uM依鲁替尼37℃二氧化碳培养箱孵育2小时,依鲁替尼是BTK的强效抑制剂,能够与BTK特异性结合,从而使BTK失去与探针143结合的能力,使用LeicaTPS-8共聚焦显微镜成像检测标记细胞荧光变化。图14A组结果显示加入上述探针14B组细胞中荧光信号微弱,说明探针荧光不受细胞内亲核试剂的影响;而图14A组中人的B淋巴细胞可以检测到强烈的荧光信号,荧光信号增强85倍。
以上实验说明探针可以实现特异性标记细胞内非过量表达的内源性蛋白,并且实现荧光特异性点亮,同时,探针荧光不受细胞内亲核试剂影响。
实施例217
首先,将表达eDHFR蛋白标签的质粒pcdna3.1-eDHFR-L28C(样品组)和对照质粒pcdna3.1-CAT导入小鼠体内。此方法是将质粒溶解在很大体积的溶液中通过尾静脉注射迅速注射入小鼠体内,小鼠肝脏和肾脏吸收DNA,进而表达目的蛋白。质粒注射后20小时,将溶于200ul PBS中的0.4μM探针27通过尾静脉注射方法注射到小鼠体内标记eDHFR靶蛋白;6小时后解剖小鼠,通过柯达多光谱活体成像系统检测不同小鼠样品肝脏部位荧光差异,结果如图15。图15A显示,注射探针27的对照质粒pcdna3.1-CAT的小鼠肝脏荧光很低,接近为未注射探针的空白肝脏的本底荧光水平,如图15C,而注射探针27的eDHFR质粒pcdna3.1-eDHFR-L28C的小鼠肝脏具有较强的荧光,如图15B,信号强度是对照组荧光的25倍。
以上实验说明探针的荧光不受动物内环境影响,可以应用于活体动物体内,且可以特异性标记表达在肝脏部位的eDHFR靶蛋白,并产生较强荧光信号。
实施例218:
为验证探针可以用于活体中蛋白标签的标记,以eDHFR-L28C为例,检测探针对斑马鱼表达蛋白的标记。将50ng/Ul eDHFR-L28C-mKate融合蛋白的表达质粒1nL注入斑马鱼的受精卵中(AB鱼动物极),28℃培养48小时,出鱼后直接由尾静脉注射5nL 0.5mM的探针21,30分钟后,使用leica TCS-8共聚焦显微镜成像检测标记效果。结果如图16显示:16(2)为mKate荧光通道,说明蛋白成功表达;16(1)组为探针荧光通道,16B为未注射探针,并且没有荧光信号,16A为注射探针,荧光信号明显,荧光强度是未注射探针的55倍,并且与mKate荧光信号具有较好的重叠。
以上实验说明探针的荧光不受动物环境的影响,可以应用于活体动物体内,且可以特异性标记表达在体内的靶蛋白,并产生较强的荧光信号。
实施例219:
为验证实施例探针可以用于活体中天然蛋白的标记,以Hela细胞为例,检测探针对其生长因子的标记。将Hela(Hela原始细胞)种于裸鼠腋下,生长3周,至肿瘤直径0.5cm左右,将20uM探针140溶于350ul 20%DMSO的PBS溶液中,通过尾静脉注射入小鼠体内标记肿瘤中生长因子(EGFR),通过柯达多光谱活体成像系统检测不同时间的小鼠肿瘤部位的荧光强度变化,结果如图17所示,未注射探针140前,小鼠肿瘤部位没有荧光,如图17A所示,注射0.3小时后,小鼠肿瘤部位荧光达到最大值,其他部位没有明显荧光信号,如图17B所示。
以上实验说明,探针不受动物体内环境的影响,可以用于活体动物体内快速标记,并且,无需对蛋白进行改造,可以直接用于标记活体内的天然蛋白。
实施例220:
通过定点突变技术,构建具有不同位点半胱氨酸eDHFR的突变体,验证结合口袋周围是否具有活性巯基,可以对探针进行加成并激活荧光性质,将探针共价结合于蛋白上,同时激活荧光。通过定点突变技术并结合蛋白晶体数据,分别获得eDHFR结合口袋周围的不同氨基酸突变类型:eDHFR-I50C、eDHFR-N18C、eDHFR-N23C、eDHFR-L28C(Z,X Chen.etal.J.Am.Chem.Soc.2012,134,13692-13699.)。未含巯基的野生型蛋白(WT)、纯化后的eDHFR各个突变体蛋白(eDHFR-I50C、eDHFR-N18C、eDHFR-N23C、eDHFR-L28C)分别同相同浓度的探针2混匀孵育后,利用酶标仪检测样品的荧光变化,如图18所示。
实验结果显示,未含巯基的野生型蛋白荧光很低,接近于探针的缓冲溶液(buffer)的荧光,含有巯基的突变体蛋白都能够激活探针的荧光,说明探针与蛋白结合并发生了加成反应,而未含巯基的蛋白样品不能激活探针的荧光。
实施例221:
6his-cys-MBP作为载体蛋白,将his-tag与半胱氨酸(cys)之间加入不同个数的氨基酸作为连接体,并将其融合表达在MBP的N端,得到带有不同连接体的重组蛋白,6his-cys-MBP命名为F0、cys-6his-MBP命名为F1、6his-aa-cys-MBP命名为F2、cys-1aa-6his-MBP命名为F3、6his-2aa-cys-MBP命名为F4、cys-2aa-6his-MBP命名为F5、6his-3aa-cys-MBP命名为R0、cys-3aa-6his-MBP命名为R2、6his-4aa-cys-MBP命名为R3、cys-4aa-6his-MBP命名为R4、6his-5aa-cys-MBP命名为R5、6his-MBP命名为6his,其中“Naa”表示将his-tag与半胱氨酸之间加入N个氨基酸。将探针90加入上述蛋白溶液中,制得最终探针浓度为2uM,蛋白浓度为5uM,37℃酶标仪进行荧光检测,结果如图19所示,具有巯基亲核试剂的突变体都可以和探针发生亲核加成反应而激活荧光,而不具有巯基的多肽(6his)不能够激活探针荧光。
实验结果显示,具有亲核基团的蛋白可以与探针发生特异性的结合,并且发生加成反应,从而激活探针荧光。

Claims (16)

1.一种荧光探针,其特征在于,其具有如式(I)所示的结构,所述荧光探针包括配体部分A、任选的连接体部分B、荧光染料部分C,所述荧光染料部分C为加成激活型荧光染料基团,包括荧光团D、任选的不饱和结构部分E、双键部分F;
A-B-C
(I)
其中:
配体部分A选自下式结构:
3
Figure FDA0003613538010000011
或4
Figure FDA0003613538010000012
连接体部分B为任选存在的基团,选自-CO-NH-(CH2)3-、或
Figure FDA0003613538010000013
荧光染料部分C为式(I)中的式(I-a)所示结构部分,
Figure FDA0003613538010000014
其中:
双键部分F为式(I-a)中的式(I-a-2)所示结构部分,
Figure FDA0003613538010000015
R1、R2均为氢;
不饱和结构部分E为不存在的基团;
荧光团D选自香豆素类基团、氟硼二吡咯甲川类基团、或呫吨类基团;
所述香豆素类基团的结构如式(II-I)所示:
Figure FDA0003613538010000016
其中,R6-为-OH或N(X1)(X2)-,X1、X2各自独立地选自氢、烷基;
所述香豆素类基团中下式(II-I-i)所示的母核结构中,所含的各氢原子任选独立地被卤原子取代;
Figure FDA0003613538010000021
式(II-I-i)上的取代基任选与X1或X2相互连接形成饱和或不饱和脂杂环;
所述氟硼二吡咯甲川类基团的结构如式(II-III)所示,其中,R7、R8为F;
Figure FDA0003613538010000022
其中,式(II-III)所示氟硼二吡咯甲川类基团中的下式(II-III-i)所示母核结构中,所含的各氢原子任选独立地被选自烷基和改性烷基的取代基取代;
Figure FDA0003613538010000023
所述呫吨类基团的结构如式(II-IV-a)、(II-IV-b)、(II-IV-c)、或(II-IV-d)所示,其中:X3、X4、X5、X6、X7各自独立地选自氢、烷基;X4与X5或X6与X7任选相互连接为饱和或不饱和的脂杂环;L为阴离子;X选自O、CRaRb、SiRaRb,其中Ra、Rb各自独立地选自氢或烷基;
Figure FDA0003613538010000024
其中,所述呫吨类基团中的下式(II-IV-i)所示母核结构中,所含的各氢原子任选独立地被选自卤原子、烷基的取代基取代;式(II-IV-i)上的取代基任选与X4、X5、X6、X7相互连接构成饱和或不饱和的脂杂环;
Figure FDA0003613538010000031
所述烷基为具有1~30个碳原子的饱和脂肪族直链或支链的烷基;
所述改性烷基为烷基的任意碳原子被选自卤原子、-O-、芳基、亚芳基中的至少一种基团置换所得的基团,所述改性烷基具有1~30个碳原子,其碳碳单键任选独立地被碳碳双键或碳碳叁键置换;
所述脂杂环为环上含有选自N杂原子的饱和或不饱和的3~10元单环或多环脂杂环;
所述芳基、或亚芳基为5~10元芳香单环或芳香稠合双环;
所述芳香杂环为环上含有选自N、O、或S中的至少一种杂原子的5~10元芳香单环或芳香稠合双环;
所述卤原子各自独立地选自F、Cl、Br、I;
所述阴离子选自:Cl-、I-、Br-
2.根据权利要求1所述的荧光探针,其特征在于:所述芳基为苯基。
3.根据权利要求1所述的荧光探针,其特征在于:所述亚芳基为亚苯基。
4.一种荧光探针,其特征在于,其具有如式(I)所示的结构,所述荧光探针包括配体部分A、任选的连接体部分B、荧光染料部分C,所述荧光染料部分C为加成激活型荧光染料基团,包括荧光团D、任选的不饱和结构部分E、双键部分F;
A-B-C
(I)
其中:
配体部分A选自下式结构:
3
Figure FDA0003613538010000032
或4
Figure FDA0003613538010000033
连接体部分B为任选存在的基团,选自-CO-NH-(CH2)3-、或
Figure FDA0003613538010000034
荧光染料部分C为式(I)中的式(I-a)所示结构部分,
Figure FDA0003613538010000035
其中:
双键部分F为式(I-a)中的式(I-a-2)所示结构部分,
Figure FDA0003613538010000041
R1、R2均为氢;
不饱和结构部分E为不存在的基团;
荧光团D为氟硼二吡咯甲川类基团;
所述氟硼二吡咯甲川类基团的结构如式(II-III)所示,其中,R7、R8为F;
Figure FDA0003613538010000042
其中,式(II-III)所示氟硼二吡咯甲川类基团中的下式(II-III-i)所示母核结构中,所含的各氢原子任选独立地被下式结构取代:
Figure FDA0003613538010000043
5.根据权利要求1所述的荧光探针,其特征在于:
所述式(II-I)选自下式(II-I-1)~(II-I-6)中的结构:
Figure FDA0003613538010000044
6.一种荧光探针,其特征在于,其具有如式(I)所示的结构,所述荧光探针包括配体部分A、任选的连接体部分B、荧光染料部分C,所述荧光染料部分C为加成激活型荧光染料基团,包括荧光团D、任选的不饱和结构部分E、双键部分F;
A-B-C
(I)
其中:
配体部分A选自下式结构:
3
Figure FDA0003613538010000051
或4
Figure FDA0003613538010000052
连接体部分B为任选存在的基团,选自-CO-NH-(CH2)3-、或
Figure FDA0003613538010000053
荧光染料部分C为式(I)中的式(I-a)所示结构部分,
Figure FDA0003613538010000054
其中:
双键部分F为式(I-a)中的式(I-a-2)所示结构部分,
Figure FDA0003613538010000055
R1、R2均为氢;
不饱和结构部分E为不存在的基团;
荧光团D选自下式(II-III-1)~(II-III-25)中的结构:
Figure FDA0003613538010000056
Figure FDA0003613538010000061
7.根据权利要求1所述的荧光探针,其特征在于:所述式(II-IV-a)、(II-IV-b)、(II-IV-c)或(II-IV-d)选自下式(II-IV-1)~(II-IV-41)中的结构:
Figure FDA0003613538010000062
Figure FDA0003613538010000071
8.一种荧光探针,其特征在于,所述荧光探针选自下式结构:
Figure FDA0003613538010000072
Figure FDA0003613538010000081
9.一种荧光激活型蛋白特异性标记方法,其特征在于,包括以下步骤:将权利要求1-8任一项所述的荧光探针与靶蛋白接触,所述荧光探针的配体部分与靶蛋白发生标记反应,将荧光探针标记到靶蛋白上,所述方法为非用于疾病的治疗或诊断的方法。
10.根据权利要求9所述的荧光激活型蛋白特异性标记方法,其特征在于,所述将荧光探针标记到靶蛋白上为共价标记。
11.根据权利要求9所述的荧光激活型蛋白特异性标记方法,其特征在于,所述标记反应的反应介质选自纯蛋白溶液、细胞裂解液或靶蛋白所处在的原位介质。
12.根据权利要求11所述的荧光激活型蛋白特异性标记方法,其特征在于,所述原位介质为细胞内介质、细胞器内介质、活体组织介质、血液或体液。
13.权利要求1-8任一项所述的荧光探针在蛋白荧光标记,蛋白的定量、检测、动力学、活性研究,以及细胞、组织、活体影像中的用途,所述用途为非用于疾病的治疗或诊断方法的用途。
14.根据权利要求13所述的用途,其特征在于,所述蛋白包括eDHFR-I50C、eDHFR-N18C、eDHFR-N23C、eDHFR-L28C、6his-cys、cys-6his、6his-aa-cys、cys-1aa-6his、6his-2aa-cys、cys-2aa-6hi、6his-3aa-cys、cys-3aa-6his、6his-4aa-cys、cys-4aa-6his、6his-5aa-cys。
15.一种探针试剂盒,其特征在于,包括权利要求1-8任一项所述的荧光探针和生物相容性介质。
16.根据权利要求15所述的探针,其特征在于,所述生物相容性介质选自二甲基亚砜、磷酸盐缓冲液、生理盐水中的至少一种。
CN201710415036.XA 2017-06-05 2017-06-05 一种荧光探针及其制备方法和用途 Active CN108976160B (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201710415036.XA CN108976160B (zh) 2017-06-05 2017-06-05 一种荧光探针及其制备方法和用途
PCT/CN2018/088987 WO2018223876A1 (zh) 2017-06-05 2018-05-30 一种荧光探针及其制备方法和用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710415036.XA CN108976160B (zh) 2017-06-05 2017-06-05 一种荧光探针及其制备方法和用途

Publications (2)

Publication Number Publication Date
CN108976160A CN108976160A (zh) 2018-12-11
CN108976160B true CN108976160B (zh) 2022-07-08

Family

ID=64502262

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710415036.XA Active CN108976160B (zh) 2017-06-05 2017-06-05 一种荧光探针及其制备方法和用途

Country Status (2)

Country Link
CN (1) CN108976160B (zh)
WO (1) WO2018223876A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109734925B (zh) * 2019-01-19 2021-02-02 湖南科技大学 一种基于卟啉的可比率检测次氯酸根的聚合物荧光传感器、制备方法及应用
CN110330444B (zh) * 2019-06-29 2021-05-14 华南理工大学 一种用于异氰酸酯类物质检测的荧光化合物及制备方法与其作为试纸型检测探针的应用
CN112794857B (zh) * 2019-11-13 2023-09-19 湖南超亟检测技术有限责任公司 一种可用于亚铁离子检测的荧光探针及制备和应用
CN113501790A (zh) * 2020-03-23 2021-10-15 纳莹(上海)生物科技有限公司 一种荧光染料及其制备方法和用途
CN112574246B (zh) * 2020-12-14 2021-09-07 山西大学 Zn2+比率荧光探针、制备及应用
CN112876392B (zh) * 2021-02-05 2022-09-13 新乡医学院 一种基于异硫氰酸酯结构特异性检测半胱氨酸的近红外荧光探针及其制备方法和应用
CN113087692B (zh) * 2021-04-02 2022-05-17 广西师范大学 一种同时双色双靶向型荧光探针及其制备方法和应用
CN114890958B (zh) * 2022-02-23 2023-10-20 四川警察学院 双光子染料化合物、其制备方法及其应用
EP4321517A1 (en) * 2022-08-12 2024-02-14 Samsung Electronics Co., Ltd. Compound, near-infrared absorbing and/or blocking film, photoelectric device, organic sensor, and electronic device including same
CN115417846B (zh) * 2022-09-21 2023-05-26 安徽科技学院 一种基于香豆素的双态高荧光材料及其合成方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103952143A (zh) * 2014-03-04 2014-07-30 中国科学院武汉物理与数学研究所 一种用于蛋白质标记的三甲川菁类荧光探针及合成方法
CN104745177A (zh) * 2015-04-07 2015-07-01 华东理工大学 一种具有蛋白标签定位的光激活荧光探针及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7282373B2 (en) * 2004-12-23 2007-10-16 Rutgers, The State University Of New Jersey Ultra-high specificity fluorescent labeling
WO2008145609A1 (en) * 2007-05-25 2008-12-04 Novartis Ag Method of making covalent conjugates with his-tagged proteins
CN103952142A (zh) * 2014-03-04 2014-07-30 中国科学院武汉物理与数学研究所 一种用于蛋白质标记的水溶性近红外荧光探针及合成方法
US10557852B2 (en) * 2014-04-29 2020-02-11 Yeda Research And Development Co. Ltd. Fluorescent molecular sensor for targeting changes in protein surfaces, and methods of use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103952143A (zh) * 2014-03-04 2014-07-30 中国科学院武汉物理与数学研究所 一种用于蛋白质标记的三甲川菁类荧光探针及合成方法
CN104745177A (zh) * 2015-04-07 2015-07-01 华东理工大学 一种具有蛋白标签定位的光激活荧光探针及其制备方法和应用

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
A Rapid and Fluorogenic TMP-AcBOPDIPY Probe for Covalent Labeling of Proteins in Live Cells;Wei Liu等;《J. Am. Chem. Soc.》;20140305;第136卷;4468-4471 *
Second-Generation Covalent TMP-Tag for Live Cell Imaging;Zhixing Chen等;《J. Am. Chem. Soc.》;20120809;第134卷;13692-13699 *
Ultrafast tissue staining with chemical tags;Johannes Kohl等;《PNAS》;20140825;E3805-E3814 *

Also Published As

Publication number Publication date
WO2018223876A1 (zh) 2018-12-13
CN108976160A (zh) 2018-12-11

Similar Documents

Publication Publication Date Title
CN108976160B (zh) 一种荧光探针及其制备方法和用途
CN109574880B (zh) 一种荧光探针及其制备方法和用途
CN107641121B (zh) 一种荧光探针及其制备方法和用途
Poronik et al. Rhodols–synthesis, photophysical properties and applications as fluorescent probes
Niu et al. Highly photostable two-photon NIR AIEgens with tunable organelle specificity and deep tissue penetration
Wu et al. Exploiting the twisted intramolecular charge transfer effect to construct a wash-free solvatochromic fluorescent lipid droplet probe for fatty liver disease diagnosis
Fang et al. Fluorescent probes for sensitive and selective detection of pH changes in live cells in visible and near-infrared channels
Zhou et al. FRET-based sensor for imaging chromium (III) in living cells
CN110498799B (zh) 一种荧光探针及其制备方法和用途
Zhang et al. A near-infrared ratiometric fluorescent probe for highly selective recognition and bioimaging of cysteine
Zhang et al. Near-infrared fluorescence of π-conjugation extended benzothiazole and its application for biothiol imaging in living cells
Bai et al. Construction of an NIR and lysosome-targeted quinoline-BODIPY photosensitizer and its application in photodynamic therapy for human gastric carcinoma cells
Zhang et al. Rational design of NIR fluorescence probes for sensitive detection of viscosity in living cells
Liu et al. A squaraine-based red emission off–on chemosensor for biothiols and its application in living cells imaging
Yang et al. A NIR facile, cell-compatible fluorescent sensor for glutathione based on Michael addition induced cascade spirolactam opening and its application in hepatocellular carcinoma
Zhu et al. A two-photon off-on fluorescence probe for imaging thiols in live cells and tissues
Ni et al. Convenient construction of fluorescent markers for lipid droplets with 1, 8-naphthalimide unit
Ma et al. A red mitochondria-targeted AIEgen for visualizing H 2 S in living cells and tumours
Singh et al. A pH‐Responsive Glycyrrhetinic‐Acid‐Modified Small‐Molecule Conjugate for NIR Imaging of Hepatocellular Carcinoma (HCC)
Varvuolytė et al. Synthesis and photodynamic properties of pyrazole-indole hybrids in the human skin melanoma cell line G361
Kurutos et al. Organelle-selective near-infrared fluorescent probes for intracellular microenvironment labeling
Zhou et al. Synthesis, biological evaluation and cellular localization study of fluorescent derivatives of Jiyuan Oridonin A
CN114456116B (zh) 一种以萘酰亚胺为骨架的小分子抗癌剂及其制备方法和应用
Zhao et al. A novel red-emission fluorescent probe for the detection of cysteine in vitro and in vivo
WO2021176428A1 (en) Phenanthroline, carbazole and flavylium based cyanines and compositions and methods of making and using the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20200408

Address after: Room 306-6, building 1, No. 116, zhongjinqiao Road, Chongming District, Shanghai (Chongming Forest Tourism Park) (Chengqiao Town, Chongming District)

Applicant after: Shanghai gaochi Asset Management Co.,Ltd.

Address before: 200237 East China University of Science and Technology, 130 Meilong Road, Shanghai, Xuhui District

Applicant before: EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY

TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20211015

Address after: 200231 room 412, 2A / F, phase I, 2715 Longwu Road, Xuhui District, Shanghai

Applicant after: Naying (Shanghai) Biotechnology Co.,Ltd.

Address before: Room 306-6, building 1, 116 zhongjinqiao Road, Chongming District, Shanghai (Chongming Forest Tourism Park) (Chengqiao Town, Chongming District)

Applicant before: Shanghai gaochi Asset Management Co.,Ltd.

GR01 Patent grant
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20181211

Assignee: Changzhou fuluosen Medical Technology Co.,Ltd.

Assignor: Naying (Shanghai) Biotechnology Co.,Ltd.

Contract record no.: X2024980002428

Denomination of invention: A fluorescent probe and its preparation method and application

Granted publication date: 20220708

License type: Exclusive License

Record date: 20240304